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Joseph Eugene Burchick Jr., PhD 
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The allenic Pauson-Khand reaction (APKR) has proven to be a powerful method for the 
construction of seven-membered rings. Despite this, only a few reports of this methodology being 
employed in total syntheses exist. Reported herein are synthetic studies targeted towards the 
elaboration of APKR adducts via the functionalization of the resulting enone motif. In addition, a 
rapid synthetic route towards the core 5,7,5-framework of biologically active 6,12-guaianolides 
was developed in an enantioselective fashion, utilizing the APKR as they key ring-forming step. 
The successful APKR adduct functionalization studies were combined with this novel synthetic 
route in an effort towards the first total synthesis of (–)-dehydroleucodine. 
v 
Table of Contents 
List of Tables .............................................................................................................................. viii 
List of Figures ............................................................................................................................... ix 
List of Schemes .............................................................................................................................. x 
List of Abbreviations .................................................................................................................. xv 
Preface ......................................................................................................................................... xvi 
1.0 Introduction ............................................................................................................................. 1 
1.1 Guaianolides and Strategies Towards the Rapid Construction of the 5,7-Ring 
System .................................................................................................................................... 1 
1.2 The Allenic Pauson-Khand Reaction ............................................................................ 4 
1.2.1 History and mechanistic details ......................................................................... 4 
1.2.2 Applications of the allenic Pauson-Khand reaction in total synthesis ........... 7 
1.3 Functional Group Interconversions of the APKR Adduct ......................................... 9 
2.0 Allylic Diazene Rearrangement and Base-Mediated Isomerization of APKR 
Adducts ........................................................................................................................................ 12 
2.1 Introduction .................................................................................................................. 12 
2.1.1 Proposed strategies for the reductive transposition of the C3-C5 enone ..... 13 
2.2 Synthesis of Model Bicyclo[5.3.0]decadienone 2.2 ..................................................... 16 
2.2.1 Synthesis of alkynyl ketone 2.7 ........................................................................ 16 
2.2.2 Synthesis of allene-yne 2.1 ................................................................................ 19 
2.2.3 Application and optimization of the APKR to allene-yne 2.1 ....................... 22 
2.3 1H NMR Studies of Tosylhydrazone Reduction with Catecholborane .................... 25 
vi 
2.4 ADR on C1-C10 Hydrogenated APKR Adduct ......................................................... 31 
2.5 ADR on Bicyclo[5.3.0]decadienone Tosylhydrazone Model System 2.6 .................. 40 
2.6 Conclusions for ADR Studies ...................................................................................... 45 
2.7 Base-Induced Transposition of α-Hydroxy Enone .................................................... 46 
2.7.1 Introduction and background .......................................................................... 46 
2.7.2 Synthesis of  α-hydroxy enone 2.53 .................................................................. 49 
2.7.3 Base-induced isomerization of α-hydroxy enone 2.53 .................................... 51 
2.8 Conclusions for the Base-Induced Enone Isomerization .......................................... 58 
3.0 Studies Towards the First Total Synthesis of (–)-Dehydroleucodine ............................... 60 
3.1 Introduction .................................................................................................................. 60 
3.2 Ring Closing Metathesis and Claisen Rearrangement of (R)-linalool ..................... 67 
3.3 Conversion of γ,δ-unsaturated Amide to γ,δ-unsaturated Ester.............................. 73 
3.4 Oxidative Cleavage ....................................................................................................... 74 
3.4.1 Ozonolysis .......................................................................................................... 74 
3.4.2 OsO4-Catalyzed oxidative cleavage ................................................................. 80 
3.5 Diastereoselective 1,2-Addition/Lactonization to 3.40 and 3.52 ............................... 84 
3.6 Conversion of Ketone 3.51 to Allenes ......................................................................... 93 
3.6.1 Formation of propargyl carbonate .................................................................. 93 
3.6.2 Synthesis of allenyl carboxyesters ................................................................... 95 
3.7 Allenic Pauson-Khand Reactions of 3.57a, 3.60a, and 3.60b .................................... 98 
3.7.1 APKR of 3,3-disubstituted allene 3.57a .......................................................... 98 
3.7.2 APKR of allenyl carboxyesters 3.60a and 3.60b .......................................... 100 
3.8 Hydrolysis of β-Keto Esters ....................................................................................... 102 
vii 
3.9 Base-Mediated Isomerization of α-Hydroxy Enone ................................................ 104 
3.10 Conclusions Towards the Total Synthesis of (–)-Dehydroleucodine (ent-3.1) .... 106 
Appendix A : Experimental Information for Chapter Two ................................................. 107 
Appendix B : Experimental Information for Chapter Three ............................................... 144 
Appendix C : NMR Spectra ..................................................................................................... 172 
Bibliography .............................................................................................................................. 266 
viii 
List of Tables 
Table 1.1. Reaxys search of 6,12- and 8,12-guaianolides. ............................................................. 2 
Table 2.1. Reaxys search for 6,12-guaianolide frameworks possessing discrete double bond at C4-
C5 position and C3-C4 position. ................................................................................................... 12 
Table 2.2. Optimization of allenic Pauson-Khand reaction of allene-yne 2.1. ............................. 24 
Table 2.3. Screening of catecholborane reduction conditions for ADR of tosylhydrazone 2.6. .. 28 
Table 2.4. Alternative reduction conditions and ADR of 2.36. .................................................... 35 
Table 2.5. Conditions for the ADR of bicyclo[5.3.0]decadienone tosylhydrazone 2.6. ............... 41 
Table 2.6. Reaxys search for 6,12-guaianolide frameworks possessing discrete double bond at C4-
C5 position and oxygen at C3 position,  and discrete double bond at C3-C4 position and oxygen 
at C2 position. ............................................................................................................................... 47 
Table 2.7. Conditions for the attempted base-induced isomerization of epoxide 2.61. ................ 58 
Table 3.1. Conditions to effect RCM and Johnson-Claisen rearrangement fo (R)-linalool (3.34).
....................................................................................................................................................... 70 
Table 3.2. Conditions for the diastereoselective 1,2-addition of propynylmagnesium bromide to β-
formyl amide 3.52. ........................................................................................................................ 90 
ix 
List of Figures 
Figure 1.1. Desired C3-C5 enone functionaliztion in the presence of C1-C10 alkene. ................ 11 
Figure 2.1. A) Reference spectrum, no catecholborane. B) 3 equiv HBcat after 1 h at 0 ⁰C. C) after 
1 h at rt. D) After addition of 3 equiv sodium acetate trihydrate and reacting at 60 ⁰C for 1 h. ... 28 
Figure 2.2. Structural confirmation of Wolff-Kishner reduction product 2.43. ........................... 43 
Figure 3.1. Determination of 3.40 enantiomeric ratio by reaction of chiral amine 3.49, and 1H NMR 
integration of imine 3.50 proton Ha. ............................................................................................. 78 
Figure 3.2. OsO4 and PhI(OAc)2-mediated oxidative cleavage of ester 3.36 with retention of C1 
stereochemistry. ............................................................................................................................ 81 
Figure 3.3. Chemical shift assignments for APKR C2 diastereomers. ....................................... 101 
x 
List of Schemes 
Scheme 1.1. Selected examples of the construction of the 5,7-ring system of guaianolides. ......... 3 
Scheme 1.2. Brummond's strategy towards the 5,7-ring system of guaianolides. .......................... 4 
Scheme 1.3. Co-mediated Pauson-Khand reaction. ........................................................................ 5 
Scheme 1.4. Rh- and Mo-catalyzed APKR and corresponding double bond selectivity of 
cyclopentenones. ............................................................................................................................. 6 
Scheme 1.5. Natural product total syntheses which employed an APKR as the key ring forming 
step. ................................................................................................................................................. 8 
Scheme 1.6. Precedent for the functional group interconversion of APKR adducts. ................... 10 
Scheme 2.1. Proposed reductive transposition of C3-C5 enone of APKR adduct 2.2 to C3-C4 
alkene 2.3. ..................................................................................................................................... 13 
Scheme 2.2. Potential strategies for the reductive transposition of bicyclo[5.3.0]decadienone 2.2.
....................................................................................................................................................... 14 
Scheme 2.3. Retrosynthetic analysis of bicyclo[5.3.0]decadienone 2.2. ...................................... 16 
Scheme 2.4. Initial synthetic route of alkynyl ketone 2.7. ............................................................ 17 
Scheme 2.5. Acetone homologation of alkynyl iodide 2.8 using tert-butyl acetoacetate. ............ 18 
Scheme 2.6. Attempted direct allenation of ketone 2.7 with alkenylidene titanocene. ................ 19 
Scheme 2.7. Optimization of 1,2-addition of ethynylmagnesium bromide to ketone 2.7 via 
transmetallation with CeCl3. ......................................................................................................... 20 
Scheme 2.8. Palladium-catalyzed hydrogenolysis of propargyl carbonate 2.16. ......................... 21 
Scheme 2.9. Palladium-catalyzed hydrogenolysis catalytic cycle and potential elimination of η1-
palladium....................................................................................................................................... 22 
 xi  
Scheme 2.10. Inverse addition of allene-yne 2.1 to Rh(I) solution. ............................................. 23 
Scheme 2.11. Attempted ADR of bicyclo[5.3.0]decadienone tosylhydrazone 2.6. ..................... 26 
Scheme 2.12. Synthesis and crystal structure of E-tosylhydrazone of bicyclo[5.3.0]decadienone 
2.2.................................................................................................................................................. 27 
Scheme 2.13. Precedent for ADRs performed on bicyclo[5.3.0]decenones. ................................ 30 
Scheme 2.14. Hydrogenation of C1-C10 double bond of 2.2. ...................................................... 32 
Scheme 2.15. Formation of tosylhydrazone 2.36 from C1-C10 hydrogenated APKR adduct 2.35.
....................................................................................................................................................... 33 
Scheme 2.16. HBcat reduction of C1-C10 hydrogenated tosylhydrazone 2.36 and ADR. .......... 34 
Scheme 2.17. (BzO)2BH reduction of tosylhydrazone 2.36 and ADR. ........................................ 38 
Scheme 2.18. Mechanism of the ADR of tosylhydrazone 2.6. ..................................................... 42 
Scheme 2.19. Proposed divergent retro-ene and radical decomposition pathways of diazene 
intermediate 2.45........................................................................................................................... 44 
Scheme 2.20. Previous precedent for base-induced isomerization of α-hydroxy enone motif. ... 48 
Scheme 2.21. Proposed conversion of α-hydroxy enone 2.53 to α-keto enol 2.54 and susequent 
deoxygenation to enone 2.55. ....................................................................................................... 48 
Scheme 2.22. A) Potential routes to hydroxy enone 2.53. B) Synthesis of allenyl esters 2.56a-b 
and Rh(I)-catalyzed APKR. .......................................................................................................... 49 
Scheme 2.23. Rh(II)-catalyzed formal 3,3-sigmatropic rearrangement of propargyl esters to allenyl 
carboxyesters 2.56......................................................................................................................... 50 
Scheme 2.24. Base induced isomerization of α-hydroxy enone 2.53 to α-keto enol 2.54 and 1H 
NMR structural confirmation. ....................................................................................................... 51 
 xii  
Scheme 2.25. Two-step, one-pot deprotection/isomerization of α-acyloxy enones 2.58a and 2.58b.
....................................................................................................................................................... 52 
Scheme 2.26. Two-step one-pot deprotection/isomerization of chloroacetate 2.58b and C3 
deoxygenation of α-keto enol 2.54. .............................................................................................. 54 
Scheme 2.27. A) Biologically active guaiane stelleraguaianone B (2.60). B) Proposed route to 
stelleraguaianone B analog 2.62. .................................................................................................. 54 
Scheme 2.28. mCPBA epoxidation of α-hydroxy ketone 2.53. .................................................... 55 
Scheme 2.29. Diastereoselective epoxidation of C1-C10 double bond of 2.53. .......................... 56 
Scheme 3.1. Retrosynthetic analysis of (+)-dehydroleucodine (3.1), employing an APKR as the 
key ring forming step, followed by isomerization. ....................................................................... 61 
Scheme 3.2. Proposed access to allenyl carboxyester 4 from β-formyl ester 3.6. ........................ 62 
Scheme 3.3. Potential retrosynthetic approaches for the enantioselective construction of β-formyl 
ester 3.6. ........................................................................................................................................ 63 
Scheme 3.4. Proposed Diels-Alder approach to β-formyl ester 3.6. ............................................ 63 
Scheme 3.5. A) Diphenylprolinol methyl ester-catylized 1,4-conjugate additions of aldehydes to 
enones. B) Imidazolidinone-catalyzed 1,4-conjugate addition of aldehydes to enones. .............. 64 
Scheme 3.6. Proposed route to γ,δ-unsaturated ester 3.12 via chiral cyclopentenol 3.25. ........... 65 
Scheme 3.7. Retrosynthetic analysis of β-formyl ester 3.6........................................................... 66 
Scheme 3.8. Reported synthetic route to (S)-linalool (3.24). ........................................................ 67 
Scheme 3.9. Reported RCM of (±)-linalool (3.29), and dehydration of cyclopentenol 3.30 in the 
presence of H-GII at elevated temperature. .................................................................................. 68 
Scheme 3.10. Attempted two-step-one-pot RCM/Johnson-Claisen rearrangement of (R)-linalool 
(3.34). ............................................................................................................................................ 69 
 xiii  
Scheme 3.11. Successful RCM/Eschenmoser-Claisen rearrangement of (R)-linalool (3.34) to 
generate γ,δ-unsaturated amide 3.37. ............................................................................................ 72 
Scheme 3.12. Tf2O-mediated esterification of amide 3.37 via imidate 3.38. ............................... 73 
Scheme 3.13. Proposed oxidative cleavage of γ,δ-unsaturated ester 3.36. ................................... 74 
Scheme 3.14. Ozonolysis of γ,δ-unsaturated ester 3.39 in CH2Cl2 mith Me2S as the terminal 
reductant. ....................................................................................................................................... 75 
Scheme 3.15. Mechanism of ozonolysis, leading to isolated secondary ozonide 3.45. ................ 76 
Scheme 3.16. Ozonolysis of γ,δ-unsaturated ester 3.36 in CH2Cl2/MeOH with Me2S as the terminal 
reductant. ....................................................................................................................................... 77 
Scheme 3.17. Ozonolysis of γ,δ-unsaturated ester 3.36 in CH2Cl2/MeOH with Me2S as the terminal 
reductant. ....................................................................................................................................... 79 
Scheme 3.18. Oxidative cleavage of γ,δ-unsaturated ester 3.36 and γ,δ-unsaturated amide 3.37, 
and use of the resuling β-formyl ester 3.40 and β-formyl amide 3.52 to generate lactone 3.51. . 82 
Scheme 3.19. Ozonolysis of γ,δ-unsaturated amide 3.37 in CH2Cl2 with PPh3 as the terminal 
reductant. ....................................................................................................................................... 82 
Scheme 3.20. Relative rates of racemization of β-formyl ester 3.40 and β-formyl amide 3.52 while 
standing in the freezer. .................................................................................................................. 83 
Scheme 3.21. OsO4 and PhI(OAc)2-mediated oxidative cleavage of β-formyl amide 3.37 with 
retention of C1 stereochemistry. ................................................................................................... 84 
Scheme 3.22. Proposed diastereoselective 1,2-addition/lactonization of β-formyl ester 3.40. .... 84 
Scheme 3.23. Precedent for the diastereoselective 1,2-addition/lactonization of β-formyl esters.
....................................................................................................................................................... 85 
 xiv  
Scheme 3.24. Reissig's proposed transition states leading to the diastereoselective 1,2-addition of 
nucleophiles to β-formyl esters. .................................................................................................... 86 
Scheme 3.25. Addition of ethynylmagnesium bromide to β-formyl ester 3.40. ........................... 87 
Scheme 3.26. Chlorotitaniumtriisopropoxide-mediated 1,2-addition of ethynylmagnesium 
bromide to β-formyl ester 3.40. .................................................................................................... 88 
Scheme 3.27. Titanium tetrachloride-mediated 1,2-addition of propynylmagnesium bromide to β-
formyl ester 3.40. .......................................................................................................................... 89 
Scheme 3.28. Proposed conversion of ketone 3.51 to allenes 3.57a and 3.57b. ........................... 93 
Scheme 3.29. Synthesis of propargyl carbonate 3.58. .................................................................. 94 
Scheme 3.30. Synthesis of 3,3-disubstituted allene 3.57a. ........................................................... 95 
Scheme 3.31. Synthesis of propargyl esters 3.59a and 3.59b. ...................................................... 96 
Scheme 3.32. Rh(II)-catalyzed formal 3,3-sigmatropic rearrangement of allenyl carboxyesters 
3.60a and 3.60b. ............................................................................................................................ 97 
Scheme 3.33. APKR of 3,3-disubstituted allene-yne 3.57a. ......................................................... 99 
Scheme 3.34. APKR of allenyl carboxyesters 3.60a and 3.60b. ................................................ 100 
Scheme 3.35. Proposed hydrolysis of α-acyloxy enone 3.62a or 3.62b to access α-hydroxy enone 
3.63.............................................................................................................................................. 103 
Scheme 3.36. Proposed base-mediated isomerization of α-hydroxy enone 3.63 to α-keto enol 3.64.
..................................................................................................................................................... 104 
Scheme 3.37. Base-mediated isomerization/eliminative lactone opening of trans-3.63 and 3.62b.
..................................................................................................................................................... 105 
xv 
List of Abbreviations 
APKR Allenic Pauson-Khand Reaction 
ADR Allylic Diazene Rearrangement 
WK Wolff-Kishner 
HBcat Catecholborane 




DMSO Dimethyl sulfoxide 
mCPBA meta-Chloroperoxybenzoic acid 
TBHP tert-Butyl hydroperoxide 
xvi 
Preface 
I would like to thank Professor Kay Brummond for her excellent mentorship in developing 
my skills as a scientist. Her consistent encouragement inspired me and gave me the confidence to 
pursue my own lines of scientific inquiry. To all current and previous Brummond group members 
which I have had the privilege of spending the past six years with, you have proven to be 
knowledgeable and entertaining colleagues, as well as great friends. 
I would also like to thank my family for their unwavering support, without which I would 
not have made it to this point. I dedicate this document to all of you. 
1 
1.0 Introduction 
1.1 Guaianolides and Strategies Towards the Rapid Construction of the 5,7-Ring System 
The guaianolides are a large class of naturally-occurring sesquiterpene lactones (SLs).
Defined by a fused 5,7,5-ring system, these SLs present a difficult and exciting challenge for the 
synthetic chemist. Utilizing the Reaxys database, two searches were performed–one for 6,12-
guaianolides and one for 8,12-guaianolides. The structures were variable at every position, with 
the dotted lines indicating either a single or double bond. The search returned 5351 6,12-
guaianolides and 838 8,12-guaianolides. The results were further filtered to identify the 
compounds which showed biological activity (pharmacological data), those which have been 
isolated from natural sources (natural source), and those which show biological activity and have 
also been isolated from a natural source (natural source + pharm. data). As can be seen from these 
search results, there are a vast number of both 6,12- and 8,12-guaianolides which are biologically 
active. In addition to their biological activity, the structural diversity of these compounds presents 
an interesting challenge from the perspective of a synthetic chemist. For these reasons the rapid 
and efficient construction of the core 5,7,5-ring system of guaianolides has been the topic of many 
synthetic studies.1,2  
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Table 1.1. Reaxys search of 6,12- and 8,12-guaianolides. 
































6,12-guaianolide 8,12-guaianolide  
Total hits 5351 838 
Pharmacological data 1787 251 
Natural source 2163 484 
Natural source + pharm. data 653 199 
Data obtained via Reaxys search using structures shown (9/28/2020). Search parameters were limited to ‘as 
substructure’ variable ‘on all atoms’, ‘stereo’, and ‘additional ring closures’. Filtered by ‘pharmacological data 
available’ and ‘isolated from natural product + pharmacological data available’. 
 
Many diverse methods have been adopted to access the core 5,7-ring system of 
guaianolides; however, a handful have been most commonly employed to access the 5,7-ring 
system of guaianolides in a single step. The most common method for the construction of the 5,7-
ring system of the 6,12-guaianolides is the photoisomerization of α-santonin (1.1) (Scheme 1.1A). 
This method is often used in the semisynthesis of 6,12-guaianolides.3 While typically low-yielding, 
Macias and coworkers found that maintaining the reaction at low temperature (~2 ⁰C) while using 
a Ni(SO4)2/Co(SO4)2 salt solution to filter wavelengths below 300 nm afforded the 
photoisomerized product in 75% yield.4 Use of this methodology grants access to 6,12-guaianolide 
cores with an enone at the C3-C5 position, and an acetoxy group at the C10 position; which can 
be eliminated under acidic conditions to install an alkene at the C1-C10 position. While α-santonin 
(1.1) is relatively cheap, toxicity is a concern for larger scale reactions.5 In addition, access to more 
functionally complex 6,12-guaianolides, or different stereochemistry difficult. Baran and 
3 
coworkers have showcased this photoisomerization process on a cross-conjugated dienone derived 
from dihydrocarvone in their total synthesis of thapsigargin.6  
α-santonin (1.1)




























































Scheme 1.1. Selected examples of the construction of the 5,7-ring system of guaianolides. 
Winne and coworkers have employed a Lewis acid-catalyzed [4+3] cycloaddition of 
furfuryl alcohol 1.3 to access the core 5,7-ring system 1.4 with a furan at the C6-C7 position, an 
alkene at the C9-C10 position, and a methyl ester at the C4 position (Scheme 1.1B).7 While good 
diastereoselectivity is achieved, the authors report modest to low yields for this transformation.  
Wissinger and coworkers were able to access the 5,7-ring system via a tandem ring-closing 
metathesis of acyclic precursor 1.5 (Scheme 1.1C).8 The resulting bicyclic system 1.6 possesses 
alkenes at the C4-C5 and C6-C7 position, as well as a silyl ether at the C8 position. The reaction 
is performed in excellent yields with complete retention of stereochemistry. 
Photoinduced [2+2] cyclization of cyclopentenone 1.7 with the vicinal silyl enol ether 1.8 
has been shown to afford the 5,4,5-tricyclic system 1.9 (Scheme 1.1D).9 Oxidative cleavage of the 
corresponding vicinal diol afforded the desired 5,7-ring system 1.10 in modest yields. Application 
of this strategy affords access to ketones at the C10 and C6 positions, as well as an alkene at the 
C4-C5 position. 
4 
The Brummond group has developed a complementary methodology to access the 5,7-ring 
system 1.12 of guaianolides by employing an allenic Pauson-Khand reaction (APKR) of allene-
yne precursors similar to 1.11 (Scheme 1.2). Application of this methodology grants access to 
alkenes at the C1-C10 and C4-C5 position, as well as a ketone at the C3 position.10 While the 
functional group array generated via the APKR is similar to that of the photoisomerization of α-
santonin, the allene-yne precursor of the APKR can be functionalized in a variety of ways; granting 
access to functionalities which are unachievable via the photoisomerization of α-santonin.11 This 
methodology could thus enable access to not only more functionally complex guaianolides, but 
also unnatural guaianolide analogs.  
10 mol% [Rh(CO)2Cl]2










Scheme 1.2. Brummond's strategy towards the 5,7-ring system of guaianolides. 
1.2 The Allenic Pauson-Khand Reaction 
1.2.1  History and mechanistic details 
The Pauson-Khand reaction is a formal [2+2+1] cyclocarbonylation reaction between an 
alkene, alkyne, and carbon monoxide, affording cyclopentenone products. First reported by Pauson 
and Khand in 1971, the reaction typically employs Co2(CO)8 as a promoter and source of CO.12 
Initial complexation of an alkyne 1.14 with Co2(CO)8 affords derivative 1.15. Loss of CO, 
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complexation of alkene 1.16, followed by oxidative addition generates the metallocycle 1.18. 
Upon CO insertion, reductive elimination, then decomplexation, cyclopentenone 1.21 is produced. 
While initial application of this methodology for the generation of cyclopentenones was limited in 
substrate scope, many improvements have been made since its first report to make the PKR a 
broadly applied strategy for the synthesis of cyclopentenones.13–20  
Narasaka and Brummond were the first to replace the alkene moiety with an allene, 













































Scheme 1.3. Co-mediated Pauson-Khand reaction. 
 
respectively.21,22 Brummond later showed that the identity of the transition metal catalyst could be 
used to double bond selectivity of the cyclopentenone product; with molybdenum selectively 
affording α-alkylidene cyclopentenones similar to 1.29, and rhodium selectively forming 4-
alkylidene cyclopentenones similar to 1.28 (Scheme 1.4).23 These results were explained 
computationally by differences in the transition state structures for the oxidative cyclization 
between the two metals.24 The lowest energy transition state structure of the Rh(I)-catalyzed 
APKR shows the distal double bond of the allene complexed to the rhodium metal, generating 
complex 1.23a with a distorted square planar geometry. This complex undergoes an oxidative 
 6  
cyclization step leading to metallocycle 1.24a. The Mo-catalyzed APKR, on the other hand shows 
the lowest energy transition state structure complexed with the proximal double bond of the allene 
affording complex 1.23b, which adopts a trigonal bipyramidal geometry. Oxidative cyclization of 
this complex affords metallocycle1 1.24b. The catalytic cycle between the two metals is similar 
from this point forward. Association of CO affords Rh(III) complex 1.25a or Mo(II) complex 
1.25b. Both complexes undergo migratory CO insertion to afford the Rh(III) complex 1.26a or the 
Mo(II) complex 1.26b. This is followed by reductive elimination, regenerating the Rh(I) or Mo(0) 

























































Rh-catalyzed APKR Mo-catalyzed APKR
 
Scheme 1.4. Rh- and Mo-catalyzed APKR and corresponding double bond selectivity of cyclopentenones. 
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1.2.2  Applications of the allenic Pauson-Khand reaction in total synthesis 
Despite its clear synthetic potential for the rapid construction of bicyclic systems, the 
APKR has only been applied to seven natural product total syntheses to date. Baran and coworkers 
employed the APKR as the key ring-forming step to generate bicyclo[5.3.0]decadienone 
intermediate 1.31 (Scheme 1.4A).25 They used this intermediate in their total syntheses of both 
(+)-phorbol (1.32) and (+)-ingenol (1.33).26,27 Mukai and coworkers showcased the application of 
the APKR in their total syntheses of (+)-achalensolide (1.36) and (+)-indicanone (1.38) (Scheme 
1.4B and 1.4C).28,29 Williams and coworkers employed an iron-mediated APKR in their total 
synthesis of (+)-ileabethoxazole (1.41) (Scheme 1.4D).30 Cramer and coworkers completed their 
total synthesis of fijiolide A (1.44) by employing an APKR to access the 5,5,6 ring system of 
intermediate 1.43 (Scheme 1.4E).31 Finally, Brummond and coworkers applied an APKR to 
silicon-tethered allene-yne 1.51 in their total synthesis of 15-deoxy-Δ12,14-prostaglandin J2.32 
While four of these total syntheses take advantage of the APKRs capability to generate medium-
sized seven-membered rings in good yield, there is a dearth of information on the synthetic 
potential of the bicyclo[5.3.0]decadienone systems generated via the APKR. 
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Scheme 1.5. Natural product total syntheses which employed an APKR as the key ring forming step. 
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1.3 Functional Group Interconversions of the APKR Adduct 
The relatively rare application of the APKR to the synthesis of bicyclic natural products 
prompted us to perform a systematic literature search for reported strategies to functionalize the 
bicyclo[x.3.0]dienone system. This search produced only a handful of transformations with all 
involving the functionalization of the double bond at the C1 position, or the ketone at the C3 
position. There have been no reports on functionalizing of the C3-C5 enone with the double bond 
at the C1 position maintained. For example, Sorin and Lannou reported an intramolecular 
conjugate addition of a C9 hydroxyl group to the C3-C5 enone of 1.48, affording tricycle 1.49 in 
low yields (Scheme 1.6A).33 This transformation first involved the deprotection and 
tautomerization of the C10 benzyl carbonate protected enol to the corresponding ketone. Thus, the 
C1-C10 alkene did not remain intact during this transformation. 
Hydrogenation of the C1-C10 double bond is also common, as showcased by Mukai and 
coworkers in their total synthesis of (+)-achalensolide (1.36) (Scheme 1.6B).28 Reduction of the 
C3 ketone of the 5,5,6-ring system 1.51 followed by mCPBA-mediated epoxidation of the C4-C5 
alkene has been reported by Mukai and coworkers, as part of their studies towards the synthesis of 
the core carbon frameowork of cyanosporasides A and B (Scheme 1.6C).34 Alcoholysis of epoxide 
1.53 proceeded smoothly in the presence of BF3∙OEt2, affording vicinal diol 1.54. Cramer was able 
to dehydroxylate the C1-C8 double bond of tricycle 1.55 in the presence of OsO4, affording 
derivative 1.56 towards their total synthesis of fijiolide A (1.44) (Scheme 1.4D).31 
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Scheme 1.6. Precedent for the functional group interconversion of APKR adducts. 
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Perhaps the most extensive studies on the further elaboration of APKR adducts has been 
performed by Baran and coworkers. With access to bicyclo[5.3.0]decadienone 1.31, they have 
been able to successfully functionalize the C1-C10 double bond via dihydroxylation, 
hydrogenation, and hydration (Scheme 1.6E).25,26,35 They were then able to further elaborate the 
enone via a Lewis acid-mediated pinacol-type rearrangement to access the 5,7,8 ring systems 1.58 
and 1.60. These intermediates were used in their total synthesis of (+)-ingenol (1.33) as well as 
their selective C-H oxidation studies of ingenanes, respectively.25,35 In addition, they were able to 
effect an allylic diazene rearrangement on cyclopentenone 1.61 as part of their total synthesis of 
(+)-phorbol (1.32).26  
          With the lack of strategies for the selective functionalization of the C3-C5 enone in the 
presence of the C1-C10 alkene of bicyclo[5.3.0]decadienones arising from the APKR, we reasoned 
that this would be the most impactful area of study to increase the synthetic utility of the APKR. 
We thus turned to the literature to develop strategies which could be applied directly to the C3-C5 
enone of the bicyclo[5.3.0]decadienone APKR adducts, without prior functionalization of the C1-
C10 double bond. Furthermore, we wanted to narrow the scope of these strategies to be directly 
applicable to the guaianolide family of natural products. Thus, we set out to determine the most 
common motifs observed in the guaianolide class which could be accessed via direct 












Figure 1.1. Desired C3-C5 enone functionaliztion in the presence of C1-C10 alkene. 
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2.0 Allylic Diazene Rearrangement and Base-Mediated Isomerization of APKR Adducts 
2.1 Introduction 
Within the guaianolide family of natural products, many different functional group patterns 
are represented. With the application of the allenic Pauson-Khand reaction to the construction of 
the 5,7-ring system, we can access guaianolides with a double bond at the C4-C5 position and an 
oxygen at the C3 position. However, transposition of the C4-C5 double bond to the C3-C4 position 
grants access to a much larger number of guaianolide frameworks. Shown in Table 1 below is a 
Reaxys search performed for 6,12-guaianloide frameworks with double bonds at the C4-C5 
position, as well as the C3-C4 position. There has been a total of 771 6,12-guaianolide structures 
reported with an explicit double bond at the C4-C5 position; 319 are biologically active, 106 have 
been isolated from a natural product, and 26 are both biologically  
Table 2.1. Reaxys search for 6,12-guaianolide frameworks possessing discrete double bond at C4-C5 














Total hits 771 1053 
Pharmacological data 319 308 
Natural source 106 647 
Natural source + pharm. data 26 174 
Data obtained via Reaxys search using structures shown (7/20/2020). Search parameters were limited to ‘as 
substructure’ variable ‘on all atoms’, ‘stereo’, and ‘additional ring closures’. Filtered by ‘pharmacological data 
available’ and ‘isolated from natural product + pharmacological data available’. 
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active and naturally occurring. The same Reaxys search performed on the regioisomeric 6,12-
guaianolide framework, with an explicit double bond at the C3-C4 position, returns a total of 1053 
unique compounds. Of these, 308 are biologically active, 647 have been isolated from natural 
sources, and 174 are both biologically active and naturally occurring. Successful transposition of 
the C4-C5 double bond to the C3-C4 position would grant us the means to access both guaianolide 
cores from a common APK intermediate. To this end, we proposed to study the feasibility of 
leveraging the inherent functional group array generated via the APKR of allene-yne 2.1 to access 
















2.1 2.2 2.3  
Scheme 2.1. Proposed reductive transposition of C3-C5 enone of APKR adduct 2.2 to C3-C4 alkene 2.3. 
 
2.1.1  Proposed strategies for the reductive transposition of the C3-C5 enone 
The first strategy we considered for the reductive transposition of the C3-C5 enone was a 
1,4-reduction followed by triflation to generate the vinyl triflate 2.4 (Scheme 2.2). Hydrogenolysis 
of the vinyl triflate would then afford the desired deoxygenated product 2.3.36 While this procedure 
is relatively straightforward, two obstacles were potentially problematic. Due to steric 
environment at the C5 position, hydride delivery from a bulky hydride source such as L-  
 





























Scheme 2.2. Potential strategies for the reductive transposition of bicyclo[5.3.0]decadienone 2.2. 
 
Selectride would most likely occur in a 1,2-fashion, at the less sterically congested C3 carbonyl 
carbon. Chemoselectivity was also a concern, with potential competitive reduction of other 
reactive functional groups on more functionally complex bicyclo[5.3.0]decadienones, required for 
the preparation of bioactives. The next strategy we considered was hydrogenation of the C4-C5 
double bond to access cyclopentanone 2.5, followed by enolization, triflation, and hydrogenolysis 
of vinyl triflate 2.4. This strategy alleviated the concern of 1,2-reduction; however, there was a 
high likelihood that hydrogenation of C1-C10 double bond would occur under standard 
hydrogenation conditions.37 To circumvent this potential chemoselectivity issue, we reasoned that 
we could use a transition metal-catalyzed 1,4-hydrosilylation strategy.38–41 Hydrolysis of the 
corresponding silyl enol ether to cyclopentanone 2.5, followed by enolization, triflation, then 
hydrogenolysis of vinyl triflate 2.4 would afford the desired reductive transposition product 2.3. 
While hydrogenation or hydrosilylation conditions could work for the selective reduction of the 
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C3-C4 double bond, our primary concern was the enolization/triflation step. Because 
deprotonation could occur at either the C4 position, giving the desired trisubstituted enolate, or the 
C2 position, we had to be mindful of regioselectivity. In the case of bicyclo[5.3.0]decadienone 
2.2, we reasoned that the thermodynamic enolate would most likely be generated via deprotonation 
at the C2 position, to generate an extended enolate in conjugation with the C1-C10 double bond. 
Thus, even if we were able to effect selective hydrogenation or hydrosilylation at the C4-C5 double 
bond, generating the desired C3-C4 enolate under either thermodynamic or kinetic conditions 
would be difficult. Hence, we proposed a third strategy which would mitigate both chemo- and 
regioselectivity issues.  
The final strategy that we proposed was an allylic diazene rearrangement (ADR). 
Condensation of enone 2.2 with tosyl hydrazide to generate tosyl hydrazone 2.6, followed by 
borane reduction and subsequent ADR would afford the desired reductive transposition product 
2.3.42–44 A major benefit of this strategy is the chemoselectivity of the reduction. We felt confident 
that the borane reduction would be selective for the reduction of the tosyl hydrazone in a 1,2-
fashion, leaving both the C1-C10 and C4-C5 double bond intact.45–47 In addition, conditions for 
the tosyl hydrazone formation are mild and functional group tolerant.48 Because the ADR proceeds 
via a concerted, 1,5-sigmatropic rearrangement, the stereochemical determining step is the initial 
1,2-reduction of the tosyl hydrazone, not the reduction of the alkene. Thus, due to its operational 
simplicity, chemoselectivity, and mild reaction conditions, we decided to first explore the allylic 
diazene rearrangement as our preferred strategy towards the reductive transposition of the C3-C5 
enone. While this strategy has been well documented in the literature, to the best of our knowledge, 
this would be the first example of an allylic diazene rearrangement being performed on a 
conjugated bicyclic system, where both double bonds are at the ring fusion positions. 
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With a suitable strategy in hand, we set out to first develop a model 
bicyclo[5.3.0]decadienone system with minimal functionality, thus preventing any undesired side 
reactions that could potentially occur in the presence of other reactive functional groups. We 
reasoned that we could synthesize bicyclo[5.3.0]decadienone 2.2 in a reasonable number of steps 
via APKR of allene-yne 2.1, which could in turn be accessed via alkynyl ketone 2.7 (Scheme 2.3). 
Unfortunately, alkynyl ketone 2.7 is not commercially available; however, we reasoned that we 
that it could be synthesized via alkynyl iodide 2.8, which has been prepared starting with 
commercially available 5-hexyn-1-ol 2.9.49 With a feasible route to bicyclo[5.3.0]decadienone 2.2 








2.8 2.9  
Scheme 2.3. Retrosynthetic analysis of bicyclo[5.3.0]decadienone 2.2. 
2.2 Synthesis of Model Bicyclo[5.3.0]decadienone 2.2 
2.2.1  Synthesis of alkynyl ketone 2.7 
Synthesis of alkynyl ketone 2.7 began with commercially available hexyn-1-ol 2.9 
(Scheme 2.4). Following a literature procedure for the synthesis of 4-hexyn-1-ol 2.10, potassium 
tert-butoxide mediated isomerization of the terminal alkyne 2.9 to the thermodynamically favored 
internal alkyne 2.10 proceeded in DMSO at room temperature in 82% yield.49 The hydroxyl group 
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was converted to the corresponding mesylate 2.11 in 97% yield in the presence of methanesulfonyl 
chloride and triethylamine in dichloromethane at 0 ºC. Attempts to convert mesylate 2.11 to ketone 
2.7 via addition of acetylacetone in the presence of K2CO3 in refluxing ethanol afforded none of 
the desired product.50 Mesylate 2.11 as well as alcohol 2.10 were both detected via 1H NMR of the 
crude reaction mixture after 42 h, suggesting that alcoholysis of the methanesulfonate group was 
the predominant reaction pathway. For this reason, mesylate 2.11 was converted to iodide 2.8 via 
reaction of sodium iodide in acetone at 65 ⁰C (oil bath temperature) in 96% yield. Alkynyl iodide 
2.8 was then reacted with acetylacetone in the presence of potassium carbonate in refluxing ethanol 
to afford the desired ketone 2.7 in 54% yield, while recovering 19% of the alkynyl iodide 2.8. In 
addition to this reaction not going to completion vinyl ether 2.12, the product of O-alkylation, was 
isolated as a single stereoisomer; the structure of which was confirmed by 1H and 13C NMR. 
Defining spectroscopic features of vinyl ether 2.12 include resonances at 2.26 (s, 3H) ppm, and 
2.15 (s, 3H) ppm corresponding to the C1 and C12 methyl protons, respectively, as well as 
resonances at 5.47 (s, 1H) ppm and 3.85 (t, 2H) ppm, corresponding to the C3 methine proton the 
C6 methylene protons, respectively. While isolated as a single stereoisomer, we did not confirm 





































Scheme 2.4. Initial synthetic route of alkynyl ketone 2.7. 
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The modest yield, due to incomplete conversion of starting material and competing O-alkylation, 
led us to consider a two-step, two-pot procedure involving the alkylation of tert-butyl acetoacetate 
followed by decarboxylation to effect the desired acetone homologation of alkynyl iodide 2.8 
(Scheme 2.5). Deprotonation of tert-butyl acetoacetate with sodium hydride in THF at 0 ºC 
followed by addition of alkynyl iodide 2.8 afforded acetoacetate 2.13. The crude residue was taken 
up in benzene and heated to 100 ⁰C in the presence of p-toluenesulfonic acid (0.2 equiv), effecting 
decarboxylation to generate the desired alkynyl ketone 2.7 in 90% yield over two steps. With the 
high yield and clean TLC reaction profile of this procedure, we reasoned that we could apply the 
same conditions to alkynyl mesylate 2.11, thus eliminating the need to convert the mesylate to 
alkynyl iodide 2.8. We thus applied the same reaction conditions  
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Scheme 2.5. Acetone homologation of alkynyl iodide 2.8 using tert-butyl acetoacetate. 
 
reported above, with addition of alkynyl mesylate 2.11 instead of alkynyl iodide 2.8 after reaction 
of tert-butyl acetoacetate with sodium hydride. While the reaction profile showed a single spot by 
TLC, suggesting no O-alkylation product, slow reaction times were observed (> 48 h) as well as 
incomplete conversion of starting material. Because conversion of the mesylate 2.11 to iodide 2.8 
was so rapid and high yielding, and the product required no further purification, we decided not to 
optimize the alkylation with alkynyl mesylate 2.11 and instead continue using alkynyl iodide 2.8. 
With a rapid, high yielding route to alkynyl ketone 2.7 in hand, we next sought to convert the 
ketone functionality to the desired 3,3-disubstituted allene 2.1. 
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2.2.2  Synthesis of allene-yne 2.1 
When examining potential procedures for the conversion of a ketone to a 3,3-disubstituted 
allene, we first explored the most direct, step-economical routes. Takeda has reported the direct 
conversion of carbonyl compounds to 3,3-disubstituted allenes via reaction of titanium 
alkenylidene 2.15, generated in situ via addition of two equiv of vinylmagnesium bromide to 
titanocene dichloride 2.14 (Scheme 2.6).51 We reasoned that this procedure would offer the most 
direct access to the desired 3,3-disubstituted allene-yne 2.1. Thus, vinylmagnesium bromide (2 














Scheme 2.6. Attempted direct allenation of ketone 2.7 with alkenylidene titanocene. 
 
into a solution alkynyl ketone 2.7, which had been dissolved in THF and cooled to -40 ⁰C. Upon 
complete consumption of 2.7, as visualized by TLC, an aliquot of the reaction mixture was worked 
up and subjected to 1H NMR, which revealed mostly uncharacterizable decomposition products. 
It was not immediately evident why this reaction failed on our system; however, it should be noted 
that the substrate scope reported by Takeda and coworkers was mostly limited to at least one 
aromatic ring adjacent to the carbonyl group, or α,β-unsaturated carbonyls. Due to the level of 
apparent decomposition, we chose not to pursue this route any further, but instead examine 
alternative, less direct routes to generate the desired 3,3-disubstituted allene 2.1. 
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Tsuji and coworkers have reported a palladium-catalyzed hydrogenolysis of propargyl 
carbonates to generate 3,3-disubstituted allenes.52 To apply these conditions to our substrate, 
alkynyl ketone 2.7 had to first be converted to propargyl carbonate 2.16 via addition of 
ethynylmagnesium bromide, followed by addition chloromethylformate (Scheme 2.7). Thus, 
ketone 2.7 was dissolved in THF and cooled to -10 ⁰C. Ethynylmagnesium bromide (1.5 equiv) 
was added and, after complete consumption of 2.7 was observed by TLC, methyl chloroformate 
(1.6 equiv) was added. Upon workup and purification via SiO2 flash column chromatography, 

















With these promising initial results in hand, we sought to improve the overall yield of this 
two-step, one-pot procedure. Cerium trichloride is known to render Grignard reagents 
simultaneously more nucleophilic, less basic, and less susceptible to participation in single-
electron transfer reactions.53 To our delight, initial transmetalation of ethynylmagnesium bromide 
with cerium trichloride followed by addition of alkynyl ketone 2.7, then trapping with methyl 
chloroformate afforded propargyl carbonate 2.16 in 98% yield.  
With propargyl carbonate 2.16 in hand, we were poised to apply Tsuji’s palladium-
catalyzed hydrogenolysis conditions.52 Thus Pd2dba3●CHCl3 (0.025 equiv) and tri-n-
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butylphosphine (0.1 equiv) were dissolved in THF, followed by addition of ammonium formate (2 
equiv) (Scheme 2.8). Propargyl carbonate 2.16 was added and the mixture reacted at room 
temperature for 24 h. Upon concentration and purification, the desired allene 2.1 was obtained in 
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2.1  
Scheme 2.8. Palladium-catalyzed hydrogenolysis of propargyl carbonate 2.16. 
 
While this reaction was consistently high-yielding, there was a single case where agitation 
of the reaction was interrupted overnight, resulting in a 3:1:1 ratio of allene 2.1, enyne 2.20 and 
enyne 2.21, respectively (Scheme 2.9). Analysis of the proposed catalytic cycle for the palladium-
catalyzed hydrogenolysis reveals a potential pathway to both enyne byproducts. As proposed by 
Tsuji and coworkers, oxidative insertion of Pd(0) followed by elimination of carbon dioxide 
affords palladium(II) methoxide species 2.17a.52 Exchange of the methoxide ligand with formate 
affords palladium(II) formate 2.18. The formate ligand undergoes a β-hydride elimination to 
generate palladium(II) hydride 2.19 and CO2. Reductive elimination affords allene 2.1 and 

























Scheme 2.9. Palladium-catalyzed hydrogenolysis catalytic cycle and potential elimination of η1-palladium. 
Due to the limited solubility of ammonium formate in THF, we propose that loss of 
agitation starves palladium(II) methoxide 2.17a of the formate necessary to generate 2.18. As the 
concentration of 2.17a increases, the palladium center could undergo a haptotropic shift, most 
likely through an η3-allylpalladium intermediate, to generate palladium(II) intermediate 2.17b. 
Ensuing β-hydride elimination of Ha or Hb then generates the observed enyne products 2.20 and 
2.21, respectively; a process that has been reported by Tsuji and coworkers.54 Thus, it is crucial to 
maintain the limited solubility of ammonium formate throughout the entire course of the reaction. 
With the success of the palladium-catalyzed hydrogenolysis to afford allene-yne 2.1, we 
were poised to complete the synthesis of the desired bicyclo[5.3.0]decadieneone 2.2 via 
application of the allenic Pauson-Khand reaction. 
2.2.3  Application and optimization of the APKR to allene-yne 2.1 
With allene-yne 2.1 in hand, we set out to test the feasibility of the allenic Pauson-Khand 
reaction (APKR) as a way to access bicyclo[5.3.0]decadienone 2.2. We opted to begin with 
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conditions previously shown by our group to be optimal for methyl substituted alkynes.55 Addition 
of allene-yne 2.1 to a dilute solution (0.025 M) of [Rh(CO)2Cl]2 (5 mol%) in toluene at 110 ºC (oil 














toluene, 110 °C         56%
 
Scheme 2.10. Inverse addition of allene-yne 2.1 to Rh(I) solution. 
 
Diagnostic 1H NMR resonances were observed at 2.91(s) ppm corresponding to the C2 methylene 
protons, 2.69 (t, J = 6.4 Hz, 2H) ppm and 2.39 (t, J = 6.0 Hz, 2H) ppm corresponding to the allylic 
protons at C6 and C9, respectively, and 1.84(s) ppm and 1.75(s) ppm, corresponding to the C10 
and C4 methyl protons, respectively. In addition to the 1H NMR data, 13C NMR resonances at 205 
ppm confirmed the presence of a ketone, and resonances at 169 ppm, 138 ppm, 137 ppm, and 132 
ppm confirmed the presence of four sp2 carbons. While the initial conditions for the conversion of 
2.1 to 2.2 were successful, the modest yield prompted us to further optimize the reaction conditions 
for this substrate.  
          Because the APKR required only 2 h to reach completion when using 5 mol% [Rh(CO)2Cl]2 
(Table 2.2, entry 1), we reasoned that we could decrease the catalyst loading in an effort to increase 
overall efficiency, while maintaining an acceptable reaction time and yield. Reducing the catalyst 
loading to 2 mol% afforded 2.2 in a comparable yield of 53%, but a slightly extended reaction time 
of 3 h (Table 2.2, entry 2). While the reaction times were reasonable using [Rh(CO)2Cl]2, we 
wanted to examine an alternative Rh(I) catalyst, in an effort to increase the yield of the APKR. 
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Cationic Rh(cod)2BF4 in the presence of a phosphine ligand has been successfully 
employed in the APKR by previous group members, often with good results.56 While 
computational studies have suggested that the rate determining step for the Rh(I)-catalyzed APKR 
is the initial oxidative cyclization of the Rh(I)-allene-yne complex in the case of a ligand-free 
catalyst, we proposed that this could also be the case for rhodium catalysts in the presence of 
phosphine ligands. It follows that the strongly σ-donating character of trialkyl and triaryl 
phosphine ligands would render the cationic Rh(I) catalyst sufficiently electron-rich to facilitate 
the oxidative cyclization, even at reduced reaction temperatures.24 Thus, we decided to first screen 
Rh(cod)2BF4 in the presence of triphenylphosphine as the next catalyst for the APKR. Rh(cod)2BF4 
  



















1 [Rh(CO)2Cl]2 5 Toluene 0.025 110 2 56 
2 [Rh(CO)2Cl]2 2 Toluene 0.025 110 3 53 
3 Rh(cod)2BF4 10 DCE 0.02 70 24 85 
4 Rh(cod)2BF4 5 DCE 0.02 70 24 90 
5 Rh(cod)2BF4 2.5 DCE 0.02 70 24 88 
6 Rh(cod)2BF4 2.5 DCE 0.1 70 20 86 
  
(10 mol%) and PPh3 (15 mol%) were dissolved in dichloroethane (Table 2.2, entry 3). The reaction 
flask was evacuated and refilled with carbon monoxide using a CO-filled balloon, and allene-yne 
2.1 was added. After 24 h, complete conversion of 2.1 was observed, and 
bicyclo[5.3.0]decadienone 2.2 was isolated in 85% yield. 
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With a marked increase in reaction yield, we again decided to lower the catalyst loading to 
determine what effect, if any, this would have on reaction time and yield. The catalyst loading was 
reduced to 5 mol% with no appreciable impact on time or yield (Table 2.2, entry 4). The loading 
was further decreased to 2.5 mol%, again with no appreciable impact on time or yield (Table 2.2, 
entry 5). With this optimal catalyst system in hand, we next wanted to explore the effect of 
substrate concentration. Previous reports using [Rh(CO)2Cl]2 suggest the formation of a dimeric 
byproduct when substrate concentrations exceed 0.025M.55 We did not see any evidence of 
byproducts when using Rh(cod)2BF4 with a substrate concentration of 0.025M, so we decided to 
increase the substrate concentration to 0.1 M, in an effort to consume less halogenated solvent 
(Table 2.2, entry 6). Gratifyingly, we saw no appreciable impact on reaction yield, and reaction 
time was decreased by 4 h. With these optimized conditions in hand, we had rapid access to the 
bicyclo[5.3.0]decadienone model system 2.2 in high yield. We were thus poised to explore the 
feasibility of reductive transposition of the C3-C5 enone.  
2.3 1H NMR Studies of Tosylhydrazone Reduction with Catecholborane 
The strategy we chose to pursue for the reductive transposition of 
bicyclo[5.3.0]decadienone 2 was an allylic diazene rearrangement (ADR), for the reasons 
enumerated above. We reasoned that catecholborane (HBcat) reduction of tosylhydrazone 2.6 
would occur chemoselectively at the hydrazone, leaving the double bonds intact.57 In addition, the 
allylic diazene rearrangement (ADR) of α,β-unsaturated hydrazones has been shown to selectively 
form the product of alkene migration, even in cases where that product is thermodynamically 
disfavored.44,58 We thus felt confident that application of the ADR to tosylhydrazone 2.6 would 
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afford the desired 1,4-alkene 2.3, despite the fact that double bond conjugation would be broken 
(Scheme 2.12). 
First, we had to convert bicyclo[5.3.0]decadienone 2.2 to the tosylhydrazone derivative 2.6 
(Scheme 2.12). This was accomplished in 77% yield via reaction of 2.2 with tosylhydrazide (1.2 
equiv) in ethanol at 85 ºC for 18 h. Diagnostic 1H resonances at 2.89(s) ppm corresponding to the 
C2 protons, 1.77(s) ppm and 1.75(s) ppm corresponding to the protons on the methyl groups at the 
C4 and C10 positions, respectively, and 2.53(t) ppm and 2.29(t) ppm, corresponding to the protons 
at the C9 and C6 positions, respectively, confirmed the formation of 2.6. We also observed that, 
under the reaction conditions, a single stereoisomer of the hydrazone was formed. We predicted 
that the E-hydrazone would be the thermodynamically preferred isomer, owing to the presence of 
an unfavorable steric between the tosyl group of the hydrazone and the methyl group at the C4 
position of the Z-isomer. The E-hydrazone stereochemistry was confirmed via single crystal X-ray 
























Scheme 2.11. Attempted ADR of bicyclo[5.3.0]decadienone tosylhydrazone 2.6. 
 
With hydrazone 2.6 in hand, initial conditions for the allylic diazene rearrangement were 
investigated (Scheme 2.12). The first step is reduction of the tosylhydrazone 2.6 to the 
corresponding tosylhydrazine derivative 2.22. The most common reagent employed for this 
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reduction is catecholborane, as it is highly selective for the reduction of tosylhydrazones in the 
presence of other reactive functional groups, and the reaction conditions are very mild.6 Thus, 
tosylhydrazone 2.6 was reacted with catecholborane (neat, 3 equiv) in chloroform at -50 ºC (Table 
3, entry 1). After 1 h, sodium acetate trihydrate (3 equiv) was added and the reaction was warmed 
to room temperature and stirred for 1 h. It was then brought to 70 ºC for an additional 1 h. Upon 
workup, 1H NMR of the crude residue revealed none of the desired ADR product 2.3, as evidenced 
by the lack of the expected C3 olefinic proton Ha between 5-6 ppm. The progress of the reaction 
was unable to be followed by TLC, due to the large excess of catecholborane overlapping with 
tosylhydrazone 2.6 on the TLC plate. Thus, we were not certain whether 2.6 was undergoing 





EtOH, 85 °C      77%
N











Scheme 2.12. Synthesis and crystal structure of E-tosylhydrazone of bicyclo[5.3.0]decadienone 2.2. 
 
To overcome this issue and accurately monitor the progress of the reduction step, we 
decided to perform the reaction in CDCl3, and periodically take aliquots for analysis by 1H NMR. 
Thus, tosylhydrazone 2.6 was dissolved in CDCl3, cooled to 0 ºC and allowed to react with 
catecholborane (neat, 3 equiv) (Table 2.3, entry 2). A reference spectrum was taken before the 
addition of catecholborane (Figure 2.1A). After stirring for 1 h with catecholborane at 0 ºC, an 
aliquot was taken and subjected to 1H NMR analysis (Figure 2.1B). The mixture was warmed to  
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Entry Reducing Agent (equiv) Solvent 
Additive 
(equiv) Time (h) 
Temp 
(°C) Result 
1 HBcat neat (3) CDCl3 - 2 -40 2.6 by NMR 
2 HBcat neat (3) CDCl3 - 1 0 - rt 2.6 by NMR 
3 HBcat neat (3) CDCl3 
SiO2 
(2 wt. equiv) 1 0 - rt 2.6 by NMR 
4 HBcat neat (3) CDCl3 AcOH (2) 1 rt 2.6 by NMR 
5 HBcat neat (6) CDCl3 - 24 0 2.6 by NMR 
 
 
Figure 2.1. A) Reference spectrum, no catecholborane. B) 3 equiv HBcat after 1 h at 0 ⁰C. C) after 1 h at rt. 
D) After addition of 3 equiv sodium acetate trihydrate and reacting at 60 ⁰C for 1 h. 
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room temperature and stirred for an additional 1 h and a second aliquot was taken (Figure 2.1C). 
Sodium acetate trihydrate (3 equiv) was added to the reaction mixture, and it was brought to 70 ºC 
for 1 h. A third aliquot was taken at this time (Figure 2.1D). 
After initial addition of the catecholborane, no starting material was detected, as evidenced 
by the disappearance of the resonances at 2.87 (s) ppm corresponding to the C2 methylene protons 
of 2.6, 2.41 (s) ppm corresponding to the tosyl methyl protons of 2.6, 1.77 (s) ppm, and 1.76 (s) 
ppm (compare Figures 2.1A and 2.1B). Warming the reaction and stirring for an additional hour 
appeared to have no effect as evidenced by the similarities between the spectra of Figure 2.1B and 
2.1C. After addition of sodium acetate trihydrate followed by heating, 1H NMR analysis of the 
crude reaction mixture revealed a substantial amount of tosylhydrazone 2.6, as evidenced by the 
reappearance of resonances at 2.90(s) ppm, 2.41(s) ppm, and 1.77(s) ppm (Figure 2.1D). The 
observation of predominately 2.6 after addition of NaOAc∙3H2O strongly suggested that reduction 
of the hydrazone was not occurring under these reaction conditions. 
With data suggesting that hydrazone reduction is not occurring, we turned to the literature 
in an effort to find alternative conditions for the catecholborane reduction of tosylhydrazones. 
McIntosh has shown that the reaction time of the catecholborane reduction of tosylhydrazones, 
followed by ADR, is reduced in the presence of SiO2 or acetic acid.59 Thus, we repeated the 
reaction using the previous conditions, this time with the introduction of SiO2 into the reaction 
mixture (two times the mass of 2.6) (Table 2.3 entry 3). The reaction was performed at 0 ⁰C, and 
after 1 h we saw no discernable difference between the spectrum of this reaction to that of the 
reaction performed without SiO2. The reaction was allowed to warm to room temperature and 
maintained for an additional hour. Again, there was no discernable change in the 1H NMR of the 
reaction mixture. We concluded that addition of SiO2 did not impact the reduction of 
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tosylhydrazone 2.6. We next wanted to screen the effect of acetic acid, as McIntosh had also shown 
it to be effective for the ADR. Thus, tosylhydrazone 2.6 was dissolved in CDCl3 and AcOH (2 
equiv) was added. Catecholborane (3 equiv) was added at room temperature and aliquots of the 
reaction mixture were subjected to 1H NMR (Table 2.3, entry 4). No reduction of 2.6 occurred 
under these reaction conditions as evidenced by 1H NMR of the crude reaction mixture. Finally, a 
large excess of catecholborane (6 equiv) was employed in an effort to force the reduction (Table 
2.3, entry 5). After reacting at room temperature for 24 h, none of the desired ADR product 2.3 













































































Scheme 2.13. Precedent for ADRs performed on bicyclo[5.3.0]decenones. 
 
reduction. It was unclear why tosylhydrazone 2.6 was so resistant to catecholborane reduction; 
however, an exhaustive literature search for ADRs performed on 5,7-ring systems revealed six 
such reports. 
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Greene applied an ADR to bicyclo[5.3.0]decenones 2.23 and 2.25 in his total syntheses of 
(+)-pachydictoyl A and (–)-dicytolene, and oxoisodehydroleucodin in 1980 and 1989, respectively 
(Scheme 2.13A and B).45,60 Iwata successfully employed an ADR on bicyclo[5.3.0]decenone 2.27 
towards the total synthesis of (+)-aromadendrene and (–)-alloaromadendrene in 1996 (Scheme 
2.13C).61 The ADR of 2.29 was a key step in Pedro’s synthesis of (+)-alismoxide in 2006 (Scheme 
2.13D).62 Sun was able to employ an ADR on tricycle 2.31 in his total synthesis of hedyosumin E 
aglycon (Scheme 2.13E).63 Recently, Baran showcased the use of an ADR of 
bicyclo[5.3.0]decenone 2.33 towards the total synthesis of (+)-phorbol (Scheme 2.13F).26 While 
most of the above examples of this transformation were performed on an enone motif, Pedro’s 
showed that this transformation can indeed be performed on a conjugated dienone of a 5,7-ring 
system. However, unlike Pedro’s dienone 2.33, both ring-fused carbons (C1 and C5) of APKR 
adduct 2.2 are sp2 hybridized. To the best of our knowledge, there have been no reported 
applications of an ADR on such systems. We sought to understand the effect of the C1-C10 double 
bond on the catecholborane reduction of 2.6, and hypothesized that hydrogenation of the C1-C10 
double bond of 2.2 would serve to simplify the 5,7-ring system and offer a direct comparison 
between the dienone 2.2 and the analogous enone. It should be noted that none of the above reports 
of the ADR performed on 5,7-ring systems resulted in high yields; suggesting that we may not 
observe high yields for our system either. 
2.4 ADR on C1-C10 Hydrogenated APKR Adduct 
In order to test the impact of the C1-C10 double on the ADR, we reasoned that a Pd-
catalyzed hydrogenation could be employed to chemoselectively reduce the C1-C10 double bond, 
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in the presence of the C3-C5 enone.37 Thus, dienone 2.2 was reacted with Pd/C (10 mol%) under 
a H2 atmosphere (1 atm, balloon), in a 4:1 mixture of MeOH/EtOAc at room temperature (Scheme 


















Scheme 2.14. Hydrogenation of C1-C10 double bond of 2.2. 
 
          A resonance at 2.91 (s) ppm corresponding to the C2 methylene protons of 2.2 was chosen 
to monitor the progress of the hydrogenation. Disappearance of this resonance was an indication 
that the reaction had gone to completion. The reaction was rapid, affording enone 2.35 in 90% 
yield after 10 mins. The reaction proceeded in a diastereoselective fashion, affording a single 
diastereomer of 2.35, as evidenced by the presence of a resonance at 1.66 (s) ppm corresponding 
to the protons on the C4 methyl group, and a resonance at 0.69 (d, J = 8.0 Hz) ppm, corresponding 
to the protons on the C10 methyl group of 2.35. It must be noted that careful monitoring of the 
reaction progress was crucial. Extended reaction times (>45 min) resulted in a complex mixture of 
products; presumably due to further reduction of 2.35. 
          With the C1-C10 hydrogenated APKR adduct 2.35 in hand, we sought to prepare the 
tosylhydrazone derivative 2.36 (Scheme 2.15). Ketone 2.35 was dissolved in ethanol and 
tosylhydrazide (1.2 equiv) added. The reaction mixture was maintained at 85 ºC for 18 h, affording 
tosylhydrazone 2.36 in 93% yield. Both the E-2.36 and Z-2.36 isomers were formed in a 71:29 
ratio, as evidenced by the presence of a resonance at 0.99 (d, J = 6.4 Hz, 1.2H) ppm in the 1H 
NMR, corresponding to the protons on the C10 methyl group of the minor Z-isomer, and a 
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resonance at 0.64 (d, J = 7.2 Hz, 3H) ppm corresponding to the protons on the C10 methyl group 
of the major E-isomer. Other resonances diagnostic of tosylhydrazone 2.36, but appearing as 































0 kcal/mol 4.86 kcal/mol
93%, 71:29 E/Z  
Scheme 2.15. Formation of tosylhydrazone 2.36 from C1-C10 hydrogenated APKR adduct 2.35. 
 
protons, as well as a resonance at 1.68 (s) ppm, corresponding to the protons on the C4 methyl  
group were also present. The two isomers were inseparable by SiO2 flash column chromatography, 
however in silico geometry optimization of E-2.36 and Z-2.36 using B3LYP with a 6-31G* basis 
set in vacuuo predicted Z-2.36 to be 4.86 kcal/mol higher in energy than E-2.36.We thus predict 
E-2.40 to be the major isomer; however, both isomers were used as a mixture for all subsequent 
transformations. 
With tosylhydrazone 2.36 in hand, the feasibility of the ADR was tested on the C1-C10 
hydrogenated 5,7-ring system and reaction progress of the catecholborane reduction monitored 
by1H NMR. Tosylhydrazone 2.36 was dissolved in CDCl3 and the mixture cooled to -40 ⁰C.  
  





































Scheme 2.16. HBcat reduction of C1-C10 hydrogenated tosylhydrazone 2.36 and ADR. 
 
Catecholborane (3 equiv, neat) was added and aliquots were taken for 1H NMR analysis every 
hour (Table 2.4, entry 1). We did not observe a resonance between 3-4 ppm corresponding to Ha 
of tosylhydrazine intermediate 2.37, suggesting that hydrazone 2.36 was not reduced with 
catecholborane (Scheme 2.16). Upon SiO2 chromatographic purification of the crude reaction 
mixture, 1H NMR of the major reaction component revealed that it was indeed tosylhydrazone 
2.36, thus confirming that reduction of the tosylhydrazone under these conditions did not take 
place. Because of this, we sought to screen alternative conditions for the reduction of the 
hydrazone. 
We reasoned that increasing the reaction temperature from -40 ⁰C to 0 ⁰C could facilitate 
the catecholborane reduction of the tosylhydrazone moiety (Table 2.4, entry 2). Thus, 
tosylhydrazone 2.36 was dissolved in CDCl3 and the solution cooled to 0 ⁰C. Catecholborane was 
added (3 equiv, neat) and the mixture stirred at 0 ⁰C. An aliquot of the reaction mixture was taken 
after 45 min and analyzed via 1H NMR. The resulting spectrum was nearly identical to the 
spectrum obtained from the previous reaction, and thus was inferred that tosylhydrazone 2.36 was 
unaffected by catecholborane under these conditions, so we decided to further increase the 
temperature to room temperature. After reacting for 45 min at room temperature, another aliquot 
of the reaction mixture was taken and analyzed by 1H NMR. The spectrum was very similar the 
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spectra previously taken at the lower temperature, indicating that tosylhydrazone 2.36 remained 
unreacted. 
We next examined the effect of 10 equiv of catecholborane, hoping to force the reduction 
of 2.36. Thus, tosylhydrazone 2.36 was dissolved in CDCl3 and cooled to -40 ⁰C. Catecholborane 
(10 equiv, neat) was added and the mixture stirred for 1 h before an aliquot of the reaction mixture 
was taken for 1H NMR analysis (Table 2.4, entry 3). The spectrum was, again, nearly identical to 
those of the previously reported conditions. It became apparent from varying the reaction  
 






































1a HBcat neat (3) CHCl3 - 4 -40 
No reduction, mostly 2.36 
by 1H NMR 
2a HBcat neat (3) CHCl3 - 1.5 0–rt 
No reduction, mostly 2.36 
by 1H NMR 
3a HBcat neat (10) CHCl3 - 4 -40 
No reduction, mostly 2.36 
by 1H NMR 
4b NaCNBH3 (4) THF pTsOH 5 rt 
No reduction, mostly 2.36 
by 1H NMR 
5b NaCNBH3 (4) THF pTsOH 18 rt - 70 Trace 2.38 
6b NaCNBH3 (10) MeOH 
AcOH 
(6) 4 70 Trace 2.38 
7 (BzO)2BH (3) 
THF/ 
CHCl3 
- 3 0 - rt 40% 2.38, 59:41 dr 
8 HBcat (1M in THF) (3) CHCl3 - 3 0 48% 2.38, 60:40 dr 
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temperature and equiv of catecholborane that the reduction of the tosylhydrazone moiety would 
not proceed under these commonly employed conditions. To continue our studies on the feasibility 
of applying the ADR to the C1-C10 hydrogenated tosylhydrazone 2.36, we turned to the literature 
in search of alternative conditions for the reduction, and subsequent ADR. 
Sodium cyanoborohydride (NaBH3CN) in the presence of stoichiometric amounts of acid 
has been used to successfully effect allylic diazene rearrangements.64 Though the reaction 
conditions are less mild than the catecholborane conditions, due to the structural simplicity of 
tosylhydrazone 2.36, we felt confident that the substrate would survive the acidic medium at the 
elevated temperature required to effect the reduction in the presence of sodium cyanoborohydride. 
Thus, we set out to apply these conditions to our system. Tosylhydrazone 2.36 was dissolved in 
THF and p-toluenesulfonic acid (pTsOH) was added. Sodium cyanoborohydride was then added 
portion-wise until 4 equiv were reached (Table 2.4, entry 4). The mixture was reacted at room 
temperature for 5 h, during which time tosylhydrazone 2.36 remained unreacted, as evidenced by 
TLC, and confirmed by the presence of resonances corresponding to 2.36 in the 1H NMR of the 
crude reaction mixture. This result led us to conclude that, while the tosylhydrazone moiety was 
not reduced, the substrate did survive the acidic reaction conditions, and we could proceed by 
increasing the reaction temperature in an effort to force the reduction. Thus, the reaction was 
repeated at elevated temperature (70 ⁰C) for an extended period of time (18 h) (Table 2.4, entry 5). 
Tosylhydrazone 2.36 was fully consumed over this time, as evidenced by TLC. Upon workup, 1H 
NMR analysis of the crude residue confirmed the complete consumption of 2.36. In addition, we 
observed a resonance at 5.25 ppm which we hypothesized could correspond to Ha of ADR product 
2.38; however, the integral value of this resonance was small relative to the other unassigned 
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resonances. With these promising preliminary results in hand, we sought to optimize the conditions 
for the formation of ADR product 2.38.  
Baran has reported the use of sodium cyanoborohydride in methanol, in the presence of 
acetic acid, as effective conditions for the reduction of a tosylhydrazone, and subsequent ADR.26 
Tosylhydrazone 2.36 was dissolved in methanol and acetic acid was added, followed by sodium 
cyanoborohydride portion-wise (Table 2.4, entry 6). The mixture was stirred at 70 ⁰C for 4 h. TLC 
indicated complete consumption of 2.36, and upon 1H NMR analysis of the crude reaction mixture, 
we observed the diagnostic resonance of Ha at 5.25 ppm. However, as in the previous case, there 
were substantial uncharacterizable resonances present in the 1H NMR. It was because of these 
suboptimal reaction profiles, low conversions to the presumed ADR product 2.38, and a large 
amount of uncharacterizable products in the aliphatic region of the 1H NMR that we again decided 
to shift our focus to alternative borane hydride sources. 
Kabalka and coworkers reported to use of bis(benzoyloxy)borane as an effective alternative 
to catecholborane for the ADR.65 Bis(benzoyloxy)borane (2.41) was prepared in situ via addition 
of BH3∙THF (1 M solution) to 2 equiv of benzoic acid (2.40) in CDCl3 (Scheme 2.17). 
Tosylhydrazone 2.36 was dissolved in CDCl3 and added to this solution at 0 ⁰C (Table 2.4, entry 
7). After reacting for 3 h while warming to room temperature, complete consumption of 2.36 was 
observed via TLC. A benefit of using bis(benzoyloxy)borane was that the reduction progress could 
be monitored via TLC, as the borane reagent remained on the baseline and stained less intensely 
than its catecholborane analog. NaOAc∙3H2O was then added and the mixture stirred at 70 ⁰C in a 
sealed reaction vessel for 1 h, during which time a large fast-moving spot was observed by TLC. 
The borane reagent was removed from the reaction mixture via mild aqueous base workup (sat. 
aq. NaHCO3), an additional benefit of using bis(benzoyloxy)borane rather than catecholborane. 
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Upon purification of the resulting crude residue via SiO2 flash column chromatography, this fast-
moving reaction component was isolated in 40% yield and confirmed to be the desired ADR 
product 2.38. The key alkenyl resonances at 5.28 (m) ppm and 5.24 (m) ppm, corresponding to Ha 
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Scheme 2.17. (BzO)2BH reduction of tosylhydrazone 2.36 and ADR. 
 
123.5 ppm and 123.3 ppm (C3) via HSQC, thus providing evidence for the presence of alkenyl 
proton Ha. In addition, resonances at 0.91 (d, J = 6.4 Hz, 2.2 H) and 0.83 (d, J = 6.8, 3H) provided 
evidence for the presence of the C10 methyl group, as well as further evidence in support of the 
ADR generating two diastereomers at C5. Finally, a 1H resonance at 1.62 (m, 5.2H) ppm showed 
a J2 correlation with the 13C alkenyl resonances at 143.7 ppm and 143.3 ppm (C4), and a J3 
correlation with the 13C alkenyl resonances at 123.5 ppm and 123.3 ppm (C3), providing support 
for the presence of a methyl group at C4. Based on the integral values of the methyl proton 
resonances at 0.91 ppm and 0.83 ppm, the ADR was shown to occur with a diastereomeric ratio 
of 59:41.  
The reaction conditions differed from those of the catecholborane reaction conditions in 
both the borane used, as well as the solvent system. In Kabalka’s initial report for the use of 
bis(benzoyloxy)borane, it was noted that the reactivity was very similar to that of catecholborane. 
Given this observation, we reasoned that the reducing capability of bis(benzoyloxy)borane was 
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similar to that of catecholborane, and tosylhydrazone 2.36 most likely could be reduced with either. 
The only other significant difference with these new reaction conditions was the solvent. The 
successful ADR was performed in the presence of a Lewis basic cosolvent (THF). We thus decided 
to reexamine the catecholborane conditions for the reduction of tosylhydrazone 2.36, with the 
addition of THF as a cosolvent. Tosylhydrazone 2.36 was dissolved in CHCl3 and the mixture 
cooled to 0 ⁰C. Catecholborane (1 M in THF) was added and the mixture stirred for 3 h (Table 2.4, 
entry 8). After addition of NaOAc∙3H2O and heating to 70 ⁰C, we observed the formation of a fast-
moving reaction component via TLC. Upon workup and purification, ADR product 2.38 was 
isolated in 48% yield with a diastereomeric ratio of 60:40, as confirmed by 1H and 13C NMR. This 
experiment confirmed the necessity for THF as a cosolvent for the reduction of the tosylhydrazone 
to take place. It was not evident what role the cosolvent was playing in the reduction of the 
tosylhydrazone, as, to the best of our knowledge, there have been no reports of THF necessary for 
the catecholborane reduction and subsequent ADR of tosylhydrazones. However, Brown and 
coworkers have reported a significant rate increase for the hydroboration of simple alkenes with 
9-borabicyclo[3.3.1]nonane dimer (9-BBN)2 in the presence of THF, as opposed to carbon 
tetrachloride.66 The authors propose that the active hydroborating agent is the 9-BBN monomer. 
THF complexes with the dimer to form two 9-BBN∙THF complexes. These complexes in turn 
dissociate into the 9-BBN monomers more rapidly than (9-BBN)2 dissociates into the 
corresponding monomers. We propose that s imilar effect could be operative in our case with the 
catecholborane reduction of tosylhydrazones.  
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2.5 ADR on Bicyclo[5.3.0]decadienone Tosylhydrazone Model System 2.6 
With the discovery that THF is necessary as a cosolvent for the successful catecholborane 
reduction and subsequent ADR of C1-C10 hydrogenated tosylhydrazone 2.36, we sought to apply 
this finding to the ADR of bicyclo[5.3.0]decadienone tosylhydrazone 2.6. Thus, 2.6 was dissolved 
in CHCl3 and cooled to 0 ⁰C (Table 2.5, Entry 1). Catecholborane (3 equiv, 1 M in THF) was added 
and the mixture reacted for 3 h. NaOAc∙3H2O (3 equiv) was added and the mixture heated to 70 
⁰C for 1 h. Upon filtration and purification, we isolated a colorless oil in 49% yield. 1H NMR of 
this residue revealed a mixture of two major products. The presence of an olefinic resonance at 
5.35 (s) ppm, presumably corresponding to Ha of ADR product 2.3, suggesting that one component 
was indeed the desired product. 13C NMR of the crude residue provided further evidence of the 
presence of two major products, each containing four sp2 carbons and eight sp3 carbons. Given this 
NMR data, the two products were tentatively assigned as ADR product 2.3, as well as the Wolff-
Kishner-type (WK) reduction product 2.43. Based upon the integral value of Ha of 2.3 relative to 
that of an allylic resonance corresponding to the four allylic protons Hb and Hc of 2.43 (see Figure 
2.2 below), the ratio was determined to be 43:57 2.3 to 2.43. The formula used to calculate the 
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1 HBcat (1 M in THF) (3) CHCl3 - 3 0 49 43:57 
2 HBcat (1 M in THF) (5) THF - 3 0 30 79:21 
3 (BzO)2BH (5) CHCl3/ THF - 3 0 38 4:96 
4 NaBH4 (10) AcOH - 1 100 Trace 2.3 - 
5 NaCNBH3 (3) MeOH AcOH (10) 1 70 Trace 2.3 - 
6 NaCNBH3 (3) AcOH - 4 70 Trace 2.3 - 
*Yield of crude reaction residue after passing through a silica plug 
 
To this point, all of the successful ADRs had been performed in a solvent mixture of 
CHCl3/THF. With the discovery that THF was necessary for the ADR to proceed on 
tosylhydrazone 2.6, we reasoned that we could entirely remove the CHCl3 from the reaction 
mixture. Thus, tosylhydrazone 2.6 was dissolved in THF and cooled to 0 ⁰C (Table 2.5, entry 2). 
Catecholborane (3 equiv, 1 M in THF) was added and the mixture reacted for 3 h. NaOAc∙3H2O 
(3 equiv) was added and the mixture heated to 70 ⁰C for 1 h. Upon filtration and purification, 30% 
of a colorless oil was isolated. Analysis of this residue by 1H NMR revealed the same product 
mixture that we had previously observed; however, the product ratio was now 79:21 2.3 to 2.43. 
Thus, we were able to show that solvent not only affects the progress of the reaction, but it also 
plays a critical role in ratio of reaction products, though we did not have an explanation for this 
phenomenon at the time. 
 42  
To the best of our knowledge, no reports of an allylic diazene intermediate, similar to 2.49 
(Scheme 2.18), preferentially decomposing to the Wolff-Kishner product 2.47 rather than 
undergoing the retro-ene process under catecholborane reduction conditions exist; however, 
Djerassi and coworkers have reported similar outcomes in the presence of sodium 
cyanoborohydride.64 Houk and coworkers have shown that the concerted retro-ene decomposition 
of cyclohexene diazene is exergonic by -51.2 kcal/mol.67 With this information in hand, we 

























2.6 2.22 2.44 2.45 2.3  
Scheme 2.18. Mechanism of the ADR of tosylhydrazone 2.6. 
 
decompose to the desired rearrangement product 2.3. We thus shifted our focus to alternative 
reaction conditions to effect this transformation, as the data collected to this point strongly 
indicated that the product ratio is dependent on the reaction conditions. We next wanted to probe 
the effect of different hydride sources, beginning with bis(benzoyloxy)borane. 
Thus, benzoic acid (10 equiv) was dissolved in THF and cooled to 0 ⁰C. Borane (1 M in 
THF) was added and the mixture reacted for 1 h (Table 2.5, entry 4). Tosylhydrazone 2.6 was 
dissolved in a minimal amount of CHCl3 was added and allowed to react for 3 h. After complete 
consumption of starting material was observed by TLC, NaOAc∙3H2O (5 equiv) was added and 
the mixture heated to 70 ⁰C and reacted for 1 h. Upon workup and purification via SiO2 flash 
column chromatography, we isolated 30% of the product mixture, but were surprised to find a ratio 
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of 4:96 2.3 to 2.43. Due to the highly selective nature of these reaction conditions for the Wolff-
Kishner product, we were able to unequivocally confirm that we were indeed generating this 


























Figure 2.2. Structural confirmation of Wolff-Kishner reduction product 2.43. 
 
We proposed that the Wolff-Kishner product could be generated via a radical 
decomposition pathway of diazene intermediate 2.45, a process that is known to occur, but has yet 
to be reported for α,β-unsaturated hydrazones (Scheme 2.19).68,69 To test this hypothesis, we 
proposed two experiments. The first involved meticulously degassing, then the constant bubbling 
of argon through the reaction mixture as the reaction proceeded. We reasoned this would prevent 
any adventitious oxygen from entering the reaction system. Thus, a two-necked flask was equipped 
with a balloon of argon with a needle inserted through a septum, and a solid addition funnel 
preloaded with NaOAc∙3H2O. Benzoic acid (10.2 equiv) was added to the flask, followed by THF 
which had been degassed by the freeze-pump-thaw method (x 3), and cooled to 0 ⁰C. At this point, 
a valve between the argon balloon and needle was opened and argon began bubbling through the 
reaction mixture. BH3 (5.1 equiv, 1 M in THF) was added dropwise and the mixture reacted for 1 
h. Tosylhydrazone 2.6 was dissolved in degassed CHCl3 (freeze-pump- thaw x 3) and added to the  
 


























2.46a 2.46b  
Scheme 2.19. Proposed divergent retro-ene and radical decomposition pathways of diazene intermediate 2.45. 
 
reaction mixture. After reacting for 3 h, NaOAc∙3H2O (7 equiv) was added via the solid addition 
funnel, thus avoid the need to open the reaction system to oxygen. The mixture warmed to 70 ⁰C 
and reacted for 2 h. An aliquot of the reaction mixture was taken and analyzed via 1H NMR, which 
revealed a Wolff-Kishner product 2.43 to ADR product 2.3 in a 94:6 ratio and 38% yield. 
Interestingly, the reaction had not gone to completion, and after purification 8% of tosylhydrazone 
2.6 was recovered.  
          Next, we proposed to run the reaction in the presence of a radical inhibitor, such as butylated 
hydroxytoluene (BHT). We reasoned that this would serve to eliminate any radical processes that 
were being initiated by any reagents or solvents. Thus, benzoic acid (1 M in THF, 20 equiv) was 
added dropwise to borane in THF (1 M, 10 equiv) and reacted at 0 ⁰C for 1 h. Tosylhydrazone 2.6 
along with BHT (2 equiv) were dissolved in THF and added dropwise to the reaction vessel. The 
reaction was maintained at 0 ⁰C for 3 h, then NaOAc∙3H2O (15 equiv) added. The vessel was 
lowered into an oil bath (70 ⁰C) where it was maintained for 1 h. Upon aqueous workup with 
Na2CO3, 1H NMR of the crude residue revealed a 17:83 ADR 2.3/WK 2.43 ratio; a slight 
improvement over the use of no radical inhibitor. While the results of these experiments provide 
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some evidence that a radical decomposition mechanism may not be operative, they cannot be used 
to definitively rule out this mechanism. 
2.6 Conclusions for ADR Studies 
The development of an efficient, high-yielding synthesis to an all-carbon model 
bicyclo[5.3.0]decadienone system with methyl groups at the C4 and C10 position was 
accomplished via application of the APKR. Initial 1H NMR experiments revealed that the 
tosylhydrazone 2.6 was highly resistant to catecholborane reduction. The system was further 
simplified via hydrogenation of the C1-C10 double bond, and it was found that the presence of 
THF in the reaction mixture was necessary to effect catecholborane reduction of 2.36. These 
conditions were applied to tosylhydrazone 2.6, where it was discovered that a mixture of ADR 
product 2.3 and Wolff-Kishner product 2.43 was obtained. The ratio was mostly dependent on the 
nature of the borane reducing agent, suggesting two competing mechanisms. We were able to rule 
out a radical decomposition pathway via inclusion of BHT in the reaction mixture; however, the 
mechanism giving rise to the Wolff-Kishner product is still unclear. Due to the low yields and poor 
ADR selectivity, we shifted our focus to alternative strategies for the transposition of the C4-C5 
double bond of systems similar to 2.2. 
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2.7 Base-Induced Transposition of α-Hydroxy Enone 
2.7.1  Introduction and background 
 We again turned to Reaxys to perform a comprehensive literature search for the most 
common motifs present in 6,12-guaianolides. We decided to search for compounds more 
similar to those generated via the APKR, possessing an oxygen at the C3 position and an 
explicit double bond at the C4-C5 position. Instead of a reductive transposition of the C3-
C5 enone, we decided to examine a formal transposition of this motif to the C2-C4 position. 
The resulting Reaxys searches for these two regioisomers are presented in Table 2.6. In the case 
of the 6,12-guaianolides with an oxygen at the C3 position and an explicit double bond at the 
C4-C5 position, there were674 total hits; 290 of which are biologically active, 59 have been 
isolated from a natural source, and 12 are both biologically active and naturally occurring. 
Transposition of the C3 oxygen to the C2 position and the C4-C5 double bond to the C3-C4 
position returned 710 total hits. Of these, 216 are biologically active, 452 are naturally 
occurring, and 131 are both naturally occurring and biologically active. With these search 
results in hand, we reasoned that transposition of the C3-C5 enone to the C2-C4 position would 
greatly expand the synthetic utility of the APKR towards the rapid access of biologically active 
6,12-guaianolides. 
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Table 2.6. Reaxys search for 6,12-guaianolide frameworks possessing discrete double bond at C4-C5 position 
and oxygen at C3 position,  and discrete double bond at C3-C4 position and oxygen at C2 position. 

















Total hits 674 710 
Pharmacological data 290 216 
Natural source 59 452 
Natural source + pharm. data 12 131 
Data obtained via Reaxys search using structures shown (7/20/2020). Search parameters were limited to ‘as 
substructure’ variable ‘on all atoms’, ‘stereo’, and ‘additional ring closures’. Filtered by ‘pharmacological data 
available’ and ‘isolated from natural product + pharmacological data available’. 
 
We next shifted our focus to strategies to effect such a transposition. To the best of our knowledge, 
such a direct transposition has yet to be reported in the literature; however, there have been three 
reports of a base-induced isomerization of α-hydroxy enones, affording α-keto enols. The 
exhaustive literature precedent for this transformation is presented in Scheme 2.20. The first report 
of this transformation was made by Yoshida and coworkers in 1965.70 Ireland further explored this 
transformation in 1970, and most recently, Yang applied this transformation to his total synthesis 
of cyanthiwigin I.71,72 All three examples result in the cis-fused 5,6-ring systems single 
diastereomers. Ireland reports this to be the thermodynamically favored product; however, there 
has been no experimental evidence provided to definitively rule out the possibility that this process 
is under kinetic control.71 To complete their total synthesis of cyanthiwigin I, Yang and coworkers 
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Scheme 2.20. Previous precedent for base-induced isomerization of α-hydroxy enone motif. 
 
were able to deoxygenate enol 2.52 via triflation and Pd-catalyzed hydrogenolysis of the resulting 
vinyl triflate. We reasoned that we could apply this methodology to α-hydroxy enone 2.53 to 
generate α-keto enol 2.54. From there, deoxygenation would afford the desired C3-C5 transposed 
































Scheme 2.21. Proposed conversion of α-hydroxy enone 2.53 to α-keto enol 2.54 and susequent deoxygenation 
to enone 2.55. 
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2.7.2  Synthesis of  α-hydroxy enone 2.53 
With a feasible method to access 2.55 in hand, we turned our attention to the synthesis of 
α-hydroxy enone 2.53. Retrosynthetically, we reasoned that we could install a hydroxyl group at 
the C2 position in two ways; oxidation of bicyclo[5.3.0]decadienone 2.2, or APKR of allenyl 
carboxyester 2.56, followed by hydrolysis (Scheme 2.22A). We opted to pursue the APKR of 
allenyl carboxyester 2.56, as there is more precedent within our group for the synthesis of allenyl 
carboxyesters and subsequent APKR than there is for α-hydroxylations of APKR adducts.73 In 
addition, we could use alkynyl ketone 2.7 as the starting material to access the desired allenyl 
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2.56b: R =
 














CH3, 85%, 20 h, 2.5 mol%
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Scheme 2.22. A) Potential routes to hydroxy enone 2.53. B) Synthesis of allenyl esters 2.56a-b and Rh(I)-
catalyzed APKR. 
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Thus, we proceeded with the synthesis of a series of allenyl carboxyesters, beginning with 
alkynyl ketone 2.7. Cerium-mediated addition of ethynylmagnesium bromide, followed by 
addition of acetyl chloride afforded the desired propargyl acetate 2.57a in 94% yield. Rh(II)-
catalyzed formal 3,3-sigmatropic rearrangement of 2.57a generated allenyl acetate 2.56a in 88% 
yield. The Rh(I)-catalyzed allenic Pauson-Khand reaction was then employed to access 
bicyclo[5.3.0]decadienone 2.58a in 85% yield. Scandium triflate mediated hydrolysis afforded the 
desired α-hydroxy ketone 2.53 in 88% yield; however, this reaction required high Sc(OTf)3 
loadings, as well as long reaction times (3 d).74 It was reasoned that substitution of the acetyl group 
at the C2 position with a more hydrolytically labile ester would increase the rate of hydrolysis.75 
To test this hypothesis, ketone 2.7 was converted to propargyl trifluoroacetate 2.57c in 83% yield. 
The Rh(II)-catalyzed formal 3,3-sigmatropic rearrangement of 2.57c to generate allenyl ester 2.56c 
was not successful, most likely due to the highly electron-withdrawing nature of the 
trifluoromethyl group rendering the ester carbonyl oxygen non-nucleophilic towards the Rh(II)-
alkyne complex 2.59 (Scheme 2.23).76 With these results in hand, an ester with electronic 
properties between those of an acetyl and a trifluoroacetyl group was selected. Thus, ketone 2.7 
was converted to propargyl chloroacetate 2.57b in 91% yield. The Rh(II)-catalyzed formal 3,3-
sigmatropic rearrangement of 2.57b proceeded in good yield, affording allenyl chloroacetate 2.56b 









2.59 2.60 2.56  
Scheme 2.23. Rh(II)-catalyzed formal 3,3-sigmatropic rearrangement of propargyl esters to allenyl 
carboxyesters 2.56. 
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2.56b afforded bicyclo[5.3.0]decadienone 2.58b in 86% yield. It should be noted that the APKR 
time for 2.56b was also extended, requiring 5 mol% Rh(cod)2BF4 to achieve comparable reaction 
times relative to that of 2.56a. With a more hydrolytically reactive ester installed at the C2 position, 
2.58b was subjected to the Sc(OTf)3 mediated hydrolysis conditions. To our delight hydrolysis of 
2.58b proceeded very rapidly with respect to the hydrolysis of 2.58a, achieving complete 
conversion to 2.53 in 1 h with 30 mol% Sc(OTf)3 loading. With conditions for the rapid hydrolysis 
of 2.58b in hand, we next sought to render the process catalytic in Sc(OTf)3. We found that we 
were able to decrease the Sc(OTf)3 loading to as low as 5 mol%, and still achieve complete 
hydrolysis in 3.5 h.  
2.7.3  Base-induced isomerization of α-hydroxy enone 2.53 
With α-hydroxy enone 2.53 in hand, efforts began to test the feasibility of the proposed 
isomerization of the C2-C5 α-hydroxy enone motif to the α-keto enol motif present in 2.54 
(Scheme 2.24). Reaction of 2.53 with potassium tert-butoxide (KOtBu) in THF at room 
temperature afforded α-keto enol 2.54 in 99% yield after 5 min. To confirm the structure of 2.54, 
one- and two-dimensional NMR techniques were employed. Disappearance of the C2 proton of 






KOtBu/HOtBu  THF, r.t.










5H4.43 ppm 2.93 ppm, d, J = 11.6 Hz
5.75 ppm (exchangeable)
 
Scheme 2.24. Base induced isomerization of α-hydroxy enone 2.53 to α-keto enol 2.54 and 1H NMR structural 
confirmation. 
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resonance at 2.93 (d, 11.6 Hz, 1H) ppm provided evidence of the bis-allylic C5 proton of 2.54; the 
chemical shift, splitting pattern, and coupling constant of which is in accordance with similar 
structures.77 A deuterium exchange experiment confirmed the proton at 5.75 ppm in product 2.54 
was exchangeable, lending support for the presence of a hydroxyl group in the compound. In 
addition to the NMR data, mass spectrometry confirmed the predicted mass of 2.54. This evidence 
was used to unambiguously confirm the successful conversion of 2.53 to 2.54. 
With the initial success of the isomerization of 2.53 to 2.54, we next wanted to test the 
feasibility of performing a two-step one-pot deprotection/isomerization of carboxyesters 2.58a and 
2.58b to α-keto enol 2.54, thus eliminating the need for the independent Sc(OTf)3-catalyzed 
hydrolysis. Thus acetate 2.58a was dissolved in THF and KOtBu (2.4 equiv of a 0.5 M solution in 
HOtBu) added (Scheme 2.25). Complete disappearance of starting material was observed by TLC 
after 10 min; however, upon working with sat. aq. NH4Cl, only starting material 2.58a was 
recovered. We reasoned that the disappearance of the starting material was most like due to 



















Scheme 2.25. Two-step, one-pot deprotection/isomerization of α-acyloxy enones 2.58a and 2.58b. 
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We next subjected the more reactive chloroacetate 2.58b to the same reaction conditions, and to 
our delight observed complete conversion to α-keto enol 2.54 in 15 min. While this reaction was 
only performed on an exploratory scale, we observed spot to spot conversion on TLC, and the 1H 
NMR of the crude residue was very clean with only trace amounts of tert-butanol. We were able 
to integrate the tert-butanol relative to 2.54 to determine that 2.54 was formed in approximately 
97% yield, though we did not purify this material. With these results in hand, we were able to show 
that a high-yielding, two-step, one-pot deprotection/isomerization process is indeed possible with 
2.64b. We next shifted our focus to the deoxygenation of 2.54 at the C3 position. 
To this end, of α-keto enol 2.54 was reacted with triflic anhydride (1.2 equiv) in the 
presence of triethylamine (1.3 equiv) in CH2Cl2. The reaction was complete in 30 min, and vinyl 
triflate 2.59 was isolated in 79% yield (Scheme 2.26). Triflate 2.59 was then reacted with 
tetrakis(triphenylphosphine)palladium(0) (0.5 equiv), lithium chloride (8.75 equiv), and 
triethylsilane (20 equiv) in degassed DMF. After 1 h, the reaction had gone to completion and 
enone 2.55 was isolated in 54% yield. Diagnostic 1H NMR resonances were observed at 6.02 ppm 
(pent, J = 1.2 Hz, 1H) corresponding the C3 alkenyl proton, and 3.08 ppm (d, J = 11.6 Hz) 
corresponding to the bis-allylic C5 proton. In addition, a 13C resonance at 197 ppm confirmed the 
presence of a carbonyl group, and resonances at 172, 151, 137, and 133 ppm confirmed the 
presence of four olefinic carbons. While we were able to show that C3 deoxygenation of 2.54 is 
possible, we did not optimize the reaction conditions in an effort to achieve a higher yield with 
lower tetrakis(triphenylphosphine)palladium(0) or triethylsilane loading.  
 














DMF, 90 °C      54%
2.54 2.59 2.55
6.02 ppm (pent, J = 1.2 Hz)




Scheme 2.26. Two-step one-pot deprotection/isomerization of chloroacetate 2.58b and C3 deoxygenation of α-
keto enol 2.54. 
 
With conditions for the rapid isomerization of both 2.53 and 2.58b to 2.54, and subsequent 
C3 deoxygenation in hand, we wanted to further probe the scope and functional group 
compatibility of this reaction. We decided to first apply these conditions to a substrate with a more 
reactive functional group at the C1-C10 position.  
Hao and coworkers have reported the isolation of the naturally occurring guaiane 
stelleraguaianone B (2.60); which has been shown to be cytotoxic against the A549 cell line with 
an IC50 of 8.52 μM (Scheme 2.27A).78 We thus sought to leverage the C2 hydroxyl group of 2.53 
to effect a stereocontrolled, directed epoxidation at the C1-C10 position (Scheme 2.27B). If 
successful, the base- mediated isomerization of the resulting epoxide 2.61 would grant rapid access 
the α-keto enol 2.62, a stelleraguaianone B analog. Literature precedent offers several 
methodologies in which a hydroxyl-directed epoxidation of an alkene can be performed.79,80 The 




















Scheme 2.27. A) Biologically active guaiane stelleraguaianone B (2.60). B) Proposed route to 
stelleraguaianone B analog 2.62. 
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the presence of catalytic vanadyl acetylacetonate (VO(acac)2); however, in some cases meta-
chloroperoxybenzoic acid (mCPBA) has been shown to effect hydroxyl-directed epoxidation of 
cyclic allylic alcohols.81 Because of the operational simplicity of mCPBA epoxidation, we chose 
first apply this methodology.  
α-Hydroxy ketone 2.53 was dissolved in CH2Cl2 and cooled to 0 ⁰C (Scheme 2.28). To this 
solution was added K2CO3 (3 equiv) followed by m-chloroperoxybenzoic acid (mCPBA) (1.5 
equiv). After reacting for 3 h TLC indicated complete consumption of starting material, and a 
solution of saturated aq. Na2S2O3 was added. 1H NMR of the crude reaction mixture revealed a 
relatively clean reaction profile; however, poor diastereoselectivity was achieved under these 
conditions. Two sets of resonances, one at 2.91 ppm corresponding to one of the C6 diastereotopic 
allylic protons of the syn-epoxidation product, and one at 2.81 ppm corresponding to the same 
proton of the anti- epoxidation product were observed. With these encouraging results in hand, we 
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dr = 61:39 syn/anti
6 6
 
Scheme 2.28. mCPBA epoxidation of α-hydroxy ketone 2.53. 
 
Tert-butyl hydroperoxide (TBHP) in the presence of VO(acac)2 has been commonly 
applied to the directed epoxidation of cyclic allylic alcohols.82 Having observed a mixture of 
diastereomers with the application of mCPBA, we turned to VO(acac)2 to effect the directed 
epoxidation. To a solution of 2.53 and VO(acac)2 (1 mol%) in benzene was added tert-butyl 
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hydroperoxide at room temperature (Scheme 2.29). This was allowed to react for 30 min, at which 
point it was complete, as evidenced by TLC. The reaction was quenched with sat. aq. Na2S2O3 
affording epoxide 2.61 in high yield without the need for further purification; however, in one 
experiment, an uncharacterized byproduct was formed upon addition of Na2S2O3. It is unclear how 


























Scheme 2.29. Diastereoselective epoxidation of C1-C10 double bond of 2.53. 
 
certain conditions.83 Addition of Na2S2O3 was circumvented by concentration of the reaction 
mixture without workup, followed by purification via SiO2 column chromatography, again 
affording 2.61 in 94% yield. 
In addition to generating 2.69 in high yield, only a single diastereomer was formed as 
evidenced by 1H and 13C NMR. Diagnostic 1H NMR resonances appear at 3.88 ppm (d, J = 3.6 
Hz) corresponding to the proton on C2, 1.48 ppm (s) corresponding to the protons on the C4 methyl 
group, and 1.82 (d, J = 0.8 Hz) ppm corresponding to the protons on the C10 methyl group. In 
addition, 13C NMR resonances at 204 ppm corresponding to the C3 carbonyl carbon, 168 ppm and 
141 ppm, corresponding to the C5 and C4 alkenyl carbons, respectively, and 71 ppm, 68.3 ppm, 
and 67.9 ppm, corresponding to the C1, C2, C10 carbons, confirmed the presence of only one 
diastereomer. The downfield 13C resonance at168 ppm confirmed that the C4-C5 double bond had 
not undergone epoxidation. Based on literature precedent for the syn-selective epoxidation of 
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allylic alcohols under these conditions, we propose that the relative stereochemistry of 2.61 is 
syn.82 With a single diastereomer of 2.61 in hand, we could now test the isomerization conditions 
that were successful for the conversion of 2.53 to 2.54 on a substrate with a C1-C10 epoxide to 
probe the functional group tolerance of this reaction.  
Epoxide 2.61 was dissolved in THF. To this was added a solution of KOtBu in tBuOH (2 
equiv, 0.5 M). The mixture was stirred for 10 min at room temp during which period it turned dark 
yellow. Under these strongly basic conditions, only decomposition of 2.61 and no desired 
isomerization product 2.62 was detected via either TLC, which showed only baseline material, or 
1H NMR of the crude reaction mixture, which showed predominately aliphatic resonances, and 
nothing in the region of 3 ppm, which is where we expect Ha to be (Table 2.8, entry 1).  
With preliminary results in hand, we decided to alter the reaction cnditions in an effort to 
mitigate decomposition and generate isomerization product 2.62. The first variable we chose to 
alter was the solvent, as this type of isomerization has been performed in both THF as well as 
tBuOH.71,72 Thus, 2.61 was dissolved in tBuOH and KOtBu in tBuOH (2 equiv, 0.5 M) was added. 
The rate of consumption of 2.61 was markedly slower when performed in tBuOH as opposed to 
THF, however only decomposition was observed, as evidenced by TLC and 1H NMR of the crude 
reaction mixture (Table 2.8, entry 2). Based upon the rapid rate of decomposition, we decided to 
run the reaction at a depressed temperature. Epoxide 2.61 was dissolved in THF and cooled to -78 
ºC. A solution of KOtBu in tBuOH (2 equiv, 0.5 M) was added. The mixture was slowly warmed 
and 2.61 did not start being consumed to any appreciable extent until the temperature reached 
about -10 ºC. Again, only decomposition of 2.61 was observed (Table 2.8, entry 3).  
It became evident that the epoxide at the C1-C10 position was incompatible with the 
strongly basic conditions required to effect the isomerization. These results suggested that the 
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base-mediated isomerization conditions were incompatible with a reactive functional group at the 
C1-C10 position. 
 











Entry Solvent Temp (⁰C) Time (min) Result 
1 THF rt 10 decomposition 
2 tBuOH rt 30 decomposition 
3 THF -78 - rt 60 decomposition 
 
2.8 Conclusions for the Base-Induced Enone Isomerization 
A rapid, high-yielding route to multiple allenyl carboxyesters was developed. It was found 
that the Sc(OTf)3-catalyzed hydrolysis to reveal the 2-hydroxy bicyclo[5.3.0]decadienone 2.53 
could be accelerated via replacement of the acetoxy group with a chloroacetoxy group. In addition, 
catalyst loading was reduced from 30 mol% to 5 mol%. The potassium tert-butoxide-mediated 
isomerization of 2-hydroxy bicyclo[5.3.0]decadienone 2.53 was a rapid, facile process affording 
the α-keto enol 2.54 in quantitative yields. It was found that a two-step, one-pot protocol could be 
applied for the hydrolysis/isomerization of the 2-chloroacetoxy bicyclo[5.3.0]decadienone 2.58b, 
affording 2.54 in cleanly and in high yields. α-Keto enol 2.54 was successfully deoxygenated to 
afford enone 2.55; validating this base-mediated isomerization process as a valid strategy to access 
the C2-C4 enone motif observed in many 6,12-guaianolide frameworks. When these base-
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mediated isomerization conditions were applied to a substrate bearing an epoxide at the C1-C10 
position, complete decomposition of the starting material was observed. This suggests that this 
method is not applicable to substrates with leaving groups at the allylic C1-C10 position. With 
these successful results in hand, we shifted our focus to the application of this methodology to a 
more complex system. We felt that it would be of interest to the synthetic community to take on a 
total synthesis project where we could showcase the base-mediated isomerization of a lactone-







3.0 Studies Towards the First Total Synthesis of (–)-Dehydroleucodine 
3.1 Introduction 
With a method to further functionalize the α-hydroxy ketones afforded by the APKR, we 
sought to apply this methodology to the total synthesis of a naturally occurring 6,12-guaianolide. 
Few reports of the use of the APKR to generate the core 5,7-ring system of guaianolides exist.84–
87 We sought to leverage what we had learned about the functionalization of the APKR adduct to 
further expand the utility of the APKR, thus showcasing its application for the rapid synthesis of 
6,12-guaianolides.  
(+)-Dehydroleucodine (3.1) is a 6,12-guaianolide first isolated from Lidbeckia pectinata in 
1972 by Bohlmann and Zdero (Scheme 3.1).88 It has been shown to be cytotoxic towards the human 
astrocytoma D384 cell line, eight different acute myeloid leukemia cell lines, and human 
glioblastoma cells.89–91 It is believed that (+)-dehydroleucodine (3.1) induces phosphorylation of 
tumor protein TP73, inducing apoptosis.89 In addition, (+)-dehydroleucodine (3.1) has been shown 
to inhibit adipogenesis; making it a compound of interest for the potential treatment of obesity.92 
With an enone at the C2-C4 position and a double bond at the C1-C10 position, we reasoned that 
this biologically active 6,12-guaianolide would be an ideal candidate for a total synthesis study. It 
would give us the opportunity to develop the first enantioselective synthetic route to the 6,12-
guianolide framework within our group, as well as test the feasibility of applying the previously 
reported base-mediated enone isomerization to a system with a potentially reactive functionality 
at the C6 position.  
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Our desire was to develop a synthetic route to access both enantiomers of dehydroleucodine 
(3.1) in a selective manner. Our first retrosynthetic disconnections were methylenation at the C11 
position of the lactone of 3.2, and deoxygenation at the C3 position of 3.2 (Scheme 3.1). Though 
previous group members have shown that the C11 methylene unit could be installed during the 
lactonization step via tandem allylboration/lactonization to afford a mixture of the trans- and cis-
lactones, the methodology has yet to be rendered enantioselective, and with the strongly 
electrophilic nature of the exocyclic α,β-unsaturated lactone, we were concerned that it would be 
incompatible with the conditions applied for the isomerization of 3.3 and deoxygenation of 3.2. 
We reasoned that 3.2 could be accessed via isomerization of α-hydroxy ketone 3.3, which could 
in turn be accessed via APKR of allenyl carboxyester 3.4, followed by deacetylation of the 
corresponding ester. With a direct route from allenyl carboxyester 3.4 to (+)-dehydroleucodine 












































Scheme 3.1. Retrosynthetic analysis of (+)-dehydroleucodine (3.1), employing an APKR as the key ring 
forming step, followed by isomerization. 
 
Installation of the allenyl carboxyester of 3.4, we reasoned, could be performed via 1,2-
addition of an ethynyl unit to ketone 3.5, followed by acetylation of the resulting propargyl alcohol, 
then Lewis acid-mediated formal 3,3-sigmatropic rearrangement of the corresponding propargyl 
carboxyester, as our group has previously shown (Scheme 3.2).93 Ketone 3.5 could in turn be  
 

















Scheme 3.2. Proposed access to allenyl carboxyester 4 from β-formyl ester 3.6. 
 
generated via 1,2-addition of a propynyl unit to β-formyl ester 3.6, followed by lactonization of 
resulting propargyl alcohol. This key step must be performed in a diastereoselective manner to 
afford the trans-lactone. Reissig has reported the diastereoselective addition of Grignard reagents 
and organocuprates to β-formyl esters, affording the trans-lactones in good to excellent 
diastereomeric ratios.94 Another criterion for this key step is the chemoselectivity of the 1,2-
addition. We would expect that 1,2-addition could occur carbonyl carbon of the ketone, ester, or 
aldehyde. While we would expect the ester to be substantially less electrophilic than either the 
ketone or the aldehyde, we needed a reagent that selectively adds to aldehydes in the presence of 
ketones in a 1,2-fashion. Reetz has shown that both organolithium and Grignard reagents, when 
transmetalated with TiCl4, add to aldehydes in the presence of ketones with complete 
chemoselectivity.95 Later, Reissig showed that they were able to achieve diastereoselective 
addition of organotitanium reagents to β-formyl esters, affording trans-lactones.96 We reasoned 
that we could use an organotitanium nucleophile to achieve both chemo- and diastereoselective 
1,2-addtion to the aldehyde, affording trans-lactone 3.5, while leaving the ketone intact. Using this 
chemoselective methodology would also circumvent the need mask the ketone with a protecting 
group. With a feasible route allenyl carboxyester 3.4 in hand, we shifted our analysis to synthesis 
of β-formyl ester 3.6 in an enantioselective fashion. 
 































Scheme 3.3. Potential retrosynthetic approaches for the enantioselective construction of β-formyl ester 3.6. 
 
Retrosynthetically, we devised three feasible routes to β-formyl ester 3.6 in an 
enantioselective fashion (Scheme 3.3). The first proposed route involved the oxidative cleavage 
of cyclohexene 3.7. Nino and Maiuolo have reported the use of a chiral imidazolidinone catalyst 
supported on an ionic liquid in water as an efficient way to access 3.7 via the enantioselective 
Diels-Alder reaction of isoprene (3.8) and acrolein (3.9) in 97% yield and 91% ee (Scheme 3.4).97 
Oxidative cleavage of 3.7 would afford aldehyde 3.14, which would then need to be selectively 
oxidized to generate β-formyl ester 3.6. To ensure regioselective oxidation at the C3 position, 
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Scheme 3.4. Proposed Diels-Alder approach to β-formyl ester 3.6. 
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Diels-Alder adduct 3.7 would most likely need to be protected as acetal 3.15, followed by oxidative 
cleavage, oxidation, then deprotection. Benefits of this route include the low cost, commercial 
availability of the starting materials, and either enantiomer of 3.6 could theoretically be accessed. 
The acetal protection/deprotection step, however, not only impacts step and atom economy, but 
the mildly acidic conditions required for the acetal protection and deprotection could cause 
epimerization of the C1 stereocenter. While feasible, alternative routes to β-formyl ester 3.6 that 
would not require a protection/deprotection sequence were examined. 
The second route to β-formyl ester 3.6 that was considered was the enantioselective 1,4-
addition of aldehyde 3.11 to methyl vinyl ketone 3.10 (Scheme 3.3). Gellman and coworkers have 
reported the use of diphenylprolinol methyl ether 3.20 and chiral imidazolidinone 3.22 as effective 
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Scheme 3.5. A) Diphenylprolinol methyl ester-catylized 1,4-conjugate additions of aldehydes to enones. B) 
Imidazolidinone-catalyzed 1,4-conjugate addition of aldehydes to enones. 
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(Scheme 3.5).98,99 This methodology benefits from low catalyst loadings, cheap and commercially 
available starting materials, good yields, and high enantiomeric excesses. While this method offers 
the most direct route to β-formyl ester 3.6, the reported substrate scope is fairly limited, with no 
reports of this methodology being applied to aldehydes or enones that possess additional 
heteroatoms. While not disqualifying, we nonetheless chose to examine the feasibility of the third 
proposed route; oxidative cleavage of γ,δ-unsaturated ester 3.12 (Scheme 3.3). 
While not as step-economical as the direct enantioselective conjugate addition of aldehyde 
3.11 to methyl vinyl ketone 3.10, the oxidative cleavage of γ,δ-unsaturated ester 3.12 offered an 
alternative way to set the stereochemistry at the C1 position. Both the enantioselective Diels-Alder 
reaction and the enantioselective 1,4-addition rely on a chiral catalyst to set the stereochemistry of 
the aldehyde at the C1 position. In the case of γ,δ-unsaturated ester 3.12, we propose the 
stereochemistry can be set in a previous step, then retained in a 3,3-sigmatropic rearrangement; in 
this case a Johnson-Claisen rearrangement of allylic alcohol 3.25 to install the desired methyl ester 
(Scheme 3.6). Unlike the enantioselective 1,4-addition of aldehyde 3.11 to methyl vinyl ketone 
10, there is literature precedent for the preparation of allylic alcohol 3.25 in an enantioselective 
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Scheme 3.6. Proposed route to γ,δ-unsaturated ester 3.12 via chiral cyclopentenol 3.25. 
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of AlMe3 to cyclic enones to afford the corresponding allylic alcohols (Scheme 3.6).100 While 
yields were typically good for 6- and 7-membered rings (72-90%), the yields for the analogous 5-
membered rings were relatively low (37-58%); however, the enantiomeric excess for all examples 
was very high (95-99% ee).  
An alternative route to access allylic alcohol 3.25 is the ring-closing metathesis of (S)-
linalool (3.24). Harvey and coworkers have shown the quantitative, solvent-free conversion of (±)-
linalool to (±)-3.25 in the presence of 0.1 mol% Hoveyda-Grubb’s 2nd generation catalyst (H-
GII).101 Though Harvey did not report the results of the reaction performed on an enantioenriched 
substrate, Minnaard and coworkers have performed ring-closing metatheses on similar substrates 
using H-GII to generate enantioenriched 3.25, and reported complete retention of stereochemistry 
under the reaction conditions.102 We thus predict that the stereochemistry of (S)-linalool (3.24) 
should be retained during the metathesis. Due to the high yield, stereoretention of the staring 
material, low catalyst loading, and solvent-free reaction conditions, we opted to pursue ring-
closing metathesis of (S)-linalool (3.24) followed by Johnson-Claisen rearrangement to afford γ,δ-












Scheme 3.7. Retrosynthetic analysis of β-formyl ester 3.6. 
 
With a feasible route to (+)-dehydroleucodine (3.1) in hand, we set out to begin our studies 
towards its total synthesis. To our surprise, (S)-linalool (3.24) was not commercially available; 
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however, (R)-linalool (3.34) (90% ee) is commercially available at a cost of $0.11 per gram. While 
it is recognized that only the (R)- enantiomer of linalool is cheap and commercially available, the 
(S)- enantiomer has been accessed via Sharpless asymmetric epoxidation of geraniol (3.26), 
followed by mesylation of the terminal hydroxyl group (Scheme 3.8).103,104 Reductive elimination 
of epoxy mesylate 3.28 with lithium naphthalenide affords (S)-linalool (2.24) in good yield, with 
retention of stereochemistry.105 Though this short synthetic route to (S)-linalool (2.24) has been 
reported, we reasoned that it would be of interest to develop a synthetic route to the unnatural (–)-
dehydroleucodine, as there is little available information on the biological activity of the unnatural 
enantiomers of guaianolides. Thus, we commenced our synthetic studies towards (–)-





TBHP, 4 Å MS
CH2Cl2, -23 °C
3.27, 94% (93% ee)
MsCl, Et3N
CH2Cl2, 0 °C       97%
Li naphthalenide
THF, - 25 °C       85%
geraniol (3.26) 3.28 (S)-linalool (3.24)
Scheme 3.8. Reported synthetic route to (S)-linalool (3.24). 
3.2 Ring Closing Metathesis and Claisen Rearrangement of (R)-linalool 
 As mentioned above, Harvey and coworkers were able to convert (±)-linalool 
(3.29) to the corresponding allylic cyclopentenol 3.30 via H-GII under solvent-free 
conditions at ambient temperature (Scheme 3.9). They then purified the product via 
vacuum distillation at room temperature, confirming the highly volatile nature of 
cyclopentenol 3.30. The authors also report the dehydration of cyclopentenol 3.30 to a mixture 
of cyclopentadienes 3.31 and 3.32, ether 3.33, as well as cyclopentadiene dimers, at elevated
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temperatures, in the presence of H-GII. The authors noted that oxidation of the H-GII catalyst by 
bubbling air through the reaction mixture mitigated the dehydration pathway completely. We 
proposed moving forward bu leveraging Harvey’s conditions to effect the ring-closing 
metathesis, then rendering the catalyst inactive via oxidation. Application of the Johnson-
Claisen rearrangement conditions would afford the desired γ,δ-unsaturated methyl ester 3.36 




neat, rt, 45 min         100% 60 °C
O
(±)-linalool (3.29) 3.30 3.31 3.32 3.33
Scheme 3.9. Reported RCM of (±)-linalool (3.29), and dehydration of cyclopentenol 3.30 in the presence of H-
GII at elevated temperature. 
Thus, Hoveyda-Grubb’s 2nd generation catalyst (H-GII, 0.001 equiv) was added to a flask 
equipped with a nitrogen inlet adapter and a second outlet adapter attached to an oil bubbler. To 
the flask was added neat (R)-linalool (3.34) at room temperature (Scheme 3.10). After 
approximately 10 min, the green solution began violently bubbling due to the release of 
isobutylene gas. The bubbling diminished over the course of 1 h, at which point complete 
consumption of starting material was observed by TLC. A needle attached to an airline was 
inserted into the reaction vessel, and air bubbled through the solution for 45 min. During this time 
the color of the solution changed from green to dark brown, indicating oxidation of the H-GII 
catalyst, as reported by Harvey. A small aliquot of the reaction mixture was taken at this point, 
and 1H NMR was employed to confirm that (R)-linaool (3.34) had been fully converted to 
cyclopentenol 3.35. The needle attached to the airline was removed and trimethyl orthoacetate (3 
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OH 1) H-GII (0.1 mol%)











Scheme 3.10. Attempted two-step-one-pot RCM/Johnson-Claisen rearrangement of (R)-linalool (3.34). 
 
equiv) was added followed by propionic acid (0.1 equiv). The solution was lowered into a 
preheated oil bath set to 130 ⁰C and cyclopentenol 3.35 was fully consumed within 30 min. 1H 
NMR of the crude reaction mixture revealed complete dehydration of cyclopentenol 3.35, 
affording a mixture of methyl cyclopentadiene isomers and dimers, as evidenced by multiple 
olefinic resonances in the 6-5 ppm region (Table 3.1 entry 1). We reasoned that the acidic 
conditions required for the Johnson-Claisen rearrangement were causing dehydration of 
cyclopentenol 3.35. Because of this, we decided to try the Johnson-Claisen with no acid catalyst. 
The RCM procedure was repeated, as reported above, and trimethyl orthoacetate (3 equiv) added 
to the crude reaction mixture. The mixture was heated to 140 ⁰C for 2 h, during which time no 
consumption of cyclopentenol 3.35 was observed by TLC (Table 3.1 entry 2). Thus, the mixture 
was transferred to a microwave vial and heated to 140 ⁰C for 30 min in a microwave reactor, as 
described by others.106 However, no reaction was observed. It was clear that we would need an 
acid catalyst, but due to the lability of the tertiary hydroxyl group of cyclopentenol 3.35, we 
reasoned that we would have to use a weak acid. We turned to the literature to seek conditions for 
which a Johnson-Claisen rearrangement was performed on an acid-sensitive, tertiary allylic cyclic 
alcohol. 
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Table 3.1. Conditions to effect RCM and Johnson-Claisen rearrangement fo (R)-linalool (3.34). 
OH




(R)-Linalool (3.34) 3.36  
Entry Additive (equiv) Temp (⁰C) Result 
1 Propionic acid 140 °C Dehydration 
2 None 140 °C No reaction 
3 Hünig’s base, 4Å mol. sieves 180 °C No reaction 
4 Hydroquinone 160 °C No desired product 
 
Brimble and Zhu have both used phenol to catalyze a Johnson-Claisen rearrangement in 
the synthetic studies towards oleocanthal, and total synthesis of (+)-peganumine A, 
respectively.107,108 Iwata and Bach reported the use of hydroquinone as a suitable, weak Brønsted 
acid for the Johnson-Claisen rearrangement used in their total syntheses of (±)-
descarboxyquadrone and meloscine, respectively.109,110 In addition to the use of phenol and phenol 
derivatives, Tokuyama and coworkers reported the use of 4 Å molecular sieves in Hünig’s base as 
a basic set of conditions to effect the Johnson-Claisen in their total synthesis of (-)-
isoschizogamine.111 With multiple sets of conditions in hand, we set out to apply a some of these 
catalysts to our system. The pKa of phenol is 9.98 while the pKa of hydroquinone is 9.96.112 Due 
to the marginal pKa difference between the two acids, we reasoned that if the reaction failed in the 
presence of hydroquinone it would be unlikely to succeed in the presence of phenol. Thus, we 
chose to screen only hydroquinone as a potential phenolic acid catalyst. H-GII (0.001 equiv) was 
added to (R)-linalool (3.34) and the mixture reacted at room temperature for 1 h. Upon complete 
consumption of starting material, as evidenced by TLC, air was bubbled through the reaction 
mixture for 1 h. Trimethyl orthoacetate (12 equiv) and benzoquinone (white crystals, 1 equiv) were 
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added and the mixture placed in a microwave reactor at 130 ⁰C for 1 h. No reaction occurred during 
this period, as evidenced by TLC, so the mixture was resubjected to the microwave at 130 ⁰C for 
4 h. Again, no appreciable reaction had occurred. The temperature was increased to 160 ⁰C, and 
the mixture reacted at this temperature for 4 h. No appreciable reaction had taken place based on 
TLC (Table 3.1 entry 4). It seemed unlikely that phenolic acid catalysts would be sufficient to 
catalyze the Johnson-Claisen rearrangement on our system, though we saw no dehydration of 3.35 
under these conditions. With these results in hand, we set out to test the effect of 4 Å molecular 
sieves in Hünig’s base on the Johnson-Claisen rearrangement. 
After the standard RCM procedure was applied to (R)-linalool (3.34), Hünig’s base (3 
equiv) was added followed by 4 Å molecular sieves (~1:1 wt/wt of (R)-linalool). The mixture was 
reacted in the microwave reactor at 140 ⁰C for 1 h, during which period no reaction had occurred, 
as evidenced by TLC. The temperature was increased to 180 ⁰C for 1 h, with no effect (Table 3.1 
entry 3). With limited success for the two-step-one pot conversion of (R)-linalool (3.34) to γ,δ-
unsaturated ester 3.36 via RCM followed by Johnson-Claisen, we decided to pursue an alternative 
route. While we still wanted to use this sequence of reactions to set the stereochemistry at the C1 
position of 3.36, it was apparent that the Johnson-Claisen rearrangement was incompatible with 
our system. We thus turned to the Eschenmoser-Claisen rearrangement, which requires no acid 
additives and affords γ,δ-unsaturated amides.113,114  
Thus H-GII (0.001 equiv) was added to (R)-linalool (3.34) (Scheme 3.11). The green 
mixture was reacted at room temperature for 1 h at which point complete consumption of starting 
material was evidenced by TLC. Air was bubbled through the reaction mixture for 1 h, followed 
by addition of toluene (0.2 M) then dimethylacetamide dimethyl acetal (3 equiv). The mixture was 
refluxed for 24 h, at which point complete consumption of allylic alcohol 3.35 was observed by 
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TLC. The mixture was concentrated and purified via SiO2 flash column chromatograph, affording 
the desired γ,δ-unsaturated amide 3.37 in 75% yield over two steps. 1H NMR and 13C NMR were 
utilized to confirm the structure of 3.37. 
 
1) H-GII, neat












Scheme 3.11. Successful RCM/Eschenmoser-Claisen rearrangement of (R)-linalool (3.34) to generate γ,δ-
unsaturated amide 3.37. 
 
A 1H resonance at 5.31–5.27 ppm (m, 1H) corresponding to alkenyl proton Ha provided 
evidence for a trisubstituted alkene. Two methyl singlets at 2.99 and 2.94 ppm corresponded to the 
methyl groups of the amide, and a third, broadened methyl resonance at 1.70 ppm corresponded 
to the protons on the C3 methyl group. The broadening of this signal most likely suggested allylic 
coupling to Ha, however the splitting pattern was not well defined, and a coupling constant could 
not be discerned. 13C NMR revealed a resonance at 172.7, corresponding to the amide carbonyl 
carbon, and two alkenyl carbons at 141.1 and 128.4 ppm, corresponding to C2 and C3, 
respectively. It was later found that the RCM proceeds in toluene in comparable yields to when 
performed neat, though the reaction time had to be extended to 3 h. By running the initial RCM in 
toluene, the process was converted to a true two-step-one-pot procedure which did not require the 
transfer of cyclopentenol 3.35 to a larger reaction vessel before application of the Eschenmoser-
Claisen conditions. With γ,δ-unsaturated amide 3.37 in hand, our next goal was to convert the 
dimethyl amide moiety to an ester. 
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3.3 Conversion of γ,δ-unsaturated Amide to γ,δ-unsaturated Ester 
Tertiary amides can be exceedingly difficult to convert to the corresponding esters, often 
requiring strongly acidic or basic reaction conditions and elevated temperatures.115 We wanted to 
avoid the harsh reaction conditions required for standard alcoholysis, so we turned to the literature 
for guidance. McClure and coworkers have shown the use of trimethyl- and triethyloxonium 
tetrafluoroborates in acidic solution for the conversion of tertiary amides to the corresponding 











CH2Cl2, -40 °C - 0 °C
3.38 3.39: R = Et, 88%
3.36: R = Me, 85%  
Scheme 3.12. Tf2O-mediated esterification of amide 3.37 via imidate 3.38. 
 
similar to 3.38 (Scheme 3.12). A milder set of conditions was reported by Charette and coworkers, 
where imidate intermediates, similar to 3.38, are generated via reaction of triflic anhydride with 
the amide.117 Addition of alcohol, followed by acidic workup afforded the esters in good to 
excellent yields. We decided to apply these conditions to amide 3.37. Thus, amide 3.37 was 
dissolved in CH2Cl2 and pyridine (3 equiv) added. The mixture was cooled to -40 ⁰C and Tf2O 
added dropwise over the course of a few mins. The mixture was reacted at -40 ⁰C for 1 h, then 
slowly warmed to 0 ⁰C over the course of 2 h. The mixture was reacted at this temperature for 1 h, 
at which point EtOH (30 equiv) was added. The mixture was warmed to room temperature and 
reacted for 16 h. It was then diluted with Et2O and 1 N aq. HCl added (approximately equal volume 
to solvent). Upon extractive workup and purification via SiO2 flash column chromatography, ethyl 
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ester 3.39 was obtained in 65% yield. While not reported by Charette, it was found that after 
addition of 1 N aq. HCl, the reaction must be allowed to stir for at least 1 h for optimal conversion. 
Doing this led to ethyl ester 3.39 being formed in 88% yield. While the authors reported the 
conversion of amides to the corresponding ethyl esters, we found that replacement of EtOH with 
MeOH afforded methyl ester 3.36 in comparable yields. With successful access to ester 3.36 in an 
enantioselective fashion, we were poised to execute the next step towards the total synthesis of (–
)-dehydroleucodine; oxidative cleavage of the C2-C3 double bond (Scheme 3.13). 
3.4 Oxidative Cleavage 












Scheme 3.13. Proposed oxidative cleavage of γ,δ-unsaturated ester 3.36. 
 
When searching the literature for suitable methods for the oxidative cleavage of 3.36, there 
were myriad conditions that seemed appropriate to generate 3.40.118 Ozonolysis conditions looked 
especially appealing, as they are mild, rapid, generate few byproducts, and do not use toxic metals. 
The first substrate we applied ozonolysis conditions to was ethyl ester 3.39. Thus, γ,δ-unsaturated 
ester 3.39 was dissolved in CH2Cl2 and the solution cooled to -78 ⁰C. A stream of O3/O2 was 
bubbled through the solution until a blue color was observed (~15 min) (Scheme 3.14). At this 
point, Me2S was added and the mixture reacted while warming to room temperature for 24 h. We 
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could visualize the disappearance of starting material 3.39 by TLC (KMnO4 stain); however, we 
were unable to visualize any other component of the reaction mixture, regardless of the stain used. 
KMnO4, p-anisaldehyde, ceric molybdate, and even 2,4-dinitrophenylhydrazone all failed at 
visualizing any reaction component. The crude reaction mixture was concentrated via rotary 
evaporation and the residue subjected to 1H NMR and 13C NMR analysis. A 1H signal at 5.71 and 
5.67 ppm suggested the presence of an alkene, though this was not likely given the reaction 












3.41, 71:29 dr3.39  
Scheme 3.14. Ozonolysis of γ,δ-unsaturated ester 3.39 in CH2Cl2 mith Me2S as the terminal reductant. 
 
values of these resonances seemed to suggest a single compound was present as two diastereomers. 
Indeed, every major resonance was associated with a corresponding minor resonance. Using the 
integral values of the signal at 5.71 and 5.67, the diastereomeric ratio was determined to be 71:29, 
respectively. In addition to this resonance, triplets corresponding to each diastereomer were 
observed at 1.30-1.23 ppm, and quartets at 4.18-4.10 ppm, providing strong evidence for the 
presence of an ethyl ester. Singlets at 1.53 and 1.51 ppm corresponded to the methyl group of each 
diastereomer. Groups of signals at 2.61-2.54 ppm integrating for 1 H, 2.45-2.35 ppm integrating 
for 2H, and 2.31-2.19 ppm integrating for 1 H, suggested the presence of relatively deshielded 
protons, though no coupling constants could be ascertained from these groups. 13C signals at 172.1 
and 171.8 confirmed the presence of an ester carbonyl carbon for each diastereomer. Interestingly, 
resonances at 108.1 and 104.5 ppm, corresponding to the major diastereomer, and 107.7 and 104.4 
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ppm, corresponding to the minor diastereomer, were observed. Based on the reaction mechanism 
of ozonolysis and these diagnostic resonances, we determined that the compound isolated was 
secondary ozonide 3.41 (Scheme 3.14). We reasoned that the isolation of secondary ozonide 3.41 
was a result of incomplete reduction of this species with the terminal reductant, in this case, Me2S. 
A common solution to this problem is the use of MeOH as a cosolvent, which is reported 
to act as a nucleophile towards carbonyl O-oxide intermediate 3.44, affording hydroperoxyl acetal 
3.46 (Scheme 3.15).119 This is then reduced to the carbonyl compound 3.47 via terminal reductant.  



































Scheme 3.15. Mechanism of ozonolysis, leading to isolated secondary ozonide 3.45. 
 
With this information in hand, we repeated the above reaction, this time on methyl ester 3.36 using 
a 4:1 CH2Cl2/MeOH solvent system (Scheme 3.16). The products of this reaction were unable to 
be visualized by TLC; however, upon concentration of the reaction mixture and 1H NMR of the 
crude residue, we noticed the presence of two distinct products. A 1H resonance at 9.67 ppm (d, J 
= 0.8 Hz) corresponding to Ha provided evidence for the presence of aldehyde 3.40; however, the 
signal was a part of the minor reaction component based on the integral value. Another key 
diagnostic resonance was observed at 4.16 ppm (d, J = 5.2 Hz), and corresponded a single proton 
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of the major reaction component. Two methyl singlets at 3.65 ppm (3 H) and 2.12 ppm (3 H) 
provided evidence for the presence of a methyl ester and a methyl ketone on the major reaction 
component. Similarly, methyl singlets at 3.67 ppm (1 H) and 2.13 ppm (1 H) confirmed the 
presence of a methyl ester and methyl ketone on aldehyde 3.40. A diagnostic methyl singlet at 3.33 
(3 H) ppm suggested the presence of a methyl ether on the major reaction component. Based upon 
this methyl singlet, as well as the downfield doublet at 4.16 ppm, we reasoned that the major 
reaction component was most likely hemiacetal3.48, where the signal at 4.16 ppm corresponded 

















Scheme 3.16. Ozonolysis of γ,δ-unsaturated ester 3.36 in CH2Cl2/MeOH with Me2S as the terminal reductant. 
 
to Hb. In addition to these data, a large singlet at 2.61 ppm (8H) corresponding to a dimethyl 
sulfoxide impurity suggested that the dimethyl sulfide had indeed been oxidized. For this reason, 
we propose a hydroperoxy acetal intermediate similar to 3.48 was formed, then reduced via action 
of dimethyl sulfide (Scheme 3.15). This result led us to the conclusion that dimethyl sulfide was 
not the optimal reducing agent for use on our system.  
We again turned to the literature for alternative reducing agents that could be used for the 
oxidative cleavage of β-formyl ester 3.36. In the meantime, with the 1:3 mixture of 3.40/3.48 in 
hand, we wanted to determine the enantiomeric ratio of β-formyl ester 3.40 to ensure that no 
epimerization of the C1 stereocenter had occurred during the oxidative cleavage. We were 
concerned with the configurational stability of the C1 aldehyde under acidic conditions and for 
this reason were reluctant to subject the mixture to silica-based chiral resolution. We searched for 
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alternative methods to determine the enantiomeric ratio of α-chiral aldehydes and came across a 
methodology developed by Gellman and coworkers.120 By reacting β-formyl ester 3.40 with the 
commercially available chiral amine (S)-1-methoxypropan-2-amine 3.49 in CDCl3in an NMR 
tube, 1H NMR can be used to ascertain the diastereomeric ratio of the resulting imine 3.50 based 
on the relative integral values of Ha for each imine diastereomer (Figure 3.1). The diastereomeric 
ratio of imine 3.50 is equivalent to the enantiomeric ratio of β-formyl ester 3.40. Using this 


















Figure 3.1. Determination of 3.40 enantiomeric ratio by reaction of chiral amine 3.49, and 1H NMR 
integration of imine 3.50 proton Ha. 
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concerning, as the enantiomeric ratio of commercially available (R)-linalool (3.34) was reported 
to be ≥95:5, suggesting that epimerization had occurred at some point. As stated above, literature 
precedent indicates the RCM of tertiary alcohols similar to (R)-linalool (3.34) can be performed 
with complete retention of stereochemistry, and it is known that Claisen rearrangements result in 
complete retention of stereochemistry. Thus, we reasoned that epimerization had to be occurring 
either during or after the oxidative cleavage. To determine whether erosion of enantiopurity was 
occurring under the oxidative cleavage reaction conditions or simply upon standing, we subjected 
another sample of the 1:3 mixture of 3.40/3.48 that had been in the freezer for 3 days to the 1H 
NMR procedure described above, and found the same 32:68 dr. Thus, we concluded that 
epimerization was occurring during ozonolysis. With this information in hand, we set out to find 
another reducing agent that would be more effective than dimethyl sulfide.  
The terminal reductant most commonly employed, other than dimethyl sulfide, is triphenyl 
phosphine.118 We decided to repeat the ozonolysis experiment described above, but replace 
dimethyl sulfide with triphenyl phosphine (Scheme 3.17). Upon workup and purification, β-formyl 
ester 3.40 was isolated in 81% yield with a 32:68 dr. We saw no evidence of the formation of any 












Scheme 3.17. Ozonolysis of γ,δ-unsaturated ester 3.36 in CH2Cl2/MeOH with Me2S as the terminal reductant. 
 
ozonide, acetal, or hemiacetal products via TLC or 1H NMR of the crude reaction mixture, 
suggesting that triphenyl phosphine was a suitable reducing agent for the complete conversion of 
γ,δ-unsaturated ester 3.36 to β-formyl ester 3.40 via ozonolysis. It was evident that epimerization 
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was occurring under the ozonolysis reaction conditions. We thus explored alternative methods for 
the oxidative cleavage of 3.36 that would not result in the epimerization of the α-stereocenter. 
3.4.2  OsO4-Catalyzed oxidative cleavage 
Nicolaou and coworkers reported the use catalytic OsO4 in the presence of N-morpholine-
N-oxide (NMO) and 2,6-lutidine in 10:1 acetone/water as an effective protocol for the oxidation 
of alkenes, followed by oxidative cleavage with PhI(OAc)2.121 We decided to apply these 
conditions to γ,δ-unsaturated ester 3.36 due to the high yields, mild reaction conditions, and broad 
substrate scope reported by Nicolaou. Thus, γ,δ-unsaturated ester 3.36 was dissolved in 
acetone/water (10:1) (Figure 3.2). To this solution was sequentially added 2,6-lutidine (2 equiv), 
NMO (1.5 equiv), and OsO4 (0.03 equiv). The solution was stirred at room temperature for 16 h 
during which period the color changed from dark yellow/brown to light yellow. Once the starting 
material was fully consumed, as evidenced by TLC, PhI(OAc)2 (1.5 equiv) was added and the 
solution stirred for 2 h. After complete conversion, as evidenced by TLC, saturated aq. Na2S2O3 
was added and the mixture transferred to a separatory funnel. The organic layer was extracted with 
saturated aq. CuSO4 to remove the 2,6-lutidine. After concentration of the organic layer and 
purification of the resulting crude residue, β-formyl ester 3.40 was obtained in 89% yield. The 
enantiomeric ratio of β-formyl ester 3.40 was determined to be 91:9; significantly higher than 
when performing the oxidative cleavage via ozonolysis, and very close to the reported 
enantiomeric ratio (R)-linool (3.34) (95:5), though we did not verify the actual enantiomeric ratio 
of the commercially-supplied starting material via chiral HPLC or optical rotation. 
 
  













Figure 3.2. OsO4 and PhI(OAc)2-mediated oxidative cleavage of ester 3.36 with retention of C1 
stereochemistry. 
 
With the successful oxidative cleavage of γ,δ-unsaturated ester 3.36 affording β-formyl 
ester 3.40 in high yields and complete retention of stereochemistry, we wanted to effect an 
analogous oxidative cleavage on γ,δ-unsaturated amide 3.37 (Scheme 3.18). We reasoned that the 
resulting β-formyl amide 3.52 would be a valuable substrate going forward into the 
diastereoselective 1,2-addition/lactonization step to generate lactone 3.51. In addition, it would 
provide a shorter route to lactone 3.51 in that we would not need to convert γ,δ-unsaturated amide 
3.37 to γ,δ-unsaturated ester 3.36. We wanted to first reexamine the ozonolysis conditions 
originally applied to γ,δ-unsaturated ester 3.36 due to the operational simplicity and clean reaction 
profile of this procedure. Because dimethyl sulfide had proven to be an ineffective reducing agent 
for the ozonolysis of γ,δ-unsaturated ester 3.36 to β-formyl ester 3.40, we decided to adopt our  
  





















Scheme 3.18. Oxidative cleavage of γ,δ-unsaturated ester 3.36 and γ,δ-unsaturated amide 3.37, and use of the 
resuling β-formyl ester 3.40 and β-formyl amide 3.52 to generate lactone 3.51. 
 
successful ozonolysis conditions, employing triphenyl phosphine as the terminal reductant. Thus, 
γ,δ-unsaturated amide 3.37 was dissolved in CH2Cl2 and the solution cooled to -78 ⁰C (Scheme 
3.19). A stream of O3/O2 was bubbled through the solution until a blue color was observed. This 
process took approximately 35 min, over twice as long as the analogous γ,δ-unsaturated ester 3.36. 
A stream of O2 was then bubbled through the solution until the color dissipated, then PPh3 (3 
equiv) added and the solution allowed to warm to room temperature while reacting for 24 h. Upon 
concentration and purification via SiO2 flash column chromatography, β-formyl amide 3.52 was 
obtained in 65% yield. Key 1H NMR resonances used for positive characterization were a signal 
at 9.75 ppm (s) corresponding to aldehyde proton Ha, singlets at 3.02 ppm and 2.93 ppm, 
corresponding to the protons on the amide methyl groups, and a singlet at 2.14 ppm, corresponding 
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Scheme 3.19. Ozonolysis of γ,δ-unsaturated amide 3.37 in CH2Cl2 with PPh3 as the terminal reductant. 
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13C resonances at 207.9 ppm, 203.4 ppm, and 170.5 ppm, confirming the presence of aldehyde, 
ketone, and amide carbonyl carbons, respectively. Surprisingly, the enantiomeric ratio was 
determined to be 88:12 using the 1H NMR procedure described above; significantly higher than 
the enantiomeric ratio of β-formyl ester 3.40 obtained via ozonolysis of γ,δ-unsaturated ester 3.36. 
It appears that, unlike the ester analog, γ,δ-unsaturated amide 3.37 does not epimerize to any 
appreciable extent under ozonolysis conditions. We propose that this is due to the acidity 
difference between Ha of ester 3.40 and Hb of amide 3.52 (Scheme 3.20). We would expect the 
methyl ester to be more electronegative than the analogous dimethyl amide, rendering Ha more 
acidic than Hb via induction. Support for this hypothesis came from the observation that, upon 
standing in the freezer, complete erosion of enantiomeric purity was observed in two weeks for β-
formyl ester 3.40, but after one month we saw no appreciable change in the enantiomeric ratio of 
β-formyl amide 3.52. Though we did not observe epimerization, ozonolysis of γ,δ-unsaturated 
amide 3.37 gave only a moderate yield of β-formyl amide 3.52. We sought to increase the yield 



















Scheme 3.20. Relative rates of racemization of β-formyl ester 3.40 and β-formyl amide 3.52 while standing in 
the freezer. 
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By applying Nicolou’s conditions to γ,δ-unsaturated amide 3.37, β-formyl amide 3.52 was 
isolated in 92% yield, and the enantiomeric ratio determined to be 94:6 (Scheme 3.21). With 
efficient, optimized routes to both β-formyl ester 3.40 and β-formyl amide 3.52 in hand, we were 
able to show that the α-stereocenter was configurationally stable under the reported reaction 
conditions. Thus, we were poised to move forward to the key diastereoselective 1,2-













Scheme 3.21. OsO4 and PhI(OAc)2-mediated oxidative cleavage of β-formyl amide 3.37 with retention of C1 
stereochemistry. 















Scheme 3.22. Proposed diastereoselective 1,2-addition/lactonization of β-formyl ester 3.40. 
 
The next step in the total synthesis of (–)-dehydroleucodine (ent-3.1) was the 
diastereoselective addition of a propynyl nucleophile to β-formyl ester 3.40, followed by acidic 
workup, leading to the lactonization of propargyl alcohol intermediate 3.53 (Scheme 3.22). A 
survey of the literature provides few reported methods for diastereoselective nucleophilic 
additions to acyclic aldehydes with a carboxylate at the β-position. Most work has been carried 
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out by Reissig on alkyl substituted β-formyl methyl esters (Scheme 3.23).96 The diastereoselective 
addition of methylmagnesium bromide to β-formyl ester 3.54 afforded lactone 3.55 with a trans/cis 
diastereomeric ratio of 62:38. The authors saw both a yield enhancement as well as an 
enhancement of diastereoselectivity when triisopropoxy(methyl)titanium was used as the 
nucleophile, isolating lactone 3.55 in 60% yield with a diastereomeric ratio of 79:21. Excellent 
  

















Scheme 3.23. Precedent for the diastereoselective 1,2-addition/lactonization of β-formyl esters. 
 
diastereoselectivity was achieved when a methyl cuprate was used as the nucleophile, affording 
lactone 3.55 with a diastereomeric ratio of 95:5, though only 34% of the lactone was isolated. 
Reissig proposes two possible mechanisms that give rise to the observed diastereomeric ratios. 
The authors propose that, in the case of the methylmagnesium bromide and 
triisopropoxy(methyl)titanium, competing Felkin-Ahn and Cram chelate transition states 3.56a 
and 3.56b (Scheme 3.24). The nucleophile approaches from the least hindered face of the aldehyde, 
resulting in the trans-lactone. The cis-lactone is generated via Felkin-Ahn transition state 3.56c, 
where the methyl group and aldehyde carbonyl oxygen are more eclipsed. Thus, the nucleophile 
approaches from the opposite face. In the case of excellent diastereoselectivity achieved via 
addition of organocuprates, the authors propose Cram chelate 3.56b is the predominate species in 
solution. 


























Scheme 3.24. Reissig's proposed transition states leading to the diastereoselective 1,2-addition of nucleophiles 
to β-formyl esters. 
 
While the conditions reported by Reissig worked well on simple alkyl- and aryl substituted 
β-formyl esters, the concern with our system was that competitive 1,2-addition to the ketone could 
occur. While rates of nucleophilic additions to aldehydes are typically faster than rates of addition 
to ketones, we wanted to apply conditions that would ensure a chemoselective 1,2-addition to the 
aldehyde, leaving the ketone intact. Reetz and others have shown complete chemoselective 1,2-
addition of organotitanium nucleophiles to aldehydes in the presence of ketones.95 Because of 
Reissig’s report of organotitanium reagents adding to β-formyl esters in a diastereoselective 
fashion, and Reetz’s reports for the chemoselective 1,2-addition of organotitanium reagents, we 
reasoned that an alkynyltitanium nucleophile would be the best option to effect the chemo and 
diastereoselective 1,2-addtion of an alkyne to β-formyl ester 3.40. While the diastereoselectivity 
of organocuprates is significantly higher than the analogous organotitanium reagents, it is well 
known that copper acetylides are inert and do not add to carbonyls in a 1,2- fashion. This 
eliminated the use of organocuprates as a possible alkyne nucleophile source. With β-formyl ester 
3.40 in hand and a proposed path to trans-lactone 3.51, we set out to examine the feasibility of a 
diastereomeric 1,2-addition of an alkyne nucleophile to β-formyl ester 3.40. 
The first thing we wanted to do was benchmark our system against Reissig’s simple alkyl-
substituted systems. We wanted to probe the effect that the C4 ketone would have on both reaction 
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yield, as well as diastereoselectivity. To do this, we first employed commercially-available 
propynylmagnesium bromide as the nucleophile. Thus, β-formyl ester 3.40 was dissolved in THF 
and the solution cooled to -40 ⁰C (Scheme 3.25). Propynylmagnesium bromide was added and 
allowed to react for 1 h while the solution was allowed to warm to room temperature. Upon 
complete consumption of starting material, as evidenced by TLC, a 50% aq. solution of H2SO4 
was added. Upon concentration of the organic layer and purification of the crude residue via SiO2 
flash column chromatography, a mixture of trans-3.51 and cis-3.51 were isolated in 39% combined 
yield, with a diastereomeric ratio of 65:35 (trans/cis). Key 1H NMR resonances at 5.13 ppm (dq, 
J1 = 7.0 Hz, J2 = 2.0 Hz, 0.34 H) and 4.65 ppm (dq, J1 = 7.0 Hz, J2 = 2.0 Hz, 0.65 H), corresponding 
to the lactone proton Ha of cis-3.51 and trans-3.51, respectively. We used literature precedent for 
the assignment of these protons to a relative stereoisomer.122 With lactone 3.51 in hand, we were 
able to make a direct comparison between the diastereoselectivity achieved by Ressig on the 
simple methyl-substituted β-formyl ester 3.54, and our system. We were encouraged that we 
observed a similar yield, and more importantly, a similar diastereomeric ratio to that reported by 
Reissig. With this information in hand, we reasoned that if we applied Reissig’s organotitanium 
conditions, we would see both a yield increase, as well as an increase in the diastereomeric ratio. 

















Scheme 3.25. Addition of ethynylmagnesium bromide to β-formyl ester 3.40. 
 
 88  
Chlorotitanium triisopropoxide (1.2 equiv) was dissolved in THF and cooled to -50 ⁰C 
(Scheme 3.26). Propynylmagnesium bromide (0.5 M in THF, 1.2 equiv) was added and the 
solution reacted for 2 h. To this was added β-formyl ester 3.40, and the solution reacted for 2 h at 
-50 ⁰C. To the reaction vessel was added aq. 1 N HCl, and the mixture was warmed to room 
temperature and reacted for 24 h. A 1H NMR spectrum was taken of the crude reaction mixture, 
which revealed that selective 1,2-addition to the aldehyde, followed by lactonization indeed 
occurred; however, the reaction proceeded with a diastereomeric ratio of 53:47 trans/cis; slightly 
worse than when using only propynylmagnesium bromide. We were unsure what had occurred to 
give us a lower diastereomeric ratio relative to the reaction being performed in the presence of 
only propynylmagnesium bromide, but we suspected the ketone carbonyl oxygen was interfering 
with chelate formation after propynylmagnesium bromide was transmetalated with the highly 
oxophilic titanium reagent. To test this hypothesis, we chose to transmetalate propynylmagnesium 
bromide with titanium tetrachloride instead of chlorotitanium triisopropoxide, as titanium 
tetrachloride is typically more Lewis acidic than its chlorotitanium alkoxide analogs.123 We 













then 1 N HCl
THF, -50 °C
3.51, 53:47 trans/cis3.40  
Scheme 3.26. Chlorotitaniumtriisopropoxide-mediated 1,2-addition of ethynylmagnesium bromide to β-
formyl ester 3.40. 
 
The above conditions were repeated by using titanium tetrachloride instead of 
chlorotitanium triisopropoxide (Scheme 3.27). Upon completion of the reaction, as evidenced by 
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TLC, 1H NMR was taken of the crude reaction mixture. We again observed selective 1,2-addition 












then 1 N HCl
THF, -60 °C
3.51, 60:40 trans/cis3.40  
Scheme 3.27. Titanium tetrachloride-mediated 1,2-addition of propynylmagnesium bromide to β-formyl ester 
3.40. 
 
ratio of 60:40 trans/cis. This result suggested that the oxophilicity of the organometallic reagent 
was not necessarily correlated to the diastereomeric outcome of the 1,2-addition. 
With these results in hand, we wanted to explore the feasibility of performing a 1,2-
addition/lactonization on β-formyl amide 3.52. Doing so would allow us to access lactone 3.51 in 
fewer overall steps, as γ,δ-unsatured amide 3.52 would not have to be converted to γ,δ-unsaturated 
ester 3.40. In addition, diastereoselective additions to a β-formyl amide of this nature have never 
been reported. It was difficult to make a prediction as to whether we would see better or worse 
diastereoselectivities. The amide functionality would be expected form a stronger chelate with the 
organotitanium reagent, as the Lewis basicity of the amide carbonyl oxygen is greater than that of 
the ester carbonyl oxygen, leading to enhanced trans/cis diastereoselectivities. However, the 
increased steric demand of the N,N-dimethyl group would be expected to lower the trans/cis 
diastereoselectivity, based on the proposed transition state structures shown above (Scheme 3.25). 
We wanted to begin our studies by comparing the result of the addition of propynylmagnesium 
bromide to β-formyl amide 3.52 to the result of addition to β-formyl ester 3.40. We reasoned that 
this would give us an idea of how this system behaves as opposed to the ester analog. 
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Thus, β-formyl amide 3.52 was dissolved in THF and cooled to -78 ⁰C (Table 3.2, Entry 
1). To this was added propynylmagnesium bromide (0.5 M in THF, 1.1 equiv). After reacting for 
2 h, 1 N aq. HCl was added and the mixture heated to 50 ⁰C for 18 h. Upon workup and purification 
via SiO2 flash column chromatography, lactone 3.51 was isolated in 55% yield, with a 
diastereomeric ratio of 66:34 trans/cis. We were encouraged by these results, as the diastereomeric 
ratio was nearly identical to when these conditions were applied to the β-formyl ester analog 3.40; 
however, the reaction yield was slightly higher at 55%, versus 34% when performed on the 3.40. 
With these results in hand, we reasoned that we could proceed with the 1,2-addition/lactonization 
of the β-formyl amide. We decided to screen a variety of different organometallic reagents in an 
effort to optimize both yield and diastereoselectivity. The second organometallic that we wanted 
to screen was propynyllithium, which can be generated in situ via deprotonation of 1-
bromopropene, followed by elimination and subsequent deprotonation of the resulting propyne.124 
 












3.52 3.51  
Entry [M] (equiv) Metal salt (equiv) Conditions Yield dr (trans/cis) 
1 MgBr (1.1) None -78 55 66:34 
2 Li (1.1) None -78 46 62:38 
3 MgBr (1.1) MnCl2 (1.1) 0 61 57:43 
4 MgBr(1.1) MnCl2 (1.1)/LiCl (2.2) 0 47 52:48 
5 MgBr (1.1) TiCl4 (1.1) -60 45 50:50 
6 MgBr (1.1) ClTi(OiPr)3 (1.1) -60 86 38:62 
 
Thus, 1-bromopropene was dissolved in THF and cooled to -78 ⁰C (Table 3.2, Entry 2). To 
this was added n-butyllithium in a dropwise fashion. The mixture was reacted for 1 h before being 
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cannulated into a solution of β-formyl amide 3.52 in THF, also cooled to 78 ⁰C. The mixture was 
reacted for 30 min then 1 N aq. HCl was added and the mixture heated to 50 ⁰C for 18 h. Upon 
workup and purification via SiO2 flash column chromatography, lactone 3.51 was isolated in 46% 
yield, with a diastereomeric ratio of 62:38 trans/cis. With similar yields and diastereomeric 
outcome to that of propynylmagnesium bromide, we drew the conclusion that the reactivity 
between the two were very similar. Due to the operational complexity of generating 
propynyllithium in situ, we decided to abandon this method for the generation of future 
organometallic nucleophiles, and opted to simply use the commercially available 
propynylmagnesium bromide in THF instead. The reaction profiles of both the organomagnesium 
and organolithium reactions were very complex by TLC, leading us to believe that, despite the 
depressed temperatures, 1,2-addition was taking place at both the aldehyde carbonyl carbon, as 
well as the ketone carbonyl carbon, leading to moderate to low reaction yields. Cahiez and 
coworkers have reported the chemoselective addition of organomanganese and manganate 
reagents to aldehydes in the presence of ketones.125–127 While no information is provided on the 
diastereoselective addition to β-formyl esters or amides such as 3.40 and 3.52, we decided to 
examine these conditions as a potential solution towards chemoselective addition to the carbonyl 
carbon of the aldehyde. 
Normant has described the preparation of various alkyl, alkenyl, and alkynyl manganese 
reagents, as well as more functionalized organomanganese reagents.125,128 Manganese(II) chloride 
(1.1 equiv) was first dehydrated by heating under vacuum with a Fisher burner, until no more 
condensation on the inside of the flask was observed (Table 3.2, entry 3). The flask was cooled 
under a constant flow of nitrogen, then suspended in THF. The suspension was cooled to 0 ⁰C and 
propynylmagnesium bromide (1.1 equiv) added dropwise. After reacting for 1 h, amide 3.52 was 
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added as a solution in THF. The mixture was reacted for 3 h before 1 N HCl was added. The 
reaction was maintained at 50 ⁰C overnight. Upon purification, the desired lactone 3.51 was 
isolated in 61% yield with a diastereomeric ratio of 57:43 (trans/cis). While the yield was improved 
with respect to the organolithium and organomagnesium reagents, the diastereomeric ratio was 
slightly depressed. Addition of LiCl has been shown to generate the corresponding 
organomanganate reagents, which we thought might provide enhanced yields or 
diastereoselectivities.127 The preparation of these reagents is similar to that reported above; 
however, inclusion of LiCl (2 equiv with respect the MnCl2) is necessary. Application of these 
conditions resulted in lactone 3.51 being isolated in 47% yield with a 52:48 diastereomeric ratio 
(Table 3.2, entry 4). The poor diastereomeric ratios and modest yields of 3.51 obtained when using 
the organomanganese reagents as the nucleophile led us to turn to the corresponding 
organotitanium reagents.  
 As stated above, organotitanium reagents chemoselectively add to aldehydes; however, 
we were concerned that we would observe low diastereoselectivity, as was seen in the case of β-
formyl ester 3.40. Nonetheless, we decided to apply both the titanium tetrachloride and 
chlorotitanium triisopropoxide conditions to β-formyl amide 3.52. Both reactions were run in an 
analogous fashion as reported above on β-formyl ester 3.40. In the presence of TiCl4, lactone 3.51 
was obtained in 45% yield, with a diastereomeric ratio of 50:50 (Table 3.2, entry 5), slightly worse 
than when performed on ester 3.40. However, to our surprise, in the presence of chlorotitanium 
triisopropoxide, lactone 3.51 was generated in 86% yield (Table 3.2, entry 6). This was a very 
promising result, as the high yield suggested that the ketone remained intact throughout the 
reaction and did not affect the overall yield to any appreciable extent. To our surprise however, 
the diastereomeric ratio was 62:38, favoring the cis diastereomer. Despite the poor trans-
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selectivity, the high yield of these conditions led us to move forward using propynyltitanium 
triisopropoxide as the preferred reagent for the transformation of amide 3.52 to lactone 3.51. 
3.6 Conversion of Ketone 3.51 to Allenes 
3.6.1  Formation of propargyl carbonate 
With a rapid route to lactone 3.51 in hand, we set out to convert the C4 ketone to the desired 
allene, setting the stage for the Allenic Pauson–Khand reaction. We reasoned that lactone 3.51 
could serve as a common intermediate towards the synthesis a variety of allenyl carboxyesters 
3.57b, as well as the terminal 3,3-disubstituted allene 3.57a (Scheme 3.28). Having access to these 
different allene functional patterns would offer access to a wider variety of 6,12-guaianolides and 
analogs. We first examined the case of 3,3-disubstituted allene 3.57a. We reasoned that we could 
use the Pd(0)-catalyzed propargyl carbonate hydrogenolysis conditions reported by Tsuji, and 
successfully applied by our group to other systems (ad supra).52 We thus set out to synthesize the 





3.57a, X = H












Scheme 3.28. Proposed conversion of ketone 3.51 to allenes 3.57a and 3.57b. 
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Application of the standard CeCl3-mediated addition of ethynylmagnesium bromide, 
followed by trapping with methyl chloroformate afforded propargyl carbonate 3.58 in 80% yield 
(Scheme 3.29). We were unable to separate any of the four diastereomers via chromatography, so 
the product was carried on as a mixture of these diastereomers; however, we observed no changed 
in the lactone diastereomeric ratio during the course of this reaction. Analysis of the 1H NMR 
spectrum revealed that the diastereomeric ratio of the trans/cis lactone remained constant 
throughout the reaction, as evidenced by a resonance at 5.15 ppm (dq, J1 = 7.2 Hz, J2 = 2.1 Hz, 
0.63 H) corresponding the Ha of cis-3.58 and a resonance at 4.69 ppm (dq, J1 =6.6 Hz, J2 = 2.1 Hz, 
0.37 H) corresponding to Ha of trans-3.58. In addition, a methyl singlet at 3.78 ppm (3 H) 
confirmed the presence of a methyl carbonate. A singlet at 2.62 ppm (1 H) suggested the presence 
of alkynyl proton Hb, and a methyl singlet at 1.74 ppm (3 H) confirmed the presence of propargyl 
protons Hc. Due to the viscosity of propargyl carbonate 3.58, it was exceedingly difficult to remove 
all of the EtOAc, even by azeotroping with a variety of solvents. With the desired propargyl 


















Scheme 3.29. Synthesis of propargyl carbonate 3.58. 
 
Application of the previously reported Pd(0)-catalyzed hydrogenolysis conditions (see 
Chapter 2) afforded allene-yne 3.57a in 73% yield (Scheme 3.30). A diagnostic 1H NMR signal at 
4.63 ppm (sept, J = 3.2 Hz, 2 H) provided evidence for the presence of allenyl protons Ha, and 
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appear to be magnetically equivalent despite the fact that the two allenyl protons are diastereotopic 
due to the presence of the lactone. A resonance at 5.14 ppm (dq, J1 = 7.2 Hz, J2 =2.0 Hz, 0.64 H) 
corresponding to Hb of cis-3.57a and 4.68 ppm (dq, J1 = 7.2 Hz, J2 = 2.0 Hz) corresponding to Hb 
of trans-3.57a confirmed that the lactone remained intact, though an accurate diastereomeric ratio 
could not be ascertained due to significant overlap of allenyl protons Ha with trans-3.57a proton 
Hb, though it was shown after the next synthetic step that the diastereomeric ratio had been 
maintained. With a successful route to 3,3-disbustituted allene 3.57a in hand, we shifted our focus 
to the synthesis of the analogous allenyl carboxy esters 3.57b, again by employing the same 
















Scheme 3.30. Synthesis of 3,3-disubstituted allene 3.57a. 
3.6.2  Synthesis of allenyl carboxyesters 
We next wanted to synthesize both propargyl acetate 3.59a as well as propargyl 
chloroacetate 3.59b (Scheme 3.32), as we had previously shown greatly enhanced rates of 
hydrolysis under mild Sc(III) conditions in the case of the chloroacetate substrates (see Chapter 
2). Thus, Lactone 3.51 was converted to propargyl acetate 3.59a and propargyl chloroacetate 3.59b 
in 88% and 85% yield, respectively via application of the previously reported conditions (see 
Chapter 2)(Scheme 3.31). Evidence for the formation of propargyl acetate 3.59a was observed via  
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Scheme 3.31. Synthesis of propargyl esters 3.59a and 3.59b. 
 
the presence of a methyl singlet at 2.04 ppm (3 H) corresponding to methyl protons Ha, a methyl 
singlet at 1.70 ppm (3 H) corresponding to methyl protons Hc, and a group of methyl singlets from 
1.90-1.88 ppm integrating for a total of 3 H, corresponding to methyl protons Hd of each of the 
four possible diastereomers of 3.59a. In addition, a signal at 2.58 ppm (s, 1 H) supported the 
presence of alkynyl proton Ha. The lactone diastereomeric ratio remained constant throughout the 
reaction, as evidenced by a signal at 5.15 ppm (m, 0.62 H) corresponding to Hb of cis-3.59a, and 
a signal at 4.70 ppm (m, 0.38 H) corresponding to Hb of trans-3.59a. Evidence for the formation 
of propargyl chloroacetate 3.59b was observed via the presence of a 1H NMR resonance at 4.02 
ppm (s) corresponding to the chloroacetyl protons Ha. As was the case with propargyl carbonate 
3.58, we did not see individual signals for each diastereomer. The lactone remained intact and did 
not epimerize, as evidenced by a resonance at 5.16 ppm (J1 = 6.8 Hz, J2 = 2.4 Hz, 0.61 H) 
corresponding to Hb of cis-3.59b and a resonance at 4.70 ppm (J1 = 6.8 Hz, J2 = 2.0 Hz, 0.39 H) 
corresponding to Hb of trans-3.59b. A methyl singlet at 1.74 ppm (3 H) confirmed the presence of 
methyl protons Hc, and a group of singlets from 1.90-1.88 integrating for a total of 3 H 
corresponded to methyl protons Hd for the four expected diastereomers of 3.59b. A singlet at 2.63 
ppm confirmed the presence of alkynyl proton He. The 13C NMR spectrum was very complex, as 
there were signals corresponding to each of the four possible diastereomers, many of which had a 
very similar chemical shift; however, based on the chemical shift regions, we reasoned that we had 
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the desired chloroacetate 3.59b. For instance, four signals at 175.78 ppm, 175.76 ppm, 175.27 
ppm, and 175.26 ppm provided evidence for the presence of four diastereomeric ester carbonyl 
carbons. Twelve signals from 76.7 ppm to 66.0 ppm provided evidence for the presence of four 
diastereomeric groups of four alkynyl carbons; however, the missing four signals are most likely 
buried in the CDCl3 resonance, or do not resolve enough to be distinguished from the other signals.  
With propargyl acetate 3.59a and propargyl chloroacetate 3.59b in hand, we were poised 
to apply the Rh(I)-catalyzed formal 3,3-sigmatropic rearrangement conditions which we have 
previously shown to be successful on other systems to access the corresponding allenyl 






3.59a R = CH3
3.59b R = CH2Cl
toluene, 50 °C O
O
3.60a R = CH3, 87%









Scheme 3.32. Rh(II)-catalyzed formal 3,3-sigmatropic rearrangement of allenyl carboxyesters 3.60a and 
3.60b. 
 
acetate 3.59a or propargyl chloroacetate 3.59b was added (Scheme 3.32). The solution was reacted 
at 50 ⁰C until complete consumption of starting material was observed. In the case of propargyl 
acetate 3.59a, the reaction time was 3 h; however, propargyl chloroacetate 3.59b required 8 h to 
reach completion. The longer reaction time was expected, as we had also observed this to be the 
case with the propargyl chloroacetate previously reported (ad supra). Upon completion, the 
mixture was cooled to room temperature and SilaMetS® Thiourea was added to scavenge the Rh(I) 
catalyst. The mixture was allowed to stir for 16 h then filtered through a celite plug. After 
concentration and purification via SiO2 flash column chromatography allenyl acetate 3.60a or 
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allenyl chloroacetate 3.60b were isolated in 87% and 87% yield, respectively. Again, none of the 
diastereomers could be separated via chromatography, making the 1H and 13C NMR spectra very 
complex; however, by examining the chemical shift regions of the resonances, we were able to 
confirm structures. In the case of allenyl acetate 3.60a, diagnostic allenyl proton Ha signals were 
observed from 7.36-7.30 ppm (1 H) and appeared to be two partially overlapping resonances, 
corresponding to two of the four diastereomers of 3.60a. A signal at 5.14 ppm (m, 0.63 H) 
corresponding to Hb of cis-3.60a and 4.67 ppm (m, 0.37 H) corresponding to Hb of trans-3.60a 
confirmed that the lactone had remained intact and had not epimerized. Overlapping methyl 
resonances from 2.15-2.13 ppm integrating for a total of 3 H provided evidence for the presence 
of an acetyl group. Overlapping methyl resonances from 1.90-1.87 ppm (total 3 H), and 1.86-1.83 
ppm (total 3 H) confirmed the presence of methyl protons Hc and Hd, respectively. With high-yield 
routes to both allene 3.57a and 3.60a and 3.60b in hand, we were poised to explore the feasibility 
of allenic Pauson–Khand reaction on these substrates. 
3.7 Allenic Pauson-Khand Reactions of 3.57a, 3.60a, and 3.60b 
3.7.1  APKR of 3,3-disubstituted allene 3.57a 
The successful application of cationic Rh(cod)2BF4 to effect the APKR on our previously 
reported methyl-substituted allene-yne led us to reason that the conditions may also be applicable 
to methyl-substituted allene-ynes with a lactone installed in the tether (see Chapter 2). Thus, 
application of these conditions to lactone 3.57a afforded the desired APKR adduct 3.61 in 57% 
yield and a 61:39 trans/cis ratio, confirming that no epimerization of the lactone had occurred 
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under the reaction conditions (Scheme 3.33). We were able to successfully separate cis-3.61 and 
trans-3.61 at this stage, trans-3.61 eluting before cis-3.61. A 1H NMR signal at 5.32 ppm (d, J = 
10.8 Hz, 1H), corresponding to Ha, provided evidence for the formation of trans-3.61. Similarly, 

























Scheme 3.33. APKR of 3,3-disubstituted allene-yne 3.57a. 
 
at 2.97 ppm (s, 2H) corresponding to Hb of trans-3.61 and 3.01 ppm (d, J = 5.2 Hz, 2H) 
corresponding to Hb of cis-3.61 were observed. A resonance at 2.02 ppm (s, 3H) and 1.88 ppm (s, 
3H) of trans-3.61 confirmed the presence of two methyl groups. Likewise, resonances at 1.92 ppm 
(s, 3H) and 1.85 ppm (s, 3H) in the 1H NMR spectrum of cis-3.61 provided evidence for the 
presence of two methyl groups. The 13C NMR spectra of trans-3.61 and cis-3.61 were very similar, 
with a signal at 204.4 ppm corresponding to the C3 carbonyl carbon of trans-3.61 and 204.3 ppm 
corresponding to the carbonyl carbon of cis-3.61. Alkenyl resonances at 161.0, 139.2, and 132.9, 
and 129.8 ppm confirmed the presence of four alkenyl carbons in trans-3.61, with a lactone 
carbonyl carbon signal observed at 175.1 ppm. Similarly, resonances at 157.7, 143.4, 137.1, and 
128.8 ppm provided evidence for the presence of four alkenyl carbons in cis-3.61, with a lactone 
carbonyl carbon signal at 176.2. To confirm the assignment of cis-3.61 and trans-3.61, we were 
able to crystallize trans-3.61 by dissolving a sample in EtOAc and allowing the solvent to slowly 
evaporate in the freezer (0 ⁰C). X-ray crystallography confirmed both the C6-C7 relative 
stereochemistry, as well as the C7 absolute stereochemistry. We used this data to conclude that Ha 
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of trans-3.61 is shifted upfield in the 1H NMR spectrum, relative to Ha of cis-3.61. With the 
successful application of the APKR to lactone-containing 3,3-disubstitued allene-yne 3.57a, we 
were poised to apply the conditions to the more functionalized allenyl carboxyesters 3.60a and 
3.60b. If successful, we would have accessed the core carbon framework of (–)-dehydroleucodine 
(ent-3.1). 
3.7.2  APKR of allenyl carboxyesters 3.60a and 3.60b  
To this end, application of the previously reported cationic Rh(I) conditions to allenyl 
carboxy esters 3.60a and 3.60b afforded the desired APKR adducts 3.62a and 3.62b in 70% and 
60% yields, respectively (Scheme 3.34). It was found that the substrate concentration had to be 
reduced to 0.03 M to achieve optimal yields for this reaction. As with the 
bicyclo[5.3.0]decadienone 3.61, the cis and trans isomers of 3.62a and 3.62b were separable via 
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Scheme 3.34. APKR of allenyl carboxyesters 3.60a and 3.60b. 
 
It was found that the APKR of both 3.60a and 3.60b proceeded with varying degrees of 
diastereocontrol at the C2 position. Trans-3.62a was generated in a 65:35 diastereomeric ratio at 
the C2 position, as evidenced by the presence of a 1H NMR resonance at 5.40 ppm (d, J = 10.8 
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Hz, 0.65 H) corresponding to Ha of the major C2 diastereomer, and a resonance at 5.32 ppm (d, J 
= 10.8 Hz, 0.35 H) corresponding to Ha of the minor C2 diastereomer (Figure 3.3A). Further 
evidence was provided via resonances at 5.58 ppm (s, 0.59 H) and 5.56 ppm (s, 0.30 H) 
corresponding to Hb of the major and minor diastereomers, respectively. Interestingly, cis-3.62a 
was formed as a single C2 diastereomer, as evidenced by a 1H NMR resonance at 5.63 ppm (d, J= 





























































Figure 3.3. Chemical shift assignments for APKR C2 diastereomers. 
 
Upon chromatographic separation of the lactone diastereomers of chloroacetate 3.62b, it 
was found that trans-3.62b was formed in a 75:25 diastereomeric ratio at the C2 position; a slight 
enhancement over the 65:35 diastereomeric ratio observed for the acetate analog trans-3.62a 
(Figure 3.3C). Evidence of this was provided via 1H NMR resonances at 5.64 ppm (s, 0.75H) and 
5.58 ppm (s, 0.25H) corresponding to Ha of the major and minor C2 diastereomers, respectively. 
In addition, resonances at 5.40 ppm (d, J = 10.8 Hz, 0.75H) and 5.32 ppm (d, J = 10.8 Hz, 0.25H) 
were assigned as Hb of the major and minor diastereomers, respectively. Interestingly, it appeared 
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as though cis-3.62b had been generated in a 71:29 diastereomeric ratio at the C2 position, unlike 
the complete diastereoselectivity observed in the case of the acetate analog cis-3.62a (Figure 
3.3D). Evidence for this was provided via 1H NMR resonances at 5.69 ppm (s, 0.29H) and 5.52 
ppm (s) corresponding to Ha of the minor and major C2 diastereomers, respectively, as well as 
resonances at 5.63 ppm (d, J = 6.0 Hz, 0.72H) and 5.54 ppm (d, J = 7.2 Hz) corresponding to Hb 
of the major and minor diastereomers, respectively. The origin of the differences in C2 
diastereomeric outcome of cis-3.62a and cis-3.62b is still unclear. 
With the success of the APKR on both allenyl carboxyesters 3.60a and 3.60b, the core 
carbon framework of (–)-dehydroleucodine was accessed in six linear steps, starting with a cheap, 
commercially available chiral pool material. We were now poised to deacetylate the C2 position 
and apply the isomerization conditions developed on the 2-hydroxy bicyclo[5.3.0]decadienone 
model system 2.59 to this system (see Chapter 2). 
3.8 Hydrolysis of β-Keto Esters 
With rapid access to lactone-containing α-acyloxy enones 3.62a and 3.62b in hand, we set 
out to apply the previously reported Sc(OTf)3-catalyzed hydrolysis conditions to access the desired 
α-hydroxy enone 3.63 (Scheme 3.35).129 Because of its slightly higher yielding APKR, the α-
acetoxy enone 3.64a was first subjected to the standard Sc(OTf)3 conditions. Thus, 3.62a was 
dissolved in MeOH/H2O (5:1 v/v, 0.025 M). To this was added Sc(OTf)3 (0.3 equiv) and the 
reaction maintained at 30 ⁰C for 24 h. Analysis of the reaction mixture by TLC revealed that, while 
the desired hydrolysis product 3.63 appeared to be present in a small quantity, there was a 
substantial amount of starting material remaining, as well as multiple other reaction components. 
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An additional portion of Sc(OTf)3 (1.7 equiv) was added and the reaction maintained for an 
additional 24 h. Despite the excess Sc(OTf)3, full conversion of 3.62a was never achieved. In 
addition, the reaction profile was very complex, as visualized by the presence of multiple spots 










3.62a R = CH3
3.62b R = CH2Cl
3.63 , 64% from 3.67b
Sc(OTf)3
MeOH/H2O (5:1)         30 °C
 
Scheme 3.35. Proposed hydrolysis of α-acyloxy enone 3.62a or 3.62b to access α-hydroxy enone 3.63. 
 
chloroacetate 3.62b,which was shown to undergo hydrolysis at a significantly faster rate than the 
corresponding acetate (see Chapter 2). Thus, chloroacetate 3.62b was dissolved in MeOH/H2O 
(0.05 M, 5:1 v/v) and Sc(OTf)3 added. The reaction was maintained for 48 h, at which point it was 
deemed complete by TLC. It should be noted that the reaction time for the chloroacetoxy substrate 
3.62b is greatly increased with respect to our previous findings on chloroacetate 2.64b. Upon 
workup and purification, 2-hydroxy enone 3.63 was isolated in 64% yield. The C2 diastereomers 
were not separated at this time. With the desired hydroxy enone 3.63 in hand, we were poised to 
apply the base-mediated isomerization conditions in an effort to transpose the C3-C5 enone to the 
C2-C4 position. 
 104  



























































EtOH, rt   22%
Barton, 1958
C
3.65 3.66  
Scheme 3.36. Proposed base-mediated isomerization of α-hydroxy enone 3.63 to α-keto enol 3.64. 
 
We wanted to examine the feasibility of applying the base-mediated isomerization 
conditions to each lactone diastereomer individually. With the assumption that the C5 
diastereomeric outcome of the isomerization is under thermodynamic control (see Chapter 2), 
different C5 epimers could arise from the two lactone diastereomers. Barton showed that in the 
presence of potassium hydroxide, sesquiterpene lactone 3.65 underwent an elimination process to 
furnish acid 3.66. This suggests that the pKa of Ha is relatively low, lending support to the notion 
that the proposed isomerization process could proceed under thermodynamic control (Scheme 
3.36C).130 We thus proposed that base-mediated isomerization of trans-3.63 would selectively 
afford the α-keto enol 3.64 with the desired stereochemistry at the C5 position (Scheme 3.36A). 
DFT calculations (B3LYP, 6-31G*, vacuum) supported this hypothesis, indicating that the desired 
C5 epimer of 3.64 was 5.52 kcal/mol more stable than its C5 epimer (Scheme 3.36B). With these 
predictions in hand, we set out to effect the base-mediated isomerization of trans-3.63.  
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Enone trans-3.63 was dissolved in THF and cooled to 0 ⁰C. Potassium tert-butoxide in tert-
butanol (2 equiv of a 0.5 M solution) was added dropwise (Scheme 3.37). The mixture instantly 
turned dark yellow as a precipitate began to form. TLC revealed complete consumption of starting 
material to a baseline spot. The reaction was quenched with sat. aq. NH4Cl, after which TLC 
indicated complete conversion of the baseline spot to another, slow-moving product. Upon workup 
and analysis of the crude residue via 1H and 13C NMR, it was determined that the lactone at the C6 





trans-3.63, R = H
trans-3.62b












Scheme 3.37. Base-mediated isomerization/eliminative lactone opening of trans-3.63 and 3.62b. 
 
position had opened via an elimination process, affording the acid 3.67 as the sole product. An 
alkenyl proton at 5.75 ppm (d, J = 4.0 Hz, 1H) was diagnostic of the C6 alkenyl proton Ha of 3.67. 
In addition, the product consisted of only a single diastereomer as evidenced by the presence of 
only two methyl resonances (2.42 ppm and 2.00 ppm). A resonance at 3.04 ppm (m, 1H) provided 
evidence for C7 proton Hb. In addition to the 1H NMR data, the 13C spectrum revealed a resonance 
at 189 ppm; confirming the presence of a ketone. Resonances at 177, 172, 155, 152, 134, 126, and 
125 ppm suggested the presence of six olefinic carbons, as well as the carbonyl carbon of the 
carboxylic acid.  
Application of these conditions to trans-3.62b also afforded acid 3.67, thus confirming that 
a two-step, one-pot deprotection/isomerization process is possible as well. While the base-
mediated isomerization conditions did not afford the desired product 3.64, the 
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isomerization/eliminative lactone opening process to afford 3.67 did occur cleanly by TLC, and 
confirms that the C3-C5 enone of this more complex substrate can be transposed to the C2-C4 
position.  
3.10 Conclusions Towards the Total Synthesis of (–)-Dehydroleucodine (ent-3.1) 
Starting with cheap chiral pool material (R)-linalool, we have shown that a C11 desmethyl 
6,12-guaianolide framework can be accessed in an enantioselective fashion in six linear steps. The 
key APKR affords products with either a C2 methylenyl or acyloxy groups, enabling rapid access 
to fused cyclopentenones with two different oxidation states. Transposition of the C4-C5 double 
bond to the C3-C4 position was accomplished via hydrolysis of the 2-chloroacetoxy 
bicyclo[5.3.0]decadienone 3.62b, followed by base-mediated isomerization affording 3.67. 
However, ring-opening of the C6 lactone to generate the carboxylic acid occurred. Further 
optimization showed that both hydrolysis and isomerization reactions could be effected with 
potassium tert-butoxide in a single step. These conditions, while an effective method for the 
transposition of the C3-C5 enone motif of allenic Pauson-Khand adducts, afford the elimination 
product with ring-opening of the lactone, suggesting that this method is not applicable to substrates 
with leaving groups at the allylic C6 position.  
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Appendix A : Experimental Information for Chapter Two 
General Methods. Unless otherwise indicated, all reactions were performed in flame-dried 
glassware under an atmosphere of dry nitrogen. All commercially available compounds used as 
received. Tetrahydrofuran (THF), dichloromethane (CH2Cl2), and diethyl ether (Et2O) were 
purified by passing through alumina using the Sol-Tek ST-002 solvent purification system. 
Toluene was distilled over calcium hydride prior to use. Deuterated chloroform (CDCl3 was dried 
over 3 Å molecular sieves prior to use. Gasses N2, H2, and CO were purchased from Matheson Tri 
Gas. Cerium chloride (anhydrous) was purchased and used as received. Flash column 
chromatography was performed using silica gel (40-63 μm particle size, 60 Å pore size). Thin-
layer chromatography (TLC) was performed on silica get F254 glass-backed plates (250 μm 
thickness). 1H and 13C NMR were recorded on a Bruker Avance 400 MHz spectrometer. Spectra 
were referenced to residual chloroform (7.26 ppm, 1H, 77.16 ppm, 13C). Chemical shifts (δ) are 
reported in ppm and multiplicities are indicated by s (singlet), d (doublet), t (triplet), q (quartet), 
quint (quintet), and m (multiplet). Coupling constants, J, are reported in hertz (Hz). NMR spectra 
were obtained at room temperature. EI mass spectroscopy was performed on a Waters Micromass 
GCT high-resolution mass spectrometer, while ES mass spectroscopy was performed on a Waters 
Q-TOF Ultima API, Micromass UK Limited high-resolution mass spectrometer. IR spectra were 
obtained using a Nicolet Avatar E.S.P. 360 FT-IR. 
 
Hex-4-yn-1-ol (2.10). To a 1-L, 3-necked round-bottom flask equipped with stir bar, 
nitrogen inlet adapter, thermometer adapter with thermometer, and septum was 
sequentially added hex-5-yn-1-ol (7.00 g, 71.3 mmol, 1.0 equiv) and DMSO (285 
HO
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mL) via syringe. Potassium tert-butoxide (20.0 g, 178 mmol, 2.5 equiv) was added in a single 
portion by temporarily removing the septum. No temperature increase was observed upon addition 
of potassium tert-butoxide. The brown reaction mixture was maintained at rt for 4 h. Upon 
complete consumption of starting material, as evidenced by TLC, the flask was lowered into an 
ice/water bath (0 °C). The septum was replaced with an addition funnel containing 285 mL 1 N 
HCl which was added dropwise over the course of 20 min while maintaining an internal 
temperature between 20–30 °C. Upon complete addition, the mixture was transferred to a 
separatory funnel, the layers separated and the aqueous phase extracted with Et2O (3 x 200 mL). 
The combined organic phases were dried over MgSO4, filtered through a medium porosity fritted 
glass vacuum funnel, and concentrated via rotary evaporation. The crude residue was purified via 
SiO2 flash column chromatography (40–70% Et2O/hexanes) affording 5.75 g of the title compound 
as a clear yellow oil (82%). JEB03-122 
 
Data for 2.10 
1H NMR: (400 MHz, CDCl3) 
 3.75 (q, J = 5.6 Hz, 2H), 2.28–2.22 (m, 2H), 1.78 (t, J = 2.4 Hz, 3H), 1.73 (pent, J 
 = 6.4 Hz, 2 H), 1.59–1.53 (m, 1 H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 78.6, 76.4, 62.2, 31.7, 15.5, 3.6 ppm; 
FTIR  (neat) 
 3328, 2921, 2874, 1436, 1350, 1329, 1175, 1054, 1034, 931, 909, 620, 551 cm-1; 
HRMS  (HRMS ESI) 
 [M + H]+ calcd for C6H11O: 99.0804; found: 99.0835; 
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TLC Rf = 0.18 (40% Et2O/hexanes) 
Silica gel, visualized with p-anisaldehyde 
Hex-4-yn-1-yl methanesulfonate (2.11). To a 250-mL, 2-necked round bottom 
flask equipped with stir bar, nitrogen inlet adapter, and septum was sequentially 
added hex-4-yn-1-ol 2.10 (5.60 g, 57.0 mmol, 1.0 equiv), CH2Cl2 (95 mL), and 
triethylamine (10.3 mL, 74.2 mmol, 1.3 equiv) via syringe. The flask was lowered into an ice/water 
bath (0 °C) and methanesulfonyl chloride (5.30 mL, 68.5 mmol, 1.2 equiv) was added dropwise 
over 5 min via syringe. Upon complete addition, the flask was removed from the ice/water bath 
and allowed to warm to rt at which it was maintained for 1.5 h. Upon complete consumption of 
starting material, as evidenced by TLC, the cloudy reaction mixture was transferred to a separatory 
funnel and washed with H2O (2 x 100 mL). The layers were separated and the combined aqueous 
phases were extracted with CH2Cl2 (1 x 100 mL). The combined organic phases were dried over 
MgSO4, filtered via medium porosity fritted glass vacuum filter, and concentrated via rotary 
evaporation. The crude residue was purified via SiO2 flash column chromatography (60% 
Et2O/hexanes), affording 9.80 g of the title compound as a pale-yellow oil (97%). JEB03-126 
Data for 2.11 
1H NMR:  (400 MHz, CDCl3) 
MsO
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 4.35 (t, J = 6.4 Hz, 2H), 3.02 (s, 3H), 2.33–2.26 (m, 2H), 1.90 (pent, J = 6.4 Hz, 
2H), 1.78 (t, J = 2.8 Hz, 3H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 77.2, 76.9, 68.8, 37.4, 28.5, 15.1, 3.6 ppm; 
FTIR (neat) 
 3028, 2923, 2855, 1439, 1348, 1332, 1169, 1089, 1007, 927, 924, 833, 792, 742, 
526, 476 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C7H13O3S: 177.0579; found: 177.0577; 
TLC Rf = 0.49 (60% Et2O in hexanes) 
 Silica gel, visualized with p-anisaldehyde (mesylate stains purple) 
 
6-iodo-hex-2-yne (2.8). To a 500-mL, 3-necked round bottom flask equipped with 
overhead stirrer, condenser with nitrogen inlet adapter, and septum was sequentially 
added sodium iodide (NaI) (20.6 g, 138 mmol, 2.5 equiv) and acetone (138 mL) via 
temporary removal of the septum. Upon complete dissolution of the NaI, hex-4-yn-yl 
methanesulfonate 2.11 (9.7 g, 55.0 mmol, 1.0 equiv) was added in a single portion via syringe. 
The flask was lowered into a preheated oil bath (65 °C) for 1.5 h, during which time a thick slurry 
formed. Upon complete consumption of the starting material, as evidenced by TLC, the flask was 
removed from the oil bath and allowed to cool to rt. Water was added (120 mL) via removal of the 
septum. The mixture transferred to a separatory funnel, the layers separated and the aqueous phase 
extracted with pentane (3 x 150 mL). The combined organic phases were dried over MgSO4, 
filtered via medium porosity fritted glass vacuum filter, and concentrated via rotary evaporation, 
I
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affording 11.0 g of the title compound as a pale-yellow oil (96%), which was taken on without 
further purification. JEB03-128 
 
Data for 2.8 
1H NMR: (400 MHz, CDCl3) 
 3.30 (t, J = 6.8 Hz, 2H), 2.29–2.23 (m, 2H), 1.95 (pent, J = 6.8 Hz, 2H), 1.78 (t, J 
= 2.4 Hz) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 76.9, 76.8, 32.5, 19.8, 5.7, 3.5 ppm; 
FTIR (neat) 
 2917, 2841, 1430, 1347, 1245, 1221, 1167, 1155, 951, 847, 747, 607, 579, 532, 492 
cm-1; 
HRMS (TOF MS ES+) 
 [M + H]+ calcd for C6H9I: 207.9749; found: 207.9735; 
TLC Rf = 0.94 (30% Et2O in hexanes) 
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Non-7-yn-2-one (2.7). To a 250-mL, 2-necked round bottom flask equipped stir bar, condenser 
topped with nitrogen inlet adapter, and septum was added sodium hydride (NaH) (60% dispersion 
in mineral oil, 2.30 g, 58.0 mmol, 1.1 equiv) and THF (132 mL) via temporary removal of the 
septum. The flask was lowered into an ice/water bath (0 °C) and tert-butyl acetoacetate (10.5 mL 
63.0 mmol, 1.2 equiv) was added dropwise over 20 min via syringe pump. Upon complete addition, 
the flask was removed from the ice/water bath and allowed to warm to rt, where it was maintained 
for 1 h. 6-Iodo-hex-2-yne 2.8 (11.0 g, 52.8 mmol, 1 equiv) was added in a single portion via 
syringe. The flask was lowered into a preheated oil bath (85 °C) and maintained for 18 h. Upon 
complete consumption of the starting material, as evidenced by TLC, the flask was removed from 
the oil bath and allowed to cool to rt. Sat. aq. NH4Cl (100 mL) was added via removal of the 
septum, and the mixture was transferred to a separatory funnel. The layers were separated and the 
aqueous phase was extracted with Et2O (2 x 50 mL). The combined organic phases were dried 
over MgSO4, filtered via medium porosity fritted glass vacuum filter, and concentrated via rotary 
evaporation. The crude residue was transferred to a 250-mL 2-necked round bottom flask equipped 
with a condenser topped with nitrogen inlet adapter, and septum via syringe. Benzene (176 mL) 
and p-toluenesulfonic acid (2.00 g, 10.6 mmol, 0.2 equiv) were sequentially added via temporary 
removal of the septum. The flask was lowered into a preheated oil bath (100 ⁰C) and maintained 
for 2 h at which point complete consumption of t-butyl acetoacetate 2.13 was observed via TLC. 
The flask was removed from the oil bath, allowed to cool to rt, transferred to a separatory funnel, 
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and washed with sat. aq. NaHCO3 (1 x 100 mL), then brine (1 x 100 mL). The combined aqueous 
phases were extracted with Et2O (2 x 100 mL), dried over MgSO4, filtered via medium porosity 
fritted glass vacuum filter, and concentrated via rotary evaporation. The crude residue was purified 
via SiO2 flash column chromatography (10%–20% Et2O/hexanes) to afford 6.60 g of the title 
compound as a yellow oil (90%). JEB03-129 
 
Data for 2.7 
1H NMR: (400 MHz, CDCl3) 
 2.44 (t, J = 7.6 Hz, 2H), 2.16–2.10 (m, 2H), 2.14 (s, 3H), 1.77 (t, J = 2.4 Hz, 3H), 
1.71–1.62 (m, 2H), 1.51–1.42 (m, 2H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 209.0, 78.8, 76.0, 43.4, 30.0, 28.6, 23.2, 18.7, 3.6 ppm; 
FTIR (neat) 
 2922, 2862, 1713, 1436, 1358, 1220, 1158, 952, 730, 592, 516 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C9H15O: 139.1117; found: 139.1113; 
TLC Rf (2.13) = 0.41 (20% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
 Rf (2.7) = 0.28 (20% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
 












Methyl (3-methyldeca-1,8-diyn-3-yl) carbonate (2.16). To a 250 mL, 3-necked round bottom 
flask equipped with stir bar, 125-mL addition funnel topped with septum, nitrogen inlet adapter, 
and septum was added anhydrous CeCl3 (4.99 g, 20.3 mmol, 1.4 equiv) in a nitrogen-filled 
glovebox. The flask was removed from the glovebox and THF (145 mL) was added via syringe. 
The white suspension was allowed to stir under nitrogen at rt for 24 h at which point the flask was 
lowered into an ice/water bath (0 °C). Ethynylmagnesium bromide (0.5 M solution in THF, 40.5 
mL, 20.3 mmol, 1.4 equiv) was cannulated into the addition funnel, and then added dropwise to 
the flask over a period of 10 min. The resulting brown suspension was maintained at 0 °C for 1.5 
h, at which point non-7-yn-2-one 2.7 (2.00 g, 14.5 mmol, 1 equiv) was added in a single portion 
via syringe. The reaction was maintained at 0 °C for 30 min until complete consumption of starting 
material was observed by TLC. Methyl chloroformate (2.24 mL, 28.9 mmol, 2 equiv) was added 
in a single portion via syringe and the flask was removed from the ice/water bath and warmed to 
rt, where it was maintained for 2 h. Upon complete consumption of intermediate S2.1, as evidenced 
by TLC, sat. aq. NH4Cl was added (50 mL) via syringe, and the mixture transferred to a separatory 
funnel. Et2O (150 mL) was added, the layers separated and the aqueous phase extracted with Et2O 
(3 x 75 mL). The combined organic phases were dried over MgSO4, filtered via medium porosity 
fritted glass vacuum filter, and concentrated via rotary evaporation. The crude residue was purified 
via SiO2 flash column chromatography (20% Et2O/hexanes) to afford 3.18 g of the title compound 
as a yellow oil (98%). JEB03-163 
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Data for 2.16 
1H NMR: (400 MHz, CDCl3) 
 3.77 (s, 3H), 2.58 (s, 1H), 2.18–2.11 (m, 2H), 2.00–1.92 (m, 1H), 1.88–1.79 (m, 
1H), 1.77 (t, J = 2.4 Hz, 3H), 1.71 (s, 3H), 1.66–1.46 (m, 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 153.7, 83.3, 78.9, 77.1, 75.9, 74.0, 54.5, 41.0, 29.0, 26.4, 23.5, 18.8, 3.6 ppm; 
FTIR (neat) 
 3283, 2952, 2863, 1751, 1439, 1376, 1256, 1163, 1088, 1028, 1013, 943, 869, 790, 
663, 598, 582, 555 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C13H19O3: 223.1328; found: 223.1331; 
TLC Rf = 0.68 (40% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
 
3-methyldeca-1,3-dien-8-yne (2.1). To a 250-mL, 2-necked round bottom flask 
equipped with stir bar, septum, and nitrogen inlet adapter was sequentially added 
ammonium formate (0.91 g, 14.4 mmol, 2 equiv), THF (58 mL) and 
Pd2dba3●CHCl3 (0.19 g, 0.18 mmol, 0.025 equiv) via temporary removal of the septum. To the red 
reaction mixture was added tri-n-butylphosphine (0.23 mL, 0.90 mmol, 0.125 equiv) [CAUTION: 
toxic, handle with care] via syringe, at which point the mixture turned yellow-green. The reaction 
mixture was maintained at rt for 10 min before methyl (3-methyldeca-1,8-diyn-3-yl) carbonate 
2.16 (1.6 g, 7.2 mmol, 1 equiv) was added in a single portion via syringe. The reaction was 
maintained at rt for 18 h until complete consumption of the starting material was observed by TLC. 
•
 116  
The mixture was filtered through a pad celite in a medium porosity fritted glass vacuum filter. The 
celite pad was rinsed with pentane (3 x 20 mL). The combined filtrates were evaporated via rotary 
evaporation and the crude residue purified via SiO2 flash column chromatography (2% 
Et2O/pentane) to afford 0.99 g of the title compound as a yellow oil (92%). The yellow color was 
removed by elution through a Silicycle FLH-R10030B-ISO40 SiliaSep™ 40g silica cartridge 
(100% pentane), affording 0.94 g of the title compound as a colorless oil; though this is not 
necessary for the success of the allenic Pauson-Khand reaction. JEB03-169 
 
Data for 2.1 
1H NMR: (400 MHz, CDCl3) 
 4.58 (sextet, J = 4.0 Hz, 2H), 2.16–2.10 (m, 2H), 1.94 (sept, J = 3.6 Hz, 2H), 1.78 
(t, J = 3.6 Hz, 3H), 1.67 (t, J = 4.0 Hz, 3H), 1.54–1.48 (m, 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 206.3, 98.3, 79.4, 75.6, 74.1, 33.1, 28.8, 26.7, 18.8, 18.7, 3.6 ppm; 
FTIR (neat) 
 2980, 2935, 2859, 1960, 1440, 1370, 1331, 1001, 845, 612, 590, 502; 
TLC Rf = 0.74 (10% Et2O/hexanes) 
 Rf = 0.40 (100% hexanes) 
 Silica gel, visualized with KMnO4 
 
3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-one (2.2) (Table 2.2, Entry 6). A 
15-mL 2-necked round bottom flask equipped with stir bar, condenser topped with 
a septum, and septum was sequentially charged with bis(1,5-
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cyclooctadiene)rhodium(I) tetrafluoroborate (7 mg, 0.02 mmol, 0.025 equiv) and PPh3 (7 mg, 0.02 
mmol, 0.038 equiv) in a nitrogen-filled glovebox via temporary removal of the septum. The flask 
was removed from the glove box and a nitrogen inlet needle was inserted into the septum on the 
condenser. 1,2-Dichloroethane (6.8 mL) was added via syringe. The resulting dark yellow solution 
was maintained at rt for 10 min at which time the flask was evacuated and refilled five times with 
CO gas (100%), alternating between an inlet needle attached to a vacuum and an inlet needle 
attached to a balloon of CO. The light-yellow solution was maintained for 10 min before 3-
methyldeca-1,3-dien-8-yne 2.1 (0.10 g, 0.67 mmol, 1 equiv) was added in a single portion via 
syringe. The flask was lowered into a preheated oil bath (70 °C) and maintained for 20 h until 
complete consumption of the starting material was observed by TLC. The flask was removed from 
the oil bath, allowed to cool to rt, and the contents transferred to a 200-mL recovery flask. The 
solvent was evaporated via rotary evaporation (40 °C bath temperature) and the crude residue was 
purified via SiO2 flash column chromatography (20–40% Et2O/hexanes) to afford 0.102 g of the 
title compound as a yellow oil which solidifies in the freezer (86%). 
 
Data for 2.2 
1H NMR: (400 MHz, CDCl3) 
 2.91 (s, 2H), 2.72–2.66 (m, 2H), 2.41–2.36 (m, 2H), 1.84 (s, 3H), 1.83–1.76 (m, 
4H), 1.75 (t, 3H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 205.0, 168.8, 137.7, 136.6, 131.6, 40.8, 35.7, 29.6, 26.9, 24.5, 24.2, 8.4 ppm; 
FTIR (neat) 
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2924, 2860, 1682, 1597, 1579, 1449, 1422, 1389, 1331, 1276, 1218, 1159, 1119, 
1090, 1071, 1050, 1002, 953, 916, 874, 845, 771, 680, 657, 637, 616, 560, 537, 509 
cm-1;
HRMS (HRMS ESI) 
[M + H]+ calcd for C12H17O: 177.1273; found: 177.1269; 
TLC Rf = 0.28 (40% Et2O/hexanes) 
Silica gel, visualized with KMnO4
methylbenzenesulfonohydrazide (2.6). To a 10–20-mL microwave vial (Biotage 
354833) equipped with a stir bar (Biotage 353930) was added tosyl hydrazide (0.38 
g, 2.0 mmol, 1.2 equiv). The vial was sealed with a microwave vial cap with septum 
(Biotage 352298), purged via nitrogen inlet needle, and ethanol (8.5 mL) was added via syringe. 
3,8-Dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-one 2.2 (0.57 g, 1.7 mmol, 1.0 equiv) was dissolved 
in EtOH (1 mL) and added to the vial via syringe. The nitrogen inlet needle was removed and the 
sealed vial was lowered into a preheated oil bath (85 ⁰C) and maintained for 18 h, at which point 
complete consumption of starting material was observed by TLC. The vial was removed from the 
oil bath, allowed to cool to rt, and the contents transferred to a 25-mL recovery flask. The solvent 
was evaporated via rotary evaporation (40 ⁰C bath temperature) and the crude residue purified via 
SiO2 flash column chromatography (40%-75% Et2O/hexanes), affording 0.45 g of the title 
compound as a yellow solid (77%).  
NTsHN
               (E)-N'-(3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-ylidene)-4-
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Data for 2.6 
1H NMR: (400 MHz, CDCl3) 
 7.88 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.13 (s, 1H), 2.89 (s, 3H), 2.56–
2.50 (m, 2H), 2.41 (s, 3H), 2.32–2.27 (m, 2H), 1.77 (s, 3H), 1.75 (s, 3H), 1.74-1.62 
(m, 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 164.1, 154.8, 143.9, 136.0, 135.6, 133.1, 132.1, 129.5, 128.2, 35.8, 32.3, 28.7, 27.5, 
25.0, 23.7, 21.7, 9.6 ppm; 
 
FTIR (neat) 
 3208, 2923, 2859, 1597, 1399, 1332, 1164 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C19H25O2N2S: 345.1631; found: 345.1623; 
m.p. 168.0-173.1 ⁰C 
TLC Rf = 0.29 (40% Et2O/hexanes) 









2.6 2.3 2.43  
 
Table 2.5 Entry 1. To a 2–5 mL microwave vial (Biotage 351521) equipped with stir bar (Biotage 
355543) was added N'-(3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-ylidene)-4-
methylbenzenesulfonohydrazide 2.6 (0.090 g, 0.26 mmol, 1 equiv). The vial was sealed with a 
crimp-on microwave vial cap with septum (Biotage 352298) and purged with N2 via nitrogen inlet 
needle. CDCl3 (0.87 mL) was added via syringe. The vial was lowered into an ice/water bath (0 
⁰C) and catecholborane (1 M in THF, 0.78 mL, 0.78 mmol, 3 equiv) was added dropwise over 1 
min via syringe. The reaction was maintained for 1 h, at which point the cap was removed from 
the vial and NaOAc∙3H2O (0.106 g, 0.78 mmol, 3 equiv) was added in a single portion. A new cap 
was placed onto the vial and the reaction warmed to room temperature where it was maintained 
for 1 h. An additional volume of CDCl3 (0.80 mL) was added as the mixture began to gel. The 
mixture was maintained for 1 h then lowered into a preheated oil bath (70 ⁰C). After reacting for 1 
h, the vial was removed from the oil bath and allowed to cool to room temperature, then filtered 
through a celite plug. The filtrate was concentration via rotary evaporation and purified via SiO2 
flash column chromatography (15% Et2O/hexanes), affording 21 mg of a yellow oil (49%). 1H 
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Table 2.5 Entry 2. To a 2–5 mL microwave vial (Biotage 351521) equipped with stir bar (Biotage 
355543) was charged N'-(3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-ylidene)-4-
methylbenzenesulfonohydrazide 2.6 (0.050 g, 0.15 mmol, 1 equiv). The vial was sealed with a 
crimp-on microwave vial with septum (Biotage 352298) and purged with nitrogen via a nitrogen 
inlet needle. THF (1.5 mL) was added via syringe. The vial was lowered into an ice/water bath (0 
⁰C) and catecholborane (1 M in THF, 0.73 mL, 0.73 mmol, 5 equiv) was added dropwise over 1 
min via syringe. The yellow solution was maintained for 3 h, at which point the cap was removed 
from the vial and NaOAc∙3H2O (0.106 g, 0.78 mmol, 3 equiv) was added in a single portion. A 
new cap was placed onto the vial which was then lowered into a preheated oil (70 ⁰C) where it was 
maintained for 1 h. The vial was removed from the oil bath and allowed to cool to room 
temperature, then filtered through a medium porosity fritted glass vacuum filter which was filled 
with celite. The filtrate was concentrated via rotary evaporation. The crude residue was purified 
via SiO2 flash column chromatography (30% Et2O/hexanes), affording 7 mg of a yellow oil (30%). 
1H NMR analysis of this oil revealed a 2.3 to 2.43 ratio of 79:21. 
 
 
Data for 2.3 (79:21 ratio 2.3/2.43) 
1H NMR: (400 MHz, CDCl3) 
 5.35 (m, 1H), 3.03 (d, J = 11.2 Hz, 1H), 2.99–2.84 (m, 2H), 2.07–1.84 (m, 4H), 
1.77–1.69 (m, 2H), 1.68 (s, 3H), 1.64 (s, 3H), 1.63–1.53 (m, 2H), 1.31–1.16 (m, 
2H), 1.01–0.87 (m, 1H)  ppm; 
13C NMR:  (100 MHz, CDCl3) 
 73.2, 70.3, 60.0, 52.8, 16.4, 33.0, 33.7, 37.5, 36.8, 43.0, 47,8 54.7 ppm; 
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TLC Rf = 0.96 (40% Et2O in hexanes) 
 Silica gel, visualized with KMnO4 
 
Table 2.5 Entry 3. To a 2–5 mL microwave vial (Biotage 351521) equipped with stir bar (Biotage 
355543) was charged with benzoic acid (0.181 g, 1.5 mmol, 10.2 equiv). The vial was sealed with 
a crimp-on microwave vial cap with septum (Biotage 352298) and purged with nitrogen via a 
nitrogen inlet needle. CDCl3 (0.48 mL) was added via syringe. The vial was lowered into an 
ince/water bath (0 ⁰C) and BH3 (1 M in THF, 0.73 mL, 0.73 mmol, 5 equiv) was added dropwise 
over 2 min via syringe, maintaining gentle bubbling. After reacting for 1 h, (E)-N'-(3,8-dimethyl-
4,5,6,7-tetrahydroazulen-2(1H)-ylidene)-4-methylbenzenesulfonohydrazide 2.6 (0.050 g, 0.15 
mmol, 1 equiv) was dissolved in CDCl3 (0.30 mL) and added to the reaction mixture via syringe. 
The reaction was maintained for 3 h at 0 ⁰C, at which point the cap was removed from the vial and 
NaOAc∙3H2O (0.138 g, 1.02 mmol, 7 equiv) was added in a single portion. A new cap was placed 
on the vial, which was then lowered into a preheated oil bath (70 ⁰C). After reacting for 1 h, the 
vial was removed from the oil bath and allowed to cool to room temperature. The contents of the 
vial were transferred to a separatory funnel and washed with sat. aq. Na2CO3 (2 x 2 mL). The 
layers were separated and the organic phase dried over MgSO4, concentrated via rotary 
evaporation, and purified via SiO2 flash column chromatography (100% hexanes), affording 9 mg 
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Data for 2.43 (4:96 ratio 2.3/2.43) 
1H NMR: (400 MHz, CDCl3) 
 2.45–2.35 (m, 4H), 2.34–2.28 (m, 2H), 2.24 (t, J = 5.6 Hz, 2H), 1.78–1.71 (m, 2H) 
1.71 (s, 3H), 1.69 (s, 3H), 1.65–1.58 (m, 2H) ppm; Impurities: 5.75–5.73 (m, 
0.17H), 3.05–3.00 (m, 0.08H), 2.93–2.88 (m, 0.13H), 2.81–2.77 (m, 0.41H), 2.70–
2.62 (m, 0.29H), 1.96–1.88 (m, 1.07H), 1.30–1.22 (m, 1.52H), 1.22–1.78 (m, 
0.94H), 1.04–0.99 (m, 0.33H), 0.97–0.92 (m, 0.29H), 0.91–0.80 (m, 1.00H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 141.9, 139.7, 138.0, 123.5, 35.51, 35.50, 29.4, 28.5, 27.4, 26.0, 23.1, 15.1 ppm; 
Impurities:155.5, 142.0, 135.4, 119.7, 43.9, 3.5, 35.4, 29.9, 29.7, 27.5,20.6, 13.6 
ppm; 
TLC Rf = 0.96 (15% Et2O in hexanes) 
 Silica gel, PAA 
 
3,8-dimethyl-4,5,6,7,8,8a-hexahydroazulen-2(1H)-one (2.35). A 25-mL two-
necked round bottom flask equipped with stir bar, nitrogen inlet adapter, and 
septum, was charged with palladium on carbon (10% Pd, 0.18 g, 0.17 mmol, 0.1 
equiv) via temporary removal of the septum. Ethyl acetate (3.4 mL) was added via syringe. 3,8-
dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-one 2.2 (0.300 g, 1.7 mmol, 1 equiv) was dissolved in 
methanol (13.6 mL) and added to the flask via syringe. A balloon filled with hydrogen gas (100%) 
was attached to a needle, and the needle inserted through the septum and into the reaction mixture. 
Hydrogen was bubbled through the mixture while being allowed to vent through the nitrogen inlet 
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filtered through a small plug of celite in a cotton-filled pipette, and concentrated via rotary 
evaporation. The residue was dissolved in CDCl3 and subjected to 1H NMR, which revealed 
complete consumption of starting material. After reacting for a total of 30 min, the reaction mixture 
was filtered through a celite-filled (6 x 4 cm) medium porosity fritted glass vacuum filter, and the 
filtrate concentrated via rotary evaporation. The crude residue was purified via SiO2 flash column 
chromatography (20–40% Et2O/hexanes), affording 0.272 g of the title compound as a colorless 
oil (90%).  
 
Data for 2.35 
1H NMR: (400 MHz, CDCl3) 
 3.09–3.03 (m, 1H), 2.76–2.67 (m, 1H), 2.53 (dd, J1 = 18.8 Hz, J2 =6.4 Hz, 1H), 
2.47–2.37 (m, 1H), 2.14–2.07 (m, 1H). 2.02 (dd, J1 = 18.4 Hz, J2 = 1.2 Hz, 1H), 
1.80–1.72 (m, 2H), 1.70–1.63 (m, 5H), 1.61–1.43 (m, 3H), 0.69 (d, J = 7.2 Hz, 3H) 
ppm; 
13C NMR:  (100 MHz, CDCl3) 
 208.8, 177.6, 137.2, 46.4, 40.8, 36.3, 35.6, 31.8, 26.6, 26.5, 13.9, 8.0 ppm; 
FTIR (neat) 
 2918, 2867, 1691, 1630, 1453, 1380, 1358, 1312 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C12H19O: 179.1430; found: 179.1428; 
TLC Rf = 0.28 (40% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
 
125 
methylbenzenesulfonohydrazide (2.36). A 2–5 mL microwave vial (Biotage 
351521) equipped with a stir bar (Biotage 353930) was charged with p-
toluenesulfonyl hydrazide (104 mg, 0.56 mmol, 2 equiv). The vial was sealed with 
a crimp-on microwave vial cap with septum (Biotage 352298) and purged with nitrogen via 
nitrogen inlet needle. EtOH was added via syringe, followed by 3,8-dimethyl-4,5,6,7,8,8a-
hexahydroazulen-2(1H)-one 2.35 (50 mg, 0.28 mmol, 1 equiv) which had been dissolved in EtOH 
(0.4 mL) via syringe. The nitrogen inlet needle was removed and the sealed vial lowered into a 
preheated oil bath (85 ⁰C) where it was maintained for 18 h. Upon complete consumption of 
starting material, as evidenced by TLC, the vial was removed from the oil bath and allowed to cool 
to rt. The contents were transferred to a 10-mL recovery flask and concentrated via rotary 
evaporation. The crude residue was purified via SiO2 flash column chromatography (20%–40% 
Et2O/hexanes), affording 90 mg of the title compound as a white solid (93%). The isomeric ratio 
of the hydrazone was determined to be 29:71 based on the integrations of the methyl doublets at 
0.97 ppm and 0.62 ppm, respectively; though we did not separate the major and minor isomers. 
Data for 2.36 
1H NMR: (400 MHz, CDCl3, *major isomer, **minor isomer) 
7.90–7.85 (m, 2H), 7.30 (d, J = 8.0 Hz, 2H), 6.90–6.84 (m, 1H), 3.02–2.97 (m, 
0.71H), 2.59–2.44 (m, 2.17H), 2.42 (s, 3.13H), 2.40–2.34 (m, 0.65H), 2.04–1.88 
(m, 1.90H), 1.86–1.79 (m, 0.41H), 1.70–1.61 (m, 5.03H), 1.60–1.52 (m, 1.76H), 
1.53–1.40 (m, 2.50H), 1.32–1.22 (0.97H), 0.97** (d, J = 6.4 Hz, 0.87H), 0.62* (d, 




N           N'-(3,8-dimethyl-4,5,6,7,8,8a-hexahydroazulen-2(1H)-ylidene)-4-
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13C NMR:  (100 MHz, CDCl3, *major isomer, **minor isomer) 
  168.1*, 167.6**, 160.7**, 160.4*, 143.89**, 143.87*, 135.6, 133.1, 132.3**, 
129.5, 128.31**, 128.29*, 52.6**, 49.2*, 40.8**, 36.6**, 36.2*, 36.0, 32.8**, 
31.4*, 30.3*, 28.8**, 27.4**, 27.0*, 26.8*, 25.0**, 22.6**, 21.7*, 13.9*, 9.1* ppm; 
FTIR (neat) 
 3213, 2912, 1619, 1443, 1402, 1387, 1334, 1308, 1289, 1186, 1163, 1089, 1019, 
927, 811, 769, 733, 704, 669, 623, 596, 575, 546, 500, 458 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C19H27O2N2S: 347.1788; found: 347.1778; 
m.p. 133.2-135.4 ⁰C 
TLC Rf = 0.23 (30% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
 
3,8-dimethyl-1,3a,4,5,6,7,8,8a-octahydroazulene (2.38) (Table 2.4, Entry 8). A 
0.5–2 mL microwave vial (Biotage 352016) equipped with stir bar (Biotage 
355544) was charged with N'-(3,8-dimethyl-4,5,6,7,8,8a-hexahydroazulen-2(1H)-
ylidene)-4-methylbenzenesulfonohydrazide 2.36 (50 mg, 0.14 mmol, 1 equiv). The vial was sealed 
with a crimp-on microwave vial cap (Biotage 352298) and flushed with N2 via an inlet needle. 
CDCl3 (0.72 mL) was added via syringe and the vial lowered into an ice/water (0 ⁰C) bath. 
Catecholborane (0.72 mL of a 1 M solution in THF, 0.72 mmol, 5 equiv) was added dropwise over 
1 min, and the reaction maintained for 3 h. NaOAc∙3H2O (87 mg, 1.01 mmol, 7 equiv) was added 
via removal of the microwave vial cap. A new cap was placed onto the vial, which was removed 
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maintained for 1 h before the vial was removed from the oil bath and cooled to rt. The contents 
were transferred to a separatory funnel, diluted with Et2O (2 mL), and washed with sat. NaHCO3 
(2 x 2 mL). The phases were separated and the combined aqueous phases extracted with Et2O (2 
x 2 mL). The combined organic phases were dried over MgSO4, filtered through a cotton plug, and 
concentrated via rotary evaporation. The crude residue was purified via SiO2 flash column 
chromatograph (10% Et2O/hexanes) affording 12 mg of the title compound as a colorless oil (48%) 
as a 63:37 diastereomeric ratio. 
 
Data for 2.38 
1H NMR: (400 MHz, CDCl3) 
5.30–5.27 (m, 0.37H), 5.27–5.24 (m, 0.63H), 2.43–2.23 (m, 2.39H), 2.19–2.13 (m, 
1.44H), 2.07–1.97 (m, 1.29H), 1.97–1.84 (m, 1.96H), 1.83–1.71 (m, 1.68H), 1.70–
1.64 (0.91H), 1.63–1.60 (m, 3.08H), 1.59–1.47 (m, 2.53H), 1.47–1.39 (m, 
1.53H)1.38–1.15 (m, 2.46H), 1.09–0.93 (m, 1.48H), 0.91 (d, J = 6.4 Hz, 1.12H), 
0.82 (d, J = 6.4 Hz, 2.08H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
143.7, 143.3, 123.5, 123.3, 53.2, 51.2, 48.6, 46.3, 38.9, 38.4, 38.24, 38.22, 34.8, 
33.3, 32.4, 32.6, 30.0, 29.1, 23.6, 23.4, 21.9, 16.8, 15.2, 15.1 ppm; 
TLC Rf = 0.94 (40% Et2O/hexanes) 
Silica gel, visualized with KMnO4 
 






(R)-3-methyldeca-1,8-diyn-3-yl acetate (2.57a). To a 50-mL 2-necked round bottom flask 
equipped with stir bar and two septa was added anhydrous CeCl3 (1.25 g, 5.1 mmol, 1.4 equiv) in 
a nitrogen-filled glove box, via temporary removal of a septum. The flask was removed from the 
glovebox and one of the septa was replaced with a nitrogen inlet adapter. THF (14 mL) was added 
via syringe and the resulting suspension was stirred under N2 at rt for 18 h. The flask was lowered 
into an ice/water bath (0 ⁰C) and ethynylmagnesium bromide (10.1 mL of a 0.5 M solution in THF, 
5.1 mmol, 1.4 equiv) was added dropwise over 10 min via syringe. The resulting brown suspension 
was maintained at 0 ⁰C for 1 h, at which point Non-7-yn-2-one 2.7 (0.50 g, 3.6 mmol, 1 equiv) was 
added dropwise over 2 min via syringe. After reacting for 10 min at 0 ⁰C, complete consumption 
of starting material was observed by TLC. Acetic anhydride (1.03 mL, 10.9 mmol, 3 equiv) was 
added in a single portion via syringe, and the mixture maintained at 0 ⁰C for 20 min, over which 
time the reaction mixture partially gelled. Upon complete consumption of intermediate S2.1, as 
evidenced by TLC, sat. aq. NH4Cl was added via syringe and the mixture transferred to a 
separatory funnel. The layers were separated and the aqueous phase extracted with Et2O (3 x 50 
mL). The combined organic phases were dried over MgSO4, filtered through a medium porosity 
fritted glass vacuum funnel, and concentrated via rotary evaporation. The crude residue was 
purified via SiO2 flash column chromatography (5% Et2O/hexanes) affording 0.71 g of the title 
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Data for 2.57a 
1H NMR: (400 MHz, CDCl3) 
  2.55 (s, 1H), 2.19–2.12 (m, 2H), 2.03 (s, 3H), 1.98–1.90 (m, 1H), 1.85–1.79 (m, 
1H), 1.78 (t, J = 2.4 Hz, 3H), 1.67 (s, 3H), 1.62–1.48 (m 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 169.5, 84.0, 79.0, 75.8, 74.9, 73.4, 41.0, 29.0, 26.5, 23.5, 22.1, 18.8, 3.6 ppm; 
FTIR (neat) 
 3279, 2940, 2864, 1742, 1438, 1368, 1237, 1166, 1097, 1015, 943, 851, 660, 611, 
536 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C13H19O2: 207.13796; found: 207.13838; 
TLC Rf (S2.1) = 0.07 (10% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
 Rf (2.57a) = 0.34 (10% Et2O/hexanes) 






3-methyldeca-1,8-diyn-3-yl 2-chloroacetate (2.57b). A 250-mL 3-necked round bottom flask 
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with anhydrous CeCl3 (4.64 g, 18.8 mmol, 1.3 equiv) in a nitrogen-filled glovebox. The flask was 
removed from the glovebox and one of the septa replaced with a nitrogen inlet adapter. THF (110 
mL) was added via temporary removal of the septum, and the resulting white suspension stirred 
under N2 at rt for 18 h. The flask was lowered into an ice/water bath (0 ⁰C). Ethynylmagnesium 
bromide (34.7 mL of a 0.5 M solution in THF, 17.4 mmol, 1.2 equiv) was cannulated into the 
addition funnel, then added dropwise to the flask over 20 min. Upon complete addition, the 
resulting brown suspension was maintained for 1.5 h at 0 ⁰C, at which point Non-7-yn-2-one 2.7 
(2.00 g, 14.5 mmol, 1 equiv) was added dropwise over 2 min via syringe. Complete consumption 
of starting material was evidenced by TLC after 15 min. Chloroacetyl chloride (1.73 mL, 21.7 
mmol, 1.5 equiv) was added dropwise over 2 min via syringe. The flask was removed from the 
ice/water bath and allowed to warm to rt, where it was maintained for 2 h. Upon complete 
consumption of intermediate S2.1, as evidenced by TLC, sat. aq. NH4Cl was added (~100 mL) via 
removal of the septum, and the mixture transferred to a 500-mL separatory funnel. The layers were 
separated and the aqueous phase extracted with Et2O (~100 mL x 2). The combined organic phases 
were dried over MgSO4, filtered through a medium porosity fritted glass vacuum funnel, and 
concentrated via rotary evaporation. The crude residue was purified via SiO2 flash column 
chromatography (10–20% Et2O/hexanes) affording 3.17 g of the title compound as a yellow oil 
(91%). 
 
Data for 2.57b 
1H NMR: (400 MHz, CDCl3) 
 4.02 (s, 2H), 2.60 (s, 1H), 2.19–2.12 (m, 2H), 2.03–1.93 (m, 1H), 1.89–1.80 (m, 
1H), 1.78 (t, J = 2.4 Hz, 3H), 1.72 (s, 3H), 1.63 1.48 (m, 4H) ppm; 
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13C NMR:  (100 MHz, CDCl3) 
 165.5, 82.9, 78.9, 77.3, 76.0, 74.4, 41.5, 40.8, 28.9, 26.4, 23.4, 18.7, 3.6 ppm; 
FTIR (neat) 
 3288, 2942, 2864, 1763, 1742, 1437, 1411, 1376, 1289, 1262, 1151, 1093, 1016, 
948, 859, 793, 637, 545 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C13H18O2Cl: 241.0995; found: 241.0984; 
TLC Rf (S2.1) = 0.19 (20% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde  
 Rf (2.57b) = 0.45 (20% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
 
3-methyldeca-1,2-dien-8-yn-1-yl acetate (2.56a). A 10–20-mL microwave 
vial (Biotage 354833) equipped with stir bar (Biotage 353930) was charged 
with rhodium(II) trifluoroacetate dimer (116 mg, 0.18 mmol, 0.05 equiv) in 
a nitrogen-filled glovebox. The vial was sealed with a crimp-on microwave vial cap with septum 
(Biotage 352298) and removed from the glove box. The septum was pierced with a nitrogen inlet 
needle and toluene (17.7 mL) was added via syringe. 3-Methyldeca-1,8-diyn-3-yl acetate 2.57a 
(0.73 g, 3.5 mmol, 1 equiv) was dissolved in toluene (1 mL) and added in a single portion via 
syringe. The nitrogen inlet needle was removed and the sealed via was lowered into a preheated 
oil bath (50 ⁰C), where it was maintained for 1.5 h. Upon complete consumption of the starting 
material, as evidenced by TLC, the vial was removed from the oil bath and allowed to cool to rt. 
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(40 ⁰C bath temperature). The crude residue was purified via SiO2 flash column chromatography 
(1–3% Et2O/hexanes), affording 0.65 g of the title compound as a pale-yellow oil (88%).   
 
Data for 2.56a 
1H NMR: (400 MHz, CDCl3) 
 7.32–7.28 (m, 1H), 2.13 (s, 3H), 2.12–2.01 (m, 4H) 1.83 (s, 3H), 1.79–1.76 (m, 
3H), 1.58–1.46 (m, 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 189.5, 169.0, 116.0, 109.8, 79.1, 75.7, 34.8, 28.6, 26.5, 21.1, 20.6, 18.7, 3.6 ppm; 
 
FTIR (neat) 
 2937, 2860, 1974, 1746, 1440, 1367, 1209, 1147, 1035, 990, 920, 787, 626, 598, 
550 cm-1; 
HRMS (HRMS ESI) 
 [M+H+] calcd for C13H19O2: 207.13796; found: 207.13767; 
TLC Rf = 0.41 (10% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
  
3-methyldeca-1,2-dien-8-yn-1-yl 2-chloroacetate (2.56b). A 50-mL 2-
necked round bottom flask equipped with stir bar, reflux condenser 
topped with septum, and septum was charged with rhodium(II) 
trifluoroacetate dimer (100 mg, 0.15 mmol, 0.037 equiv) in a nitrogen-filled glovebox. The flask 
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inlet adapter. Toluene was added (24 mL) via syringe, followed by 3-methyldeca-1,8-diyn-3-yl 2-
chloroacetate 2.57b (1.00 g, 4.15 mmol, 1 equiv) dissolved in toluene, in a single portion via 
syringe. The flask was lowered into a preheated oil bath (50 ⁰C) where it was maintained for 8 h. 
Upon complete consumption of starting material, as evidenced by TLC, the flask was removed 
from the oil bath and allowed to cool to rt. SilametS Thiourea (350 mg, 1.07 mmol/g, 2.5 equiv 
with respect to rhodium(II) trifluoroacetate dimer) was added via temporary removal of the 
septum. The mixture was maintained at rt for 16 h then filtered through a medium porosity fritted 
glass vacuum filter filled with celite (6 x 4 cm). The filtrate was concentrated via rotary 
evaporation and the crude residue purified via SiO2 flash column chromatography (5% 
Et2O/hexanes), affording 0.89 g of the title compound as a yellow oil (89%).  
 
Data for 2.56b 
1H NMR: (400 MHz, CDCl3) 
 7.32 (sextet, J = 2.0 Hz, 1H), 4.16 (s, 2H), 2.19–2.08 (m, 4H), 1.86 (d, J = 2.0 Hz, 
3H), 1.80 (t, J = 2.4 Hz, 3H), 1.60–1.49 (m, 4H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 189.5, 165.4, 117.3, 110.3, 79.1, 75.8, 40.9, 34.7, 28.6, 26.4, 20.6, 18.7, 3.6 ppm; 
FTIR (neat) 
 1769, 1746, 1308, 1285, 1236, 1149, 1057, 1004, 942, 787 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C13H18O2Cl: 241.09898; found: 241.09919; 
TLC Rf = 0.69 (20% Et2O/hexanes) 
 Silica gel, visualized with p-anisaldehyde 
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3,8-dimethyl-2-oxo-1,2,4,5,6,7-hexahydroazulen-1-yl acetate (2.58a). A 100-
mL 2-necked round bottom flask equipped with stir bar, reflux condenser topped 
with septum, and a septum, was sequentially charged with bis(1,5-
cyclooctadiene)rhodium(I) tetrafluoroborate (31 mg, 0.08 mmol, 0.025 equiv) 
and PPh3 (30 mg, 0.11 mmol, 0.038 equiv) in a nitrogen-filled glovebox. The flask was removed 
from the glovebox and a nitrogen inlet needle was inserted into the septum on top of the reflux 
condenser. 1,2-Dichloroethane (30 mL) was added via syringe. The resulting dark yellow solution 
was maintained at rt for 10 min at which time the flask was evacuated and refilled five times with 
CO gas (100%), alternating between an inlet needle attached to a vacuum and an inlet needle 
attached to a balloon of CO. The light-yellow solution was maintained for 10 min before 3-
methyldeca-1,2-dien-8-yn-1-yl acetate 2.56a (0.62 g, 3.0 mmol, 1 equiv) was added in a single 
portion via syringe. The flask was lowered into a preheated oil bath (70 ⁰C) and maintained for 20 
h. Upon complete consumption of starting material, as evidenced by TLC, the flask was removed 
from the oil bath, allowed to cool to rt, and the contents transferred to a 100-mL recovery flask. 
The solvent was evaporated via rotary evaporation (40 °C bath temperature) and the crude residue 
purified via SiO2 flash column chromatography (20–40% Et2O/hexanes) affording 0.60 g of the 
title compound as a pale-yellow solid (85%). 
 
Data for 2.58a 
1H NMR: (400 MHz, CDCl3) 
 5.66 (s, 1H), 2.72 (t, J = 5.6 Hz, 2H), 2.48–2.34 (m, 2H), 2.13 (s, 3H), 1.89–1.69 
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13C NMR:  (100 MHz, CDCl3) 
 200.3, 170.0, 169.2, 140.5, 134.8, 131.9, 72.2, 35.6, 29.0, 26.5, 24.2, 23.5, 20.8, 8.3 
ppm; 
FTIR (neat) 
 2923, 1739, 1694, 1574, 1433, 1371, 1338, 1277, 1224, 1024, 968, 929, 747, 586, 
518 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C14H19O3: 235.1334; found: 235.1348; 
TLC Rf = 0.36 (40% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
 
3,8-dimethyl-2-oxo-1,2,4,5,6,7-hexahydroazulen-1-yl 2-chloroacetate 
(2.58b). A 50-mL 2-necked round bottom flask equipped with stir bar, reflux 
condenser topped with septum, and a septum was sequentially charged with 
bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate (51 mg, 0.13 mmol, 0.05 
equiv) and PPh3 (49 mg, 0.19 mmol, 0.075 equiv) in a nitrogen-filled glovebox. The flask was 
removed from the glovebox and a nitrogen inlet needle was inserted into the septum on top of the 
reflux condenser. 1,2-dichloroethane (25 mL) was added via syringe. The resulting dark yellow 
solution was maintained at rt for 10 min at which time the flask was evacuated and refilled five 
times with CO gas (100%), alternating between an inlet needle attached to a vacuum and an inlet 
needle attached to a balloon of CO. The light-yellow solution was maintained for 10 min before 
3-methyldeca-1,2-dien-8-yn-1-yl 2-chloroacetate 2.56b (0.60 g, 2.5 mmol, 1 equiv) was added in 
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for 20 h. Upon complete consumption of starting material, as evidenced by TLC, the flask was 
removed from the oil bath, allowed to cool to rt, and the contents transferred to a 100-mL recovery 
flask. The solvent was evaporated via rotary evaporation (40 °C bath temperature) and the crude 
residue purified via SiO2 flash column chromatography (30% Et2O/hexanes) affording 0.58 g of 
the title compound as a pale-yellow solid (86%). 
 
Data for 2.58b 
1H NMR: (400 MHz, CDCl3) 
 5.69 (s, 1H), 4.12 (d, J = 0.4 Hz, 2H), 2.73 (t, J = 5.6 Hz, 2H), 246–2.37 (m, 2H), 
1.92–1.71 (m, 4H), 1.85 (s, 3H), 1.79 (s, 3H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 199.2, 169.7, 166.5, 141.4, 134.9, 131.1, 73.6, 40.8, 35.6, 29.0, 26.4, 24.1, 23.7, 8.3 
ppm; 
FTIR (neat) 
 2936, 1735, 1689, 1568, 1454, 1415, 1392, 1323, 1257, 1162, 1026, 977, 855, 799, 
782, 746, 690, 557, 542, 508, 455, 429 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C14H18O3Cl: 269.0945; found: 269.0931; 
m.p. 83.4-84.4 ⁰C 
TLC Rf = 0.37 (40% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
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1-hydroxy-3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-one (2.53). A 100-mL 
2-necked round bottom flask equipped with stir bar, reflux condenser topped with 
nitrogen inlet adapter, and septum, was charged with 3,8-dimethyl-2-oxo-
1,2,4,5,6,7-hexahydroazulen-1-yl 2-chloroacetate 2.58b (0.52 g, 1.94 mmol, 1 equiv) via 
temporary removal of the septum, and MeOH (32 mL) via syringe. Scandium(III) triflate (48 mg, 
0.097 mmol, 0.05 equiv) was added to a scintillation vial and dissolved in 6.5 mL H2O. This 
solution was added to the flask via syringe. The flask was lowered into a preheated oil bath (30 
⁰C) and maintained for 3.5 h, at which point complete consumption of starting material was 
evidenced by TLC. The flask was removed from the oil bath, allowed to cool to rt, and the contents 
transferred to a 125-mL separatory funnel. Brine (20 mL) was added, the layers separated, and the 
aqueous phase extracted with EtOAc (2 x 20 mL). The combined organic phases were dried over 
MgSO4, filtered through a medium porosity fritted glass vacuum filter, and concentrated via rotary 
evaporation. The crude residue was purified via SiO2 flash column chromatography (40–60% 
Et2O/hexanes) affording 0.33 g of the title compound as a white solid (88%).  
 
Data for 2.53 
1H NMR: (400 MHz, CDCl3) 
 4.44 (d, J = 2 Hz, 1H), 2.74–2.68 (m, 3H), 2.50–2.34 (m, 2H), 2.05 (s, 3H), 1.90–
1.69 (m, 4H), 1.77 (s, 3H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 205.7, 170.2, 141.5, 134.2, 133.6, 72.0, 35.8, 29.3, 26.5, 24.2, 23.8, 8.2 ppm; 
FTIR (neat) 
 3286, 2918, 1667, 1563, 1394, 1335, 1256, 1129, 1041, 801, 762, 580  
O
HO
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 cm-1; 
HRMS (HRMS ESI) 
 [M + H]+ calcd for C12H17O2: 193.12231; found: 193.12232; 
m.p. 81.6-83.7 ⁰C 
TLC Rf = 0.12 (40% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
 
2-hydroxy-3,8-dimethyl-4,5,6,7-tetrahydroazulen-1(3aH)-one (2.54). A 25-mL 
2-necked round bottom flask equipped with stir bar, nitrogen inlet adapter, and 
septum was sequentially charged with 1-hydroxy-3,8-dimethyl-4,5,6,7-
tetrahydroazulen-2(1H)-one 2.53 (105 mg, 0.55 mmol, 1 equiv) via temporary removal of the 
septum, and THF (10.9 mL) via syringe. To this solution was added potassium tert-butoxide (1.3 
mL of a 0.5 M solution in tBuOH, 0.66 mmol, 1.2 equiv) via syringe, and the reaction maintained 
at rt for 5 min, during which period a yellow precipitate formed. After complete consumption of 
starting material, as evidenced by TLC, the mixture was diluted with EtOAc (10 mL), transferred 
to a 60-mL separatory funnel and sat. NH4Cl (20 mL) added. The layers were separated and the 
organic phase was dried over MgSO4 and concentrated via rotary evaporation, affording 104 mg 










Data for 2.54 
1H NMR: (400 MHz, CDCl3) 
5.75 (s, 1H), 2.93 (d, J = 11.6 Hz, 1H), 2.43 (1, J = 13.2 Hz, 1H), 2.39 (s, 3H), 
2.23–2.03 (m, 3H), 1.95 (s, 3H), 1.90–1.81 (m, 1H), 1.64–1.51 (m, 1H), 1.30–1.17 
(m, 1H), 0.94–0.81 (m, 1H) ppm; 
13C NMR: (100 MHz, CDCl3) 
189.9, 153.4, 150.5, 136.8, 134.0, 45.2, 38.8, 31.5, 31.2, 25.5, 21.2, 11.4 ppm; 
FTIR (neat) 
3304, 2930, 2850, 1666, 1614, 1436, 1401, 1353, 1331, 1292, 1215, 1184, 1158, 
1091, 1048, 989, 965, 948, 835, 818, 785, 672, 653, 599, 556, 535, 508, 483 cm-1; 
HRMS (HRMS ESI) 
[M + H]+ calcd for C12H17O2: 193.12231; found: 193.12213; 
TLC Rf = 0.65 (40% Et2O/hexanes, visualized with KMnO4) 
trifluoromethanesulfonate (2.59). A 0.5–2 mL microwave vial (Biotage 352016) 
equipped with stir bar (Biotage 355544) was charged with 2-hydroxy-3,8-dimethyl-
4,5,6,7-tetrahydroazulen-1(3aH)-one 2.54 (18 mg, 0.09 mmol, 1 equiv). The vial was sealed with 
a crimp-on microwave vial cap (Biotage 352298) and flushed with N2 via an inlet needle. CH2Cl2 
(0.94 mL) was added via syringe and the vial lowered into an ice/water (0 ⁰C) bath. Triethylamine 
(26 μL, 0.19 mmol, 2.0 equiv) and triflic anhydride (19 μL, 0.11 mmol, 1.2 equiv) were 
sequentially added dropwise via syringe. The reaction was maintained for 1 h at which point 
complete consumption of starting material was observed by TLC. The via was removed from the 
O
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ice/water bath and the contents transferred to a recovery flask. Upon concentration and purification 
of the crude residue via SiO2 flash column chromatography (20% Et2O/hexanes), 24 mg of the title 
compound were isolated as a pale-yellow oil (79%). The product was contaminated with a small 
amount of an identified product which was not observable by TLC. 
 
Data for 2.59 
1H NMR: (400 MHz, CDCl3) 
3.12 (d, J = 11.6 Hz, 1H), 2.48–2.41 (m, 1H), 2.40 (s, 3H), 2.28–2.21 (m, 1H), 
2.17–2.12 (m, 2H) 2.09 (s, 3H), 1.92–1.86 (m, 1H), 1.69–1.58 (m, 1H) 1.33–1.24 
(m, 1H), 1.09–1.00 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
185.0, 156.9, 156.8, 146.3, 132,2, 118.7 (q, J = 318.3 Hz), 46.1, 38.9, 31.2, 30.7, 
25.0, 21.4, 12.6 ppm; 
TLC Rf = 0.53 (40% Et2O/hexanes)  
 Silica gel, visualized with KMnO4 
 
3,8-dimethyl-4,5,6,7-tetrahydroazulen-1(3aH)-one (2.55). A 2–5 mL microwave 
vial (Biotage 521521) equipped with stir bar (Biotage 355543) was charged with 
Tetrakis(triphenylphosphine)-palladium(0) (34 mg, 0.03 mmol, 0.5 equiv) and 
lithium chloride (22 mg, 0.51 mmol, 8.75 equiv). The vial was sealed with a crimp-on microwave 
vial cap (Biotage 352298), and flushed with nitrogen via an inlet needle. 3,8-Dimethyl-1-oxo-
1,3a,4,5,6,7-hexahydroazulen-2-yl trifluoromethanesulfonate 2.59 (19 mg, 0.06 mmol, 1 equiv) 
was dissolved in DMF (5.9 mL) and added to the vial via syringe. The solution was degassed for 
O
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10 min by bubbling nitrogen through the solution via an inlet needle. Triethylsilane (0.19 mL, 1.2 
mmol, 20.4 equiv) was added via syringe. The inlet needle was removed and the sealed vial 
lowered into a preheated oil bath (90 ⁰C), where it was maintained for 15 min. Upon complete 
consumption of starting material, as evidenced by TLC, the vial was removed from the oil bath 
and allowed to cool to rt. The contents were transferred to a separator funnel, diluted with Et2O (5 
mL), and washed with H2O (2 x 3 mL). The organic phase was dried over MgSO4 and concentrated 
via rotary evaporation. The crude residue was purified via SiO2 flash column chromatography 
(20% Et2O/hexanes) affording 5.6 mg of the title compound as a colorless oil (54%). The product 
was contaminated with triethylsilane. 
 
Data for 2.55 
1H NMR: (400 MHz, CDCl3) 
 6.02 (pent, J = 1.2 Hz, 1H), 3.08 (d, J = 11.6 Hz, 1H), 2.43–2.37 (m, 1H), 2.35 (s, 
3H), 2.19–2.13 (m, 1H), 2.12–2.06 (m, 2H), 2.05 (m, 3H), 1.88–1.80 (m, 1H), 1.67–
1.54 (m, 2H), 1.32–1.26 (m, 1H) ppm; Impurities: 0.97 (t, J = 8.0 Hz, 2.13H), 0.59 
(q, J = 8.0 Hz, 1.46H) ppm (triethyl silane); 
13C NMR:  (100 MHz, CDCl3) 
197.4, 172.1, 151.5, 136.8, 133.5, 50.4, 39.1, 31.5, 31.0, 25.5, 20.8, 16.8 ppm; 
Impurities: 6.7, 5.9 ppm (triethyl silane); 
TLC Rf = 0.51 (30% Et2O/hexanes)  




7(8H)-one (2.61). A 100-mL 2-necked round bottom flask equipped with stir bar, 
nitrogen inlet adapter, and septum was charged with vanadyl acetylacetonate (4 
mg, 0.016 mmol, 0.01 equiv) via temporary removal of the septum. Benzene (31 mL) was added 
via syringe, followed by 1-hydroxy-3,8-dimethyl-4,5,6,7-tetrahydroazulen-2(1H)-one 2.53 (300 
mg, 1.56 mmol, 1 equiv), which had been dissolved in benzene (3 mL), via syringe. Tert-butyl 
hydroperoxide (~5 M in decanes, 0.37 mL, 1.87 mmol, 1.2 equiv) was added dropwise over 1 min 
via syringe, during which period the reaction mixture turned deep red. The reaction was maintained 
at rt for 1 h, during which period the color changed to light yellow. Upon complete consumption 
of starting material, as evidenced by TLC, the mixture was concentrated via rotary evaporation. 
The crude residue was purified via SiO2 flash column chromatography (40% Et2O/hexanes), 
affording 307 mg of the title compound as a white solid and single diastereomer (94%). 
Data for 2.61 
1H NMR: (400 MHz, CDCl3) 
3.89 (d, J = 3.2 Hz, 1H), 2.91 (m, 1H), 2.39 (d, J = 4 Hz, 1H), 2.32–2.25 (m, 1H) 
2.21–2.11 (m, 1H), 2.02–1.87 (m, 2H) 1.82 (d, J = 1.6 Hz, 3H), 1.76–1.66 (m, 1H), 
1.66–1.57 (m, 1H), 1.48 (s, 3H), 1.20–1.07 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
203.9, 167.8, 140.9, 71.5, 68.3, 67.9, 35.5, 29.1, 25.9, 24.4, 23.5, 8.7 ppm; 
FTIR (neat) 
1769, 1746, 1308, 1285, 1236, 1149, 1057, 1004, 942, 787 cm-1; 
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 3432, 2927, 1684, 1615, 1441, 1389, 1339, 1326, 1281, 1225, 1175, 1158, 1127, 
1108, 1045, 1028, 982, 886, 854, 824, 768, 724, 653 ,610, 545, 475 cm-1; 
 [M + H]+ calcd for C12H17O3: 209.11722; found: 209.11741; 
TLC Rf = 0.20 (60% Et2O/hexanes) 
 Silica gel, visualized with KMnO4 
 
 144  
Appendix B : Experimental Information for Chapter Three 
General Methods. Unless otherwise indicated, all reactions were performed in flame-dried 
glassware under an atmosphere of dry nitrogen. All commercially available compounds used as 
received. Tetrahydrofuran (THF), dichloromethane (CH2Cl2), and diethyl ether (Et2O) were 
purified by passing through alumina using the Sol-Tek ST-002 solvent purification system. 
Toluene was distilled over calcium hydride prior to use. Deuterated chloroform (CDCl3 was dried 
over 3 Å molecular sieves prior to use. Gasses N2, H2, and CO were purchased from Matheson Tri 
Gas. Flash column chromatography was performed using silica gel (40-63 μm particle size, 60 Å 
pore size). Thin-layer chromatography (TLC) was performed on silica get F254 glass-backed plates 
(250 μm thickness). 1H and 13C NMR were recorded on a Bruker Avance 400 MHz spectrometer. 
Spectra were referenced to residual chloroform (7.26 ppm, 1H, 77.16 ppm, 13C). Chemical shifts 
(δ) are reported in ppm and multiplicities are indicated by s (singlet), d (doublet), t (triplet), q 
(quartet), quint (quintet), and m (multiplet). Coupling constants, J, are reported in hertz (Hz). NMR 
spectra were obtained at room temperature. EI mass spectroscopy was performed on a Waters 
Micromass GCT high-resolution mass spectrometer, while ES mass spectroscopy was performed 
on a Waters Q-TOF Ultima API, Micromass UK Limited high-resolution mass spectrometer. IR 
spectra were obtained using a Nicolet Avatar E.S.P. 360 FT-IR. 
 
 (R)-N,N-dimethyl-2-(3-methylcyclopent-2-en-1-yl)acetamide (3.37). Two-
step, two-pot procedure.  A 2–5-mL microwave vial (Biotage 351521) 
equipped with stir bar (Biotage 355543) was charged with Hoveyda-Grubbs 2nd 




microwave vial cap with septum (Biotage 352298) and purged with N2 via an inlet needle. (R)-
linalool (0.50 g, 0.57 mL, 3.2 mmol, 1 equiv) was added and a second needle attached to an oil 
bubbler was inserted into the septum. The mixture was reacted at rt while being allowed to vent 
through the oil bubbler for 1 h, at which point complete consumption of starting material was 
observed by TLC. The nitrogen inlet needle was removed and a needle attached to an air line was 
inserted through the septum and into the reaction mixture. Air was bubbled through the green 
solution for 20 min during which time the solution turned black. A syringe was used to transfer 
the solution to a 50-mL 2-necked round bottom flask which was equipped with a stir bar, septum, 
and reflux condenser topped with nitrogen inlet adapter. Freshly distilled toluene (13 mL) was 
added via syringe, followed by N,N-dimethylacetamide dimethyl acetal (1.4 mL, 9.7 mmol, 3 
equiv) via syringe. The flask was lowered into a preheated oil bath set to 115 ⁰C and reacted for 
24 h at which point TLC revealed the reaction to be complete. The flask was removed from the 
oil bath, allowed to cool to rt, transferred to a 100-mL recovery flask, and concentrated via rotary 
evaporation (40 °C bath temperature). Purification via SiO2 flash column chromatography (40–
60% Et2O/hexanes), afforded 0.40 g of the title compound as an orange oil (75%). 
 Two-step, one-pot procedure. This reaction was performed as described above with the 
following modifications: Hoveyda-Grubbs 2nd generation catalyst (< 1 mg, spatula tip) was 
dissolved in toluene (2.6 mL). (R)-Linalool (0.100 g, 0.12 mL, 0.65 mmol, 1 equiv) was added in 
a single portion via syringe. Reacted at rt for 1.5 h. Air was bubbled through the reaction mixture 
for 40 min before N,N-dimethylacetamide dimethyl acetal (0.24 mL, 1.62 mmol, 2.5 equiv) was 
added in a single portion via syringe. Reacted at 115 ⁰C for 24 h. Contents transferred to a 
recovery flask and concentrated via rotary evaporation. 0.083 g of the title compound as an 
orange oil (77%). 
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NOTE: This one-pot procedure was scaled up to 5 g and 68% of the title compound was isolated; 
however, catalyst loading had to be increased to 0.3 mol% for the metathesis to reach completion.  
 
Data for 3.37 
1H NMR: (400 MHz, CDCl3) 
 5.31–5.27 (m, 1H), 3.16–3.06 (m, 1H), 2.99 (s, 3H), 2.94 (s, 3H), 2.39–2.27 (m, 
2H), 2.27–2.14 (m, 3H), 1.71 (s, 3H) 1.53–1.42 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
172.7, 141.1, 128.4, 42.5, 39.9, 37.5, 36.3, 35.4, 31.1, 16.8 ppm; 
FTIR (neat) 
2920, 1738, 1641, 1493, 1445, 1393, 1327, 1266, 1129, 1084, 1056, 1005, 986, 
815, 824, 614, 455 cm-1; 
HRMS (HRMS ESI) 
 calcd for C10H18NO (M+H+): 168.1382; found: 168.1375; 
TLC Rf = 0.13 (50% Et2O in hexanes) 
 Silica gel, visualized with KMnO4 
 
Methyl (R)-2-(3-methylcyclopent-2-en-1-yl)acetate (3.36). A 250-mL 2-
necked round-bottom flask equipped with stir bar, nitrogen inlet adapter, and 
septum was charged with (R)-N,N-dimethyl-2-(3-methylcyclopent-2-en-1-
yl)acetamide 3.37 (1.75 g, 10.5 mmol, 1 equiv) via syringe. Dichloromethane (105 mL) was added 
via temporary removal of the septum, followed by pyridine (2.5 mL, 31.4 mmol, 3 equiv) via 
syringe. The flask was lowered into an ethanol bath cooled to -40 °C via immersion chiller. Triflic 
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anhydride (2.3 mL, 13.6 mmol, 1.3 equiv) was added dropwise over 20 min via syringe pump. 
Upon complete addition, the ethanol bath was warmed to 0 °C over 2 h by gradually increasing 
the temperature of the immersion chiller. Upon reaching 0 ⁰C the reaction was maintained for 2 h, 
at which point the starting material had been consumed as evidenced by TLC. Methanol (12.7 mL, 
314 mmol, 30 equiv) was added dropwise over 3 min via syringe, and the flask removed from the 
ethanol bath and allowed to warm to rt, where it was maintained for 16 h. 1 N HCl was added (50 
mL) via temporary removal of the septum, and the biphasic mixture was stirred at rt for 3 h. The 
reaction mixture was transferred to a separatory funnel and the layers separated. The aqueous phase 
was extracted with CH2Cl2 (1 x). The combined organic phases were dried over MgSO4, filtered 
through a medium-porosity fritted glass vacuum filter, and concentrated via rotary evaporation. 
The crude residue was purified via SiO2 flash column chromatography (40% Et2O/pentane), 
affording 1.36 g of the title compound as a pale-yellow oil (85%). 
 
Data for 3.36 
1H NMR: (400 MHz, CDCl3) 
 5.27–5.23 (m, 1H), 3.67 (s, 3H), 3.10–2.99 (m, 1H), 2.38–2.10 (m, 5H), 1.71 (s, 
3H), 1.53–1.44 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
173.7, 141.6, 127.6, 51.5, 42.4, 40.7, 36.3, 30.7, 16.7 ppm; 
FTIR (neat) 
2951, 2844, 1736, 1657, 1436, 1360, 1315, 1253, 1190, 1156, 1074, 1014, 996, 
883, 821, 655, 593 
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HRMS (HRMS ESI) 
 calcd for C9H15O2 (M+H+): 155.1066; found: 155.1060; 
TLC Rf = 0.74 (40% Et2O/hexanes) 
 Silica gel, visualized via KMnO4 
 
Methyl (R)-3-formyl-6-oxoheptanoate (3.40). A 25-mL 2-necked round 
bottomed flask equipped with stir bar, nitrogen inlet adapter, and septum 
was charged with methyl (R)-2-(3-methylcyclopent-2-en-1-yl)acetate 3.36 
(150 mg, 0.97 mmol, 1 equiv). Acetone (8.8 mL), deionized water (0.9 mL), and 2,6-lutidine (0.23 
mL, 1.95 mmol, 2 equiv) were sequentially added via syringe. N-Methylmorpholine N-oxide (170 
mg, 1.46 mmol, 1.5 equiv) was added, followed by osmium tetroxide (7 mg, 0.03 mmol, 0.03 
equiv) via temporary removal of the septum. The brown-yellow reaction mixture was maintained 
at rt for 16 h, at which point complete consumption of starting material was observed by TLC. 
Iodobenzene diacetate (470 mg, 1.46 mmol, 1.5 equiv) was added via temporary removal of the 
septum and the mixture maintained at rt for 2 h. Upon completion, as evidenced by TLC, saturated 
aqueous Na2S2O3 (10 mL) was added and the mixture stirred for 10 min. The mixture was 
transferred to a separatory funnel and EtOAc (10 mL) was added. The layers were separated and 
the aqueous phase extracted with EtOAc (2 x 10 mL). The combined organic phases were washed 
with saturated aqueous CuSO4 (3 x 10 mL). The organic phase was dried over MgSO4, filtered 
through a medium porosity fritted glass vacuum filter, and concentrated via rotary evaporation. 
The crude residue was purified via SiO2 flash column chromatography (40–80% EtOAc/hexanes), 
affording 161 mg of the title compound as a colorless oil (89%). 
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Data for 3.40 
1H NMR: (400 MHz, CDCl3) 
9.68 (d, 0.8 Hz, 1H), 3.68 (s, 3H), 2.85–2.77 (m, 1H), 2.72 (dd, J1 = 16.4 Hz, J2 = 
8 Hz, 1H), 2.57–2.48 (m, 2H), 2.42 (dd, J1 = 16.4 Hz, J2 = 5.6 Hz, 1H), 2.14 (s, 
3H), 2.06–1.95 (m, 1H), 1.83–1.71 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
207.3, 202.3, 172.1, 52.1, 46.9, 40.3, 33.2, 30.1, 22.3 ppm; 
TLC Rf = 0.24 (40% EtOAc in hexanes)  
 Rf = 0.05 (40% Et2O in hexanes) 
 Silica get, visualized with p-anisaldehyde 
 
(R)-3-formyl-N,N-dimethyl-6-oxoheptanamide (3.52). To a 250 mL 2-
necked round-bottom flask equipped with stir bar, nitrogen inlet adapter, 
and septum were sequentially added (R)-N,N-dimethyl-2-(3-
methylcyclopent-2-en-1-yl)acetamide 3.37 (2.18 g, 13.0 mmol, 1 equiv), acetone (118 mL), 
deionized water (12 mL), 2,6-lutidine (3.00 mL, 26.0 mmol, 2 equiv), N-methylmorpholine N-
oxide (2.29 g, 19.6 mmol, 1.5 equiv), and osmium tetroxide (99 mg, 0.39 mmol, 0.03 equiv), via 
temporary removal of the septum. The brown-yellow mixture was reacted at rt for 20 h, at which 
point the starting material had been fully consumed, as evidenced by TLC. Iodobenzene diacetate 
(6.30 g, 19.6 mmol, 1.5 equiv) was added in a single portion via temporary removal of the septum, 
and the mixture reacted at rt for 1.5 h. Upon completion, as evidenced by TLC, sat. aq. Na2S2O3 
(50 mL) was added. The biphasic mixture was allowed to stir for 5 min before being transferred 
to a separatory funnel and diluted with EtOAc (30 mL). The layers were separated and the aqueous 
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layer extracted with EtOAc (3 x 50 mL). The combined organic layers were dried over MgSO4, 
filtered through a fritted glass vacuum filter, and concentrated via rotary evaporation. The crude 
residue was purified via SiO2 flash column chromatography (5% MeOH/45% EtOAc/50% 
hexanes), affording 2.40 g of the title compound as a yellow oil (92%). The enantiomeric ratio was 
determined to be 94:6, following a procedure developed by Gellman and coworkers.120 A pipette 
tip of the title compound was dissolved in CDCl3 (~0.6 mL) in an NMR tube. To this was added a 
drop of (S)-1-methoxypropan-2-amine via pipette. The mixture was shaken vigorously and 
subjected to 1H NMR within 10 min of addition of (S)-1-methoxypropan-2-amine. 
 
Data for 3.52 
1H NMR: (400 MHz, CDCl3) 
9.74 (d, J = 1.2 Hz, 1H), 3.02 (s, 3H), 2.93 (s, 3H), 2.88 (pent, J = 6.8 Hz, 1H), 2.76 
(dd, J1 = 16.4 Hz, J2 = 8 Hz, 1H), 2.63-2.46 (m, 2H), 2.42 (dd, J1 = 16.4 Hz, J2 = 
5.2 Hz, 1H), 2.14 (s, 3H), 2.04-1.92 (m, 1H), 1.80-1.69 (m, 1 H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
207.9, 203.4, 170.5, 46.9, 40.9, 37.4, 35.7, 33.5, 30.1, 22.9 ppm; 
FTIR (neat) 
2928, 1711, 1635, 1498, 1401, 1364, 1263, 1146, 1060, 964, 901, 801, 742, 621, 
589 cm-1; 
HRMS (HRMS ESI) 
 calcd for C10H18O3N (M+H+): 200.1281; found: 200.1271; 
TLC Rf = 0.24 (5% MeoH/60% EtOAc/35% hexanes) 
 Silica gel, visualized with p-anisaldehyde (product stained pink) 
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4R)-4-(3-oxobutyl)-5-(prop-1-yn-1-yl)dihydrofuran-2(3H)-one (3.51). To a 
10-mL 2-necked round bottom flask equipped with stir bar, nitrogen inlet 
adapter, and septum, were sequentially added chlorotriisopropoxytitanium(IV) 
(0.50 mL of a 1 M solution in hexane, 0.50 mmol, 2 equiv) and THF (1.0 mL) 
via syringe. The flask was lowered into an ethanol-filled immersion chilled bath set to –60 °C. 1-
Propynylmagnesium bromide (1.0 mL of a 0.5 M solution in THF, 0.50 mmol, 2 equiv) was added 
dropwise over a period of 5 min via syringe. The solution was reacted for 1 h, during which period 
a precipitate was formed. To this mixture was added (R)-3-formyl-N,N-dimethyl-6-
oxoheptanamide 3.52 (50 mg, 0.25 mmol, 1 equiv) in a single portion at -60 ⁰C. The mixture was 
maintained for 2 h at which point TLC indicated complete consumption of starting material. 1 N 
HCl was added (1 mL) via syringe, and the flask was removed from the ethanol bath and 
immediately transferred to a preheated oil bath set to 50 °C. The mixture was reacted for 16 h at 
which point the flask was removed from the oil bath, allowed to cool to rt, and the contents 
transferred to a separatory funnel. The layers were separated and the aqueous phase extracted with 
EtOAc (3 x 5 mL). The combined organic layers were dried over MgSO4, filtered through a cotton 
plug and concentrated via rotary evaporation. The crude residue was purified via SiO2 flash column 
chromatography (40% EtOAc in hexanes) affording 42 mg of the title compound as a pale-yellow 
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Data for 3.51 
1H NMR: (400 MHz, CDCl3) 
 5.18-5.13 (m, 0.62H, cis-), 4.70-4.66 (m, 0.38H, trans-), 2.75 (dd, J1 = 17.2 Hz, J2 
= 8.0 Hz, 0.47H), 2.65-2.49 (m, 3.75H), 2.35 (dd, J1 = 16.8 Hz, J2 = 10.8 Hz, 
0.77H), 2.26-2.20 (m, 0.45H), 2.19 (s, 3H), 1.97-1.85 (m, 5H), 1.18-1.71 (m, 
0.64H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
207.4, 207.0, 175.6, 175.0, 87.3, 85.2, 75.2, 74.5, 73.1, 72.4, 43.1, 41.0, 40.9, 39.1, 
34,7, 33.6, 30.1, 26.1, 24.4, 3.8 ppm; 
FTIR (neat) 
2924, 2245, 1775, 1711, 1417, 1359, 1290, 1264, 1218, 1159, 1086, 971, 900, 859, 
838, 800, 744, 693, 591, 524 cm-1; 
HRMS (HRMS ESI) 
 calcd for C11H15O3 (M+H+): 195.1015; found: 195.1012; 
TLC Rf = 0.68 (100% EtOAc) 
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was charged with anhydrous CeCl3 (0.36 g, 1.4 mmol, 1.4 equiv) in a nitrogen-filled glovebox. 
The flask was removed from the glovebox and one of the septa replaced with a nitrogen inlet 
adapter. THF (7.4 mL) was added via syringe and the resulting suspension stirred at rt for 16 h. 
The flask was lowered into an ice/water bath (0 °C) and ethynylmagnesium bromide (2.9 mL of a 
0.5 M solution in THF, 1.4 mmol, 1.4 equiv) was added dropwise over a period of 5 min via 
syringe. The resulting brown suspension maintained at 0 °C for 1 h before the flask was removed 
from the ice/water bath and lowered into a dry ice/acetone bath (-78 °C). (4R)-4-(3-Oxobutyl)-5-
(prop-1-yn-1-yl)dihydrofuran-2(3H)-one 3.51 (0.20 g, 1.0 mmol, 1 equiv) was added in a single 
portion via syringe and the reaction maintained for 10 min at which point complete consumption 
of starting material was observed by TLC. Methyl chloroformate (0.16 mL, 2.1 mmol, 2 equiv) 
was added in a single portion via syringe, and the flask was removed from the dry ice/acetone bath 
and allowed to warm to rt, where it was maintained for 1 h. Upon complete consumption of 
intermediate S3.1, as evidenced by TLC, sat. aq. NH4Cl (5 mL) was added via syringe and the 
mixture transferred to a separatory funnel. EtOAc (5 mL) was added, the layers separated, and the 
aqueous phase extracted with EtOAc (3 x 5 mL). The combined organic phases were dried over 
MgSO4, gravity filtered through a cotton plug, and concentrated via rotary evaporation. The crude 
residue was purified via SiO2 flash column chromatography (20% EtOAc/hexanes) affording 0.23 
g of the title compound as a viscous yellow oil (80%). 
 
Data for 3.58 
1H NMR: (400 MHz, CDCl3) 
5.17-5.13 (m, 0.50H), 4.71-4.67 (m, 0.50H), 3.80-3.75 (m, 3.34H), 2.81-2.75 (dd, 
J1 = 14.0 Hz, J2 = 6.8 Hz, 0.55 H), 2.62 (s, 1H), 2.60-2.55 (m, 0.61H), 2.55-2.45 
 154  
(m, 1H), 2.40-2.31 (m, 0.63H), 2.27-2.18 (m, 0.58H), 2.05-1.94 (m, 1.27H), 1.92-
1.84 (m, 5.49H), 1.74 (s, 3H), 1.72-1.61 (m, 1.54H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
175.7, 175.1, 153.6, 87.2, 87.1, 85.2, 82.8, 82.6, 76.44, 76.39, 76.36, 74.7, 74.6, 
74.5, 74.4, 54.7, 54.6, 43.44, 43.40, 39.64, 39.6, 39.4, 39.2, 39.1, 34.64, 34.56, 33.8, 
33.7, 27.4, 27.3, 26.5, 26.4, 3.81, 3.77 ppm; 
FTIR (neat) 
2249, 1779, 1749, 1440, 1375, 1262, 1149 cm-1; 
HRMS (HRMS ESI) 
 calcd for C15H18O5Na (M+Na+): 301.1046; found: 301.1055; 
TLC Rf = 0.55 (30% EtOAc in hexanes) 




(3.59a). A 100-mL two-necked round bottom flask equipped with a stir bar and two septa was 
charged with anhydrous CeCl3 (1.35 g, 5.5 mmol, 1.4 equiv) in a nitrogen-filled glovebox by 
temporary removal of a septum. The flask was removed from the glovebox and one septum was 
replaced with a nitrogen inlet adapter. THF (16 mL) was added via syringe and the white 












 155  
ethynylmagnesium bromide (10.2 mL of a 0.5 M solution in THF, 5.1 mmol, 1.3 equiv) was added 
dropwise over 10 min via syringe. The flask was removed from the ice/water bath and lowered 
into a dry ice/acetone bath (-78 ⁰C), where it was maintained for 1.5 h. (4R)-4-(3-oxobutyl)-5-
(prop-1-yn-1-yl)dihydrofuran-2(3H)-one 3.51 (0.76 g, 3.9 mmol, 1 equiv) was dissolved in THF 
(2 mL) and added dropwise to the reaction mixture via syringe over 2 min. Upon completion of 
addition, the mixture was maintained for 2 h then the flask was removed from the dry ice/acetone 
bath and allowed to warm to rt. After 30 min at this temperature, complete consumption of the 
starting material was evidenced by TLC, and acetic anhydride (0.74 mL, 7.8 mmol, 2 equiv) was 
added in a single portion via syringe at rt. The mixture was allowed to react for 16 h, after which 
time complete consumption of the intermediate S3.1 was evidenced by TLC. The mixture was 
transferred to a separatory funnel, diluted with EtOAc (15 mL) and washed with sat. aq. NH4Cl (2 
x 20 mL). The layers were separated and the combined aqueous phases were extracted with EtOAc 
(2 x 20 mL). The combined organic phases were dried over MgSO4, concentrated via rotary 
evaporation, and the crude residue purified via SiO2 flash column chromatography (20–40% 
EtOAc/hexanes), affording 0.90 g of the title compound as a viscous orange oil (88%). 
 
Data for 3.59a 
1H NMR: (400 MHz, CDCl3) 
5.18–5.13 (m, 0.62H), 4.73–4.68 (m, 0.38H), 2.78 (ddd, J1 = 17.2 Hz, J2 = 8.0 Hz, 
J3 = 1.2 Hz, 0.51H), 2.58 (s, 1.19H), 2.65–2.60 (m, 0.43H), 2.56–2.46 (m, 1.02H), 
2.41–2.33 (m, 0.66H), 2.26–2.18 (m, 0.58H), 2.04 (s, 3.27H), 1.92–1.87 (m, 
3.66H), 1.87–1.73 (m, 3.17H), 1.71–1.68 (m, 2.92H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
 156  
175.7, 175.3, 169.3, 87.1, 85.1, 83.5, 83.3, 83.2, 74.43, 74.40, 74.0, 73.9, 73.3, 73.2, 
58, 43.4, 39.7, 39.3, 39.10, 39.07, 34.62, 34.59, 33.78, 33.72, 28.2, 27.4, 26.6, 26.5, 
25.4, 25.3, 22.0, 15.4, 3.82, 3.80 ppm; 
FTIR (neat) 
13276, 2925, 2245, 1779, 1739, 1441, 1368, 1239, 1153, 1097, 1013, 975, 856, 
672, 611, 535 cm-1; 
HRMS (HRMS ESI) 
 calcd for C15H19O4 (M+H+): 263.1278; found: 263.1305; 
TLC Rf = 0.71 (50% EtOAc) 




chloroacetate (3.59b). A 25-mL two-necked round bottom flask equipped with a stir bar and two 
septa was charged with anhydrous CeCl3 (0.533 g, 2.16 mmol, 1.4 equiv) in a nitrogen-filled 
glovebox by temporary removal of a septum. The flask was removed from the glovebox and one 
septum was replaced with a nitrogen inlet adapter. THF (6.3 mL) was added via syringe and the 
white suspension stirred at rt under N2 for 16 h. The flask was placed in an ice/water bath (0 ⁰C) 
and ethynylmagnesium bromide (4.0 mL of a 0.5 M solution in THF, 2.00 mmol, 1.3 equiv) was 













 157  
allowed to warm to rt. After 2 h, the flask was lowered into a dry ice/acetone bath (-78 ⁰C) and 
(4R)-4-(3-oxobutyl)-5-(prop-1-yn-1-yl)dihydrofuran-2(3H)-one 3.51 (0.300 g, 1.55 mmol, 1 
equiv) was dissolved in THF (2 mL) and added dropwise to the reaction mixture via syringe over 
2 min. Upon completion of addition, the mixture was maintained for 15 min then the flask was 
removed from the dry ice/acetone bath and allowed to warm to rt. After 30 min at this temperature, 
an additional portion of ethynylmagnesium bromide (4.0 mL of a 0.5 M solution in THF, 2.00 
mmol, 1.3 equiv) was added dropwise over 10 min. After 30 min complete consumption of the 
starting material was evidenced by TLC, and chloroacetyl chloride (0.37 mL, 4.64 mmol, 3 equiv) 
was added in a single portion via syringe at rt. The mixture was allowed to react for 1 h, at which 
point the reaction had reached completion based upon consumption of the intermediate S3.1, as 
evidenced by TLC. The mixture was transferred to a separatory funnel, diluted with EtOAc (10 
mL) and washed with sat. aq. NH4Cl (2 x 15 mL). The layers were separated and the combined 
aqueous phases were extracted with EtOAc (2 x 15 mL). The combined organic phases were dried 
over MgSO4, concentrated via rotary evaporation, and the crude residue purified via SiO2 flash 
column chromatography (20% to 40% EtOAc/hexanes), affording 0.390 g of the title compound 
as a viscous yellow oil (85%). 
 
Data for 3.59b 
1H NMR: (400 MHz, CDCl3) 
5.18-5.13 (m, 0.6H), 5.42-4.68 (m, 0.4H), 4.02 (s, 2H), 2.79 (ddd, J1 = 17.2 Hz, J2 
= 8.0 Hz, J3 = 1.2 Hz, 0.4H), 2.63 (s, 1H), 2.61-2.48 (m, 1.5H), 2.41-2.30 (m, 0.6H), 
2.22 (ddd, J1 = 17.2 Hz, J2 = 8.0 Hz, J3 = 3.2 Hz, 0.4H), 2.10-1.95 (m, 1.1H), 1.91-
1.87 (m, 3.6H), 1.87-1.80 (m, 1.7H), 1.76-1.71 (m, 3.2H) ppm; 
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13C NMR:  (100 MHz, CDCl3) 
175.78, 175.76, 175.27, 175.26, 165.43, 165.38, 87.3, 87.2, 85.3, 82.4, 82.2, 82.13, 
82.11, 76.7, 76.6, 75.2, 75.15, 75.13, 75.09, 74.9, 74.58, 74.51, 73.23, 73.18, 72.3, 
43.35, 43.32, 41.4, 40.6, 39.57, 39.55, 39.16, 39.14, 38.99, 38.97, 34.62, 34.57, 
33.73, 33.69, 27.28, 27.26, 26.52, 26.49, 26.4, 25.3, 25.2  ppm; 
FTIR (neat) 
1762, 1310, 1233, 1148, 1035, 972, 864, 792, 672, 529 cm-1; 
HRMS (HRMS ESI) 
calcd for C15H18O4Cl (M+H+): 297.0888; found: 297.0891; 
TLC Rf = 0.71 (50% EtOAc) 
Silica get, p-anisaldehyde 
bar, nitrogen inlet adapter, and septum, was sequentially charged with 
ammonium formate (102 mg, 1.6 mmol, 2 equiv), THF (6.5 mL), and 
Pd2dba3●CHCl3 (21 mg, 0.02 mmol, 0.025 equiv) via temporary removal of the septum. To the red 
reaction mixture was added tri-n-butylphosphine (30 μL, 0.12 mmol, 0.13 equiv) via syringe, at 
which point the mixture turned yellow-green. The reaction mixture was maintained at rt for 10 min 
before methyl ((3R)-3-methyl-5-((3R)-5-oxo-2-(prop-1-yn-1-yl)tetrahydrofuran-3-yl)pent-1-yn-
3-yl) carbonate 3.58 (225 mg, 0.81 mmol, 1 equiv) was dissolved in 0.5 mL THF and added in a 
single portion via syringe. The reaction was maintained at rt for 18 h, at which point complete 
consumption of starting material was observed by TLC. The mixture was filtered through a pad of 
                          (4R)-4-(3-methylpenta-3,4-dien-1-yl)-5-(prop-1-yn-1-yl)dihydrofuran-
• 2(3H)-one (3.57a). A 25-mL 2-necked round bottom flask equipped with stir 
O
O
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celite in a medium porosity fritted glass vacuum filter. The celite pad was rinsed with Et2O (2 x 
20 mL). The combined filtrates were concentrated via rotary evaporation, and the crude residue 
purified via SiO2 flash column chromatography (10% to 20% Et2O in hexanes gradient), affording 
120 mg of the title compound as a pale-yellow oil (73%). 
 
Data for 3.57a 
1H NMR: (400 MHz, CDCl3) 
5.16-5.11 (m, 0.38H), 4.70-4.59 (m, 2.62H), 2.75 (dd, J1 = 17.2 Hz, J2 = 8.4 Hz, 
0.69H), 2.66-2.58 (m, 0.43H), 2.56-2.47 (m, 1.07H), 2.34 (dd, J1 = 16.8 Hz, J2 = 
11.2 Hz, 0.45H), 2.20 (dd, J1 = 17.2 Hz, J2 = 8.4 Hz, 0.57H), 2.03-1.93 (m, 2.22H), 
1.90-1.87 (m, 3.18H), 1.86-1.72 (m, 1.54H), 1.72-1.67 (m, 3.26H), 1.57-1.48 (m, 
1.17H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
206.2, 206.1, 176.1, 175.5, 97.5, 97.4, 86.9, 84.9, 75.4, 75.2, 74.8, 74.7, 73.4, 72.8, 
43.3, 39.3, 34.7, 33.6, 31.3, 31.1, 30.2, 28.1, 18.9, 18.7, 3.8, 3.7 ppm; 
FTIR (neat) 
2246, 1959, 1778, 1442, 1149, 977, 847 cm-1; 
HRMS (HRMS ESI) 
 calcd for C13H17O2 (M+H+): 205.1223; found: 205.1219; 
TLC Rf = 0.46 (20% EtOAc in hexanes) 




yl)penta-1,2-dien-1-yl acetate (3.60a). A 50-mL 2-necked round bottom 
flask equipped with stir bar, reflux condenser topped with septum, and 
septum was added rhodium(II) trifluoroacetate dimer (0.107 g, 0.16 mmol, 
0.05 equiv) in a nitrogen-filled glovebox via temporary removal of the septum. The flask was 
removed from the glovebox and the septum on top of the condenser replaced with a nitrogen inlet 
adapter. Freshly distilled toluene (13 mL) was added via syringe, followed by (3R)-3-methyl-5-
((3R)-5-oxo-2-(prop-1-yn-1-yl)tetrahydrofuran-3-yl)pent-1-yn-3-yl acetate 3.59a (0.850 g, 3.2 
mmol, 1 equiv), which was dissolved in toluene (3.2 mL), in a single portion via syringe. The flask 
was lowered into a preheated oil bath (50 ⁰C), and the mixture maintained for 3 h. Upon complete 
consumption of starting material, as evidenced by TLC, the flask was removed from the oil bath 
and allowed to cool to rt. SilametS Thiourea (1.08 g, 1.07 mmol/g, 7.2 equiv with respect to 
rhodium(II) trifluoroacetate dimer) was added via temporary removal of the septum, and the 
mixture maintained for 16 h. The mixture was filtered through a pad of celite in a medium porosity 
fritted glass vacuum filter. The celite pad was rinsed with EtOAc (2 x 10 mL). The combined 
filtrates were concentrated via rotary evaporation, and the crude residue purified via SiO2 flash 
column chromatography (10–30% EtOAc/Hexanes), affording 0.742 g of the title compound as a 







Data for 3.60a 
1H NMR: (400 MHz, CDCl3) 
 7.36–7.30 (m, 1H), 5.17–5.10 (m, 0.63H), 4.70–4.65 (m, 0.37H), 2.79–2.70 (m, 
0.46H), 2.65–2.57 (m, 0.90H), 2.56–2.46 (m, 1H), 2.39–2.29 (m, 0.83H), 2.16–2.08 
(m, 3.42H), 1.90–1.87 (m, 2.75H), 1.86–1.83 (m, 3H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
189.8, 189.7, 175.9, 175.3, 174.1, 168.8, 123.8, 114.8, 113.9, 110.6, 110.4, 110.3, 
107.7, 100.1, 87.0, 75.2, 74.6, 73.3, 72.6, 66.0, 64.9, 43.1, 39.3, 39.2, 34.6, 33.6, 
33.6, 32.9, 32.7, 32.6, 30.0, 29.9, 28.0, 21.1, 21.0, 20.6, 15.4, 3.8 ppm; 
FTIR (neat) 
1777, 1744, 1369, 1212, 1154, 1040, 970, 794, 599, 548 cm-1; 
HRMS (HRMS ESI) 
calcd for C15H19O4 (M+H+): 263.1278; found: 263.1279; 
TLC Rf = 0.42 (30% EtOAc in hexanes) 
Silica get, visualized with p-anisaldehyde 
3-methyl-5-((3R)-5-oxo-2-(prop-1-yn-1-yl)tetrahydrofuran-3-
yl)penta-1,2-dien-1-yl 2-chloroacetate (3.60b). A 15-mL 2-necked 
round bottom flask equipped with stir bar, reflux condenser topped 
with nitrogen septum, and septum was added rhodium(II) 
trifluoroacetate dimer (0.039 g, 0.06 mmol, 0.05 equiv) in a nitrogen-filled glovebox via temporary 
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condenser replaced with a nitrogen inlet adapter. Freshly distilled toluene (5.9 mL) was added via 
syringe, followed by (3R)-3-methyl-5-((3R)-5-oxo-2-(prop-1-yn-1-yl)tetrahydrofuran-3-yl)pent-
1-yn-3-yl 2-chloroacetate 3.59b (0.350 g, 1.18 mmol, 1 equiv), which was dissolved in toluene (2 
mL), in a single portion via syringe. The flask was lowered into a preheated oil bath (50 ⁰C), and 
the mixture maintained for 8 h. Upon complete consumption of starting material, as evidenced by 
TLC, the flask was removed from the oil bath and allowed to cool to rt. SilametS Thiourea (0.393 
g, 1.07 mmol/g, 7 equiv with respect to rhodium(II) trifluoroacetate dimer) was added via 
temporary removal of the septum, and the mixture maintained for 11 h. The mixture was filtered 
through a pad of celite in a medium porosity fritted glass vacuum filter. The celite pad was rinsed 
with EtOAc (2 x 10 mL). The combined filtrates were concentrated via rotary evaporation, and the 
crude residue purified via SiO2 flash column chromatography (15%-20% EtOAc/Hexanes), 
affording 0.303 g of the title compound as a pale yellow oil (87%). 
 
Data for 3.60b 
1H NMR: (400 MHz, CDCl3) 
 7.35-7.29 (m, 1H), 5.16-5.10 (m, 0.65H), 4.69-4.65 (m, 0.36H), 4.15-4.12 (m, 
2.06H), 2.79-2.70 (m, 0.35H), 2.64-2.47 (m, 1.63H), 2.39-2.29 (m, 0.72H), 2.24-
2.10 (m, 2.41H), 1.90-1.85 (m, 6.42H), 1.84-1.71 (m, 2.11H) ppm; 
TLC Rf = 0.43 (30% EtOAc in hexanes) 
 Silica get, visualized with p-anisaldehyde 
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(3aR)-6,9-dimethyl-3a,5,7,9b-tetrahydroazuleno[4,5-b]furan-2,8(3H,4H)-
dione (3.61). A 15-mL 2-necked round bottom flask equipped with stir bar, 
reflux condenser topped with septum, and septum was sequentially added 
bis(1,5,-cyclooctadiene)rhodium(I) tetrafluoroborate (5.0 mg, 0.013 mmol, 
0.025 equiv) and PPh3 (5.0 mg, 0.019 mmol, 0.038 equiv) in a nitrogen-filled glovebox via 
temporary removal of the septum. The flask was removed from the glove box and a nitrogen inlet 
needle was inserted into the septum on the condenser. 1,2-Dichloroethane (5 mL) was added via 
syringe. The resulting dark yellow solution was maintained at rt for 10 min at which time the flask 
was evacuated and refilled five times with CO gas (100%), alternating between an inlet needle 
attached to a vacuum and an inlet needle attached to a balloon of CO. The light-yellow solution 
was maintained for 10 min before (4R)-4-(3-methylpenta-3,4-dien-1-yl)-5-(prop-1-yn-1-
yl)dihydrofuran-2(3H)-one 3.57a (0.10 g, 0.51 mmol. 1 equiv) was added in a single portion via 
syringe, using 0.5 mL 1,2-dichloroethane to rinse the syringe. The flask was lowered into a 
preheated oil bath (70 °C), and the reaction maintained for 18 h. Very little starting material had 
been consumed at this point, as evidenced by TLC. Bis-(1,5-cyclooctadiene)rhodium(I) 
tetrafluoroborate (12 mg, 0.06 equiv) and PPh3 (12 mg, 0.09 equiv) were added to a flame-dried 
scintillation vial in a nitrogen-filled glove box. The vial was sealed with a septum, removed from 
the glovebox and 1,2-dichloroethane (0.1 mL) added via syringe. The resulting solution was 
transferred to the reaction flask via syringe. The reaction was maintained at 70 °C for an additional 
24 h at which point complete consumption of starting material was observed by TLC. The flask 
was removed from the oil bath and allowed to cool to rt. The contents were transferred to a 50-mL 
recovery flask, using CH2Cl2 to rinse the flask forward. Concentration via rotary evaporation (40 
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chromatography (40% EtOAc/hexanes) afforded 67 mg of the title compound as an off-white solid 
(57%). Cis-3.61 and trans-3.61 isomers were separable at this stage. 8 mg of cis-3.61 and 8 mg of 
trans-3.61 were isolated, along with 51 mg of combined cis-3.61 and trans-3.61. 
 
Data for trans-3.61 
1H NMR: (400 MHz, CDCl3) 
5.32 (d, J = 10.8 Hz, 1H), 2.97 (s, 2H), 2.77 (dd, J1 = 16.8 Hz, J2 = 8 Hz, 1H), 2.66-
2.54 (m, 2H), 2.39 (dd, J1 = 16.8 Hz, J2 = 12.4 Hz, 1H), 2.29-2.19 (m, 2H), 2.03 (s, 
3H), 1.88 (s, 3H), 1.78-1.71 (m, 1H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
204.4, 175.1, 161.0, 139.2, 132.9, 129.8, 82.3, 40.4, 40.3, 36.5, 32.6, 28.0, 24.6, 9.9 
ppm; 
FTIR (neat) 
2249, 1779, 1749, 1440, 1375, 1262, 1149 cm-1; 
HRMS (HRMS ESI) 
 calcd for C14H17O3 (M+H+): 233.1172; found: 233.1174; 
TLC Rf = 0.30 (40%EtOAc in hexanes) 
 Silica gel, visualized with KMnO4 
 
Data for cis-3.61 
1H NMR: (400 MHz, CDCl3) 
5.59 (d, J = 5.6 Hz, 1H), 3.07-2.98 (m, 2H), 2.98-2.88 (m, 2H), 2.50-2.24 (m, 4H), 
1.92 (s, 3H), 1.90-1.87 (m, 1H), 1.85 (s, 3H) ppm; 
165 
13C NMR:  (100 MHz, CDCl3) 
204.4, 176.2, 157.7, 143.4, 137.1, 128.8, 79.7, 41.2, 38.4, 36.3, 32.8, 31.2, 24.1, 9.0 
ppm; 
(3aR)-6,9-dimethyl-2,8-dioxo-2,3,3a,4,5,7,8,9b-octahydroazuleno[4,5-
b]furan-7-yl acetate (3.62a). To a 500-mL 2-necked round bottom flask
equipped with stir bar, reflux condenser topped with septum, and septum 
was sequentially added bis-(1,5-cyclooctadiene)rhodium(I)
tetrafluoroborate (20 mg, 0.049 mmol, 0.025 equiv) and PPh3 (20 mg, 0.076 mmol, 0.038 equiv) 
in a nitrogen-filled glovebox via temporary removal of the septum. The flask was removed from 
the glovebox, a nitrogen inlet needle was inserted into the septum on the condenser, and 1,2-
dichloroethane (200 mL) added via syringe. The resulting dark yellow solution was maintained at 
rt for 10 min at which time the flask was evacuated and refilled five times with CO gas (100%), 
alternating between an inlet needle attached to a vacuum and an inlet needle attached to a balloon 
of CO. The light-yellow solution was maintained for 10 min before 3-methyl-5-((3R)-5-oxo-2-
(prop-1-yn-1-yl)tetrahydrofuran-3-yl)penta-1,2-dien-1-yl acetate 3.60a (0.525 g, 2.00 mmol. 1 
equiv) dissolved in 1,2-dichloroethane (5 mL), was added in a single portion via syringe. The flask 
was lowered into a preheated oil bath set to 70 °C, and the mixture reacted for 19 h, at which point 
an addition portion of bis-(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate (20 mg, 0.049 mmol, 
0.025 equiv) and PPh3 (20 mg, 0.076 mmol, 0.038 equiv) were added via temporary removal of 
the septum. The reaction was maintained for 24 h at which point the starting material had been 
consumed, as evidenced by TLC. The flask was removed from the oil bath and allowed to cool to 
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°C bath temperature). The crude residue was purified via SiO2 flash column chromatography (40–
60% EtOAc/hexanes), affording 0.405 g of the title compound as a stick, off-white solid (70%). A 
small amount of the cis and trans lactone isomers were semi-separable at this stage, affording 
0.010 g trans-3.62a, 0.010 g cis-3.62a. 
 
Data for 3.62a 
1H NMR: (400 MHz, CDCl3) 
5.65–5.61 (m, 1H), 5.58 (s, 0.59H), 5.56–5.54 (m, 0.39H), 5.44 (s, 0.71H), 5.39 (d, 
J = 10.8 Hz, 0.67H), 5.32 (d, J = 10.8 Hz, 0.33H), 3.04–2.92 (m, 2.11H), 2.83–2.73 
(m, 1.24H), 2.72–2.54 (m, 2.38H), 2.49–2.35 (m, 3.52H), 2.34–2.15 (m, 4.11H), 
2.51–2.10 (m, 5.93H), 2.06–2.03 (m, 3.03H), 2.03–1.95 (m, 1.83H), 1.95–1.92 (m, 
2.71H), 1.89–1.87 (m, 2.86H), 1.85–1.82 (m, 3.30H), 1.81–1.71 (m, 2.35H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
200.4, 200.1, 176.4, 174.8, 169.7, 169.5, 161.5, 161.1, 156.9, 140.0, 139.3, 137.6, 
136.6, 135.9, 135.6, 130.7, 129.5, 128.8, 82.0, 81.5, 81.0, 18.5, 73.7, 72.0, 71.2, 
39.9, 39.8, 37.0, 36.4, 36.2, 35.7, 34.3, 33.0, 32.5, 31.7, 31.6, 29.8, 28.3, 27.9, 24.2, 
23.6, 23.3, 23.1, 20.8, 20.6, 20.5, 15.4, 10.1, 9.8, 9.5, 8.8 ppm; 
FTIR (neat) 
2927, 1781, 1743, 1703, 1217, 1160, 1039, 732 cm-1; 
HRMS (HRMS ESI) 
 calcd for C16H19O5 (M+H+): 291.1227; found: 291.1246; 
TLC Rf = 0.29 (50% EtOAc/hexanes) 
 Silica gel, visualized with KMnO4 
167 
1H NMR trans-3.62a 
1H NMR: (400 MHz, CDCl3) 
5.58 (s, 0.59H), 5.56 (s, 0.30H), 5.40 (d, J = 12.0 Hz 0.65H), 5.32 (d, J = 8.0 Hz), 
2.84–2.74 (m, 1.14H), 2.72–2.53 (m, 2.58H), 2.45–2.32 (m, 1.52H), 2.32–2.15 (m, 
3.37H), 2.15–2.11 (m, 2.77H), 2.07–2.03 (m, 2.64H), 1.90–1.87 (m, 2.93H), 1.80–
1.69 (m, 1.58H) ppm; 
1H NMR for cis-3.62a 
1H NMR: (400 MHz, CDCl3) 
5.63 (d, J = 6.0 Hz, 1H), 5.44 (s, 0.90H), 3.04–2.94 (m, 2.68H), 2.46–2.36 (m, 
2.82H), 2.29–2.17 (m, 2.68H), 2.16–2.10 (m, 3.73H), 2.07–1.95 (m, 3.22H), 1.95–
1.90 (m, 3.92H), 1.90–1.82 (m, 4.44H), 1.81–1.73 (m, 2.22H) ppm; 
octahydroazuleno[4,5-b]furan-7-yl 2-chloroacetate (3.62b). To a 50-
mL 2-necked round bottom flask equipped with stir bar, reflux condenser 
topped with septum, and septum was sequentially added bis-(1,5-
cyclooctadiene)rhodium(I) tetrafluoroborate (5.0 mg, 0.013 mmol, 0.025 equiv) and PPh3 (5.0 mg, 
0.019 mmol, 0.038 equiv) in a nitrogen-filled glovebox via temporary removal of the septum. The 
flask was removed from the glovebox, a nitrogen inlet needle was inserted into the septum on the 
condenser, and 1,2-dichloroethane (21 mL) added via syringe. The resulting dark yellow solution 
was maintained at rt for 10 min at which time the flask was evacuated and refilled five times with 
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attached to a balloon of CO. The light-yellow solution was maintained for 10 min before 3-methyl-
5-((3R)-5-oxo-2-(prop-1-yn-1-yl)tetrahydrofuran-3-yl)penta-1,2-dien-1-yl 2-chloroacetate 3.60b 
(0.185 g, 0.62 mmol. 1 equiv) dissolved in 1 mL 1,2-dichloroethane, was added in a single portion 
via syringe. The flask was lowered into a preheated oil bath set to 70 °C, and the mixture reacted 
for 28 h, at which point the starting material had been consumed, as evidenced by TLC. The flask 
was removed from the oil bath and allowed to cool to rt. The contents were transferred to a recovery 
flask and concentrated via rotary evaporation (40 °C bath temperature). The crude residue was 
purified via SiO2 flash column chromatography (20% to 50% EtOAc/hexanes), affording 0.121 g 
of the title compound as a yellow solid (60%). The cis and trans lactone isomers were semi-
separable at this stage, affording 0.026 g trans-3.62b, 0.036 g cis-3.62b, and 0.059 g 3.62b as a 
mixture. 
 
Data for trans-3.62b 
1H NMR: (400 MHz, CDCl3) 
5.64 (s, 0.75H), 5.58 (s, 0.25H), 5.40 (d, J = 10.8 Hz, 0.75H), 5.32 (d, J = 10.8 Hz, 
0.25H), 4.15-4.08 (m, 2H), 2.83-2.75 (m, 1H) 2.71-2.53 (m, 2.28H), 2.43-2.35 (m, 
1.26H, 2.32-2.16 (m, 3.04H), 2.07-2.03 (m, 2.90H), 1.94-1.85 (m, 4.18H), 1.82-
1.72 (m, 1.35H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
199.6, 199.1, 174.7, 174.6, 166.33, 161.8, 161.5, 138.6, 136.9, 136.6, 135.7, 129.9, 
128.7, 127.7, 81.9, 81.4, 73.3, 73.0, 72.7, 40.6, 40.5, 39.8, 39.4, 38.2, 36.4, 36.2, 




2924, 1768, 1704, 1157, 1008, 954, 784, 478 cm-1; 
HRMS (HRMS ESI) 
calcd for C16H18O5Cl (M+H+): 325.0837; found: 325.0837; 
TLC Rf = 0.29 (50% EtOAc/hexanes) 
Silica gel, visualized with KMnO4 
Data for cis-3.62b 
1H NMR: (400 MHz, CDCl3) 
5.69 (s, 0.29H), 5.63 (d, J = , 0.72H), 5.54 (d, J = , ), 5.56-5.50 (m, 1H), 4.15-4.10 
(m, 2H), 3.04-2.95 (m, 1.77H), 2.82-2.74 (0.67H) 2.47-2.37 (m, 2.22H), 2.31-2.21 
(m, 1.54H), 2.08-1.99 (m, 1.38H), 1.98 (s, 1H), 1.95 (s, 2H), 1.88-1.84 (m, 3H), 
1.82-1.75 (m, 1.30H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
199.4, 199.0, 176.3, 175.6, 166.3, 166.0, 158.6, 157.4, 141.2, 141.0, 139.4, 138.8, 
128.6, 128.0, 80.9, 78.4, 74.9, 74.1, 40.7, 40.6, 40.5, 40.4, 37.0, 35.7, 35.6, 34.3, 
31.7, 31.5, 29.8, 23.6, 23.4, 9.5, 8.8 ppm; 
yl)acetic acid (3.67). A 0.5–2-mL microwave vial (Biotage 3532016) 
equipped with stir bar (Biotage 355544) was charged with (3aR)-6,9-
dimethyl-2,8-dioxo-2,3,3a,4,5,7,8,9b-octahydroazuleno[4,5-b]furan-7-yl 2-
chloroacetate 3.62b (10 mg, 0.031 mmol, 1 equiv). The vial was sealed with a crimp-on microwave 
O
OH                     (R)-2-(2-hydroxy-3,8-dimethyl-1-oxo-1,5,6,7-tetrahydroazulen-5-
OH
O
 170  
vial cap with septum (Biotage 352298) and flushed with nitrogen via an inlet needle. THF (1 mL) 
was added via syringe, and the vial was lowered into an ice/water (0 ⁰C) bath. Potassium tert-
butoxide (0.18 mL of a 0.5 M solution it tert-butanol, 0.09 mmol, 3 equiv) was added dropwise 
over 1 min, during which period the solution turned dark orange as a precipitate formed. The 
mixture was maintained for 10 min, at which point complete consumption of the starting material 
was evidenced by TLC. Sat. NH4Cl (1 mL) was added, and the mixture transferred to a separatory 
funnel. The layers were separated and the organic layer dried over MgSO4 and concentrated via 
rotary evaporation, affording 7 mg of a red residue. 1H NMR and 13C NMR of this residue was 
used for characterization. The NMR was contaminated with tert-butanol and a product of the 
chloroacetate deprotection. 
 
Data for 3.67 (crude) 
1H NMR: (400 MHz, CDCl3) 
5.75 (d, 4.0 Hz, 1H), 3.08–2.99 (m, 1H), 2.61–2.56 (m, 2H), 2.54 (d, J = 6.8 Hz, 
1H), 2.48 (d, J = 8.0 Hz, 1H), 2.42 (s, 3H), 2.00 (s, 3H), 1.98–1.94 (m, 1H), 1.92–
1.87 (m, 1H), 1.87–1.78 (m, 2H) ppm; 
13C NMR:  (100 MHz, CDCl3) 
189.4, 177.4, 171.6, 155.4, 151.6, 134.3, 125.7, 125.0, 40.3, 37.9, 37.0, 30.6, 22.0, 
8.5 ppm; 
FTIR (neat) 
2922, 1701, 1644, 1600, 1414, 1153, 1054, 907, 787, 590, 471 cm-1; 
HRMS (HRMS ESI) 
 calcd for C14H17O4 (M+H+): 249.1121; found: 249.1123; 
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TLC Rf = 0.23 (60% EtOAc in hexanes) 
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